<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Biomolecules</journal-id><journal-id journal-id-type="iso-abbrev">Biomolecules</journal-id><journal-id journal-id-type="publisher-id">biomolecules</journal-id><journal-title-group><journal-title>Biomolecules</journal-title></journal-title-group><issn pub-type="epub">2218-273X</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7823413</article-id><article-id pub-id-type="pmid">33374457</article-id><article-id pub-id-type="doi">10.3390/biom11010011</article-id><article-id pub-id-type="publisher-id">biomolecules-11-00011</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Antiviral Role of Phenolic Compounds against Dengue Virus: A Review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Loaiza-Cano</surname><given-names>Vanessa</given-names></name><xref ref-type="aff" rid="af1-biomolecules-11-00011">1</xref></contrib><contrib contrib-type="author"><name><surname>Monsalve-Escudero</surname><given-names>Laura Milena</given-names></name><xref ref-type="aff" rid="af1-biomolecules-11-00011">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0628-5783</contrib-id><name><surname>Filho</surname><given-names>Carlos da Silva Maia Bezerra</given-names></name><xref ref-type="aff" rid="af2-biomolecules-11-00011">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7180-4896</contrib-id><name><surname>Martinez-Gutierrez</surname><given-names>Marlen</given-names></name><xref ref-type="aff" rid="af1-biomolecules-11-00011">1</xref><xref rid="c1-biomolecules-11-00011" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9429-0058</contrib-id><name><surname>de Sousa</surname><given-names>Dami&#x000e3;o Pergentino</given-names></name><xref ref-type="aff" rid="af2-biomolecules-11-00011">2</xref><xref rid="c1-biomolecules-11-00011" ref-type="corresp">*</xref></contrib></contrib-group><aff id="af1-biomolecules-11-00011"><label>1</label>Grupo de Investigacion en Ciencias Animales-GRICA, Universidad Cooperativa de Colombia, 680003 Bucaramanga, Colombia; <email>vaneloaiza@gmail.com</email> (V.L.-C.); <email>lauramilemo@hotmail.com</email> (L.M.M.-E.)</aff><aff id="af2-biomolecules-11-00011"><label>2</label>Department of Pharmaceutical Sciences, Federal University of Para&#x000ed;ba, CEP 58051-970 Jo&#x000e3;o Pessoa, PB, Brazil; <email>carlosmaia1996@gmail.com</email></aff><author-notes><corresp id="c1-biomolecules-11-00011"><label>*</label>Correspondence: <email>marlen.martinezg@campusucc.edu.co</email> (M.M.-G.); <email>damiao_desousa@yahoo.com.br</email> (D.P.d.S.); Tel.: +57-310-543-8583 (M.M.-G.); +55-833-216-7347 (D.P.d.S.)</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><volume>11</volume><issue>1</issue><elocation-id>11</elocation-id><history><date date-type="received"><day>17</day><month>11</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Phenolic compounds have been related to multiple biological activities, and the antiviral effect of these compounds has been demonstrated in several viral models of public health concern. In this review, we show the antiviral role of phenolic compounds against dengue virus (DENV), the most widespread arbovirus globally that, after its re-emergence, has caused multiple epidemic outbreaks, especially in the last two years. Twenty phenolic compounds with anti-DENV activity are discussed, including the multiple mechanisms of action, such as those directed against viral particles or viral proteins, host proteins or pathways related to the productive replication viral cycle and the spread of the infection.</p></abstract><kwd-group><kwd>natural products</kwd><kwd>flavonoids</kwd><kwd>tannins</kwd><kwd>phenol</kwd><kwd>medicinal plants</kwd><kwd>mosquitoes</kwd><kwd>dengue virus</kwd><kwd>viruses</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-biomolecules-11-00011"><title>1. Introduction</title><p>Dengue virus (DENV) is an arbovirus that belongs to the family Flaviviridae, which includes Zika virus, yellow fever, Japanese encephalitis and West Nile viruses. Regarding genetic and structural characteristics, DENV is enveloped and has a spherical shape, with a positively sensed and single-stranded RNA that encodes structural proteins (capsid, membrane and envelope precursor) as well as nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5). In addition, DENV has four genetically distinct serotypes (DENV-1, DENV-2, DENV-3 and DENV-4) [<xref rid="B1-biomolecules-11-00011" ref-type="bibr">1</xref>].</p><p>DENV infection is highly prevalent in tropical and subtropical areas. It is estimated that more than 50 million infections occur worldwide each year, and there are more than 2.5 billion people at risk of acquiring the infection [<xref rid="B2-biomolecules-11-00011" ref-type="bibr">2</xref>]. All DENV serotypes can cause symptomatic infections, ranging from mild flu-like syndrome to more severe symptoms, such as coagulopathies and increased vascular permeability that can culminate in dengue hemorrhagic fever and hypovolemic shock [<xref rid="B3-biomolecules-11-00011" ref-type="bibr">3</xref>]. DENV infection progresses to a severe form in only 1% of cases; however, the mortality in these cases is greater than 20% [<xref rid="B4-biomolecules-11-00011" ref-type="bibr">4</xref>]. Thus, the search for molecules that have biological activity against DENV has become relevant.</p><p>Phenolic compounds are secondary metabolites produced mainly by plants. These compounds are chemically characterized by having one or more aromatic rings attached to at least one hydroxyl substituent, and it is estimated that more than 8000 different phenolic compounds have already been identified [<xref rid="B5-biomolecules-11-00011" ref-type="bibr">5</xref>]. Phenolic compounds are ubiquitous in nature and have already been isolated from several plant families, including Sapindaceae [<xref rid="B6-biomolecules-11-00011" ref-type="bibr">6</xref>], Vitaceae [<xref rid="B7-biomolecules-11-00011" ref-type="bibr">7</xref>], Zygophyllaceae [<xref rid="B8-biomolecules-11-00011" ref-type="bibr">8</xref>], Rubiaceae [<xref rid="B9-biomolecules-11-00011" ref-type="bibr">9</xref>], Crassulaceae [<xref rid="B10-biomolecules-11-00011" ref-type="bibr">10</xref>], Punicaceae [<xref rid="B11-biomolecules-11-00011" ref-type="bibr">11</xref>], and Fabaceae [<xref rid="B12-biomolecules-11-00011" ref-type="bibr">12</xref>]. They have strong antioxidant activity due to the presence of phenolic hydroxyls that give them the ability to neutralize several free radicals through the donation of hydrogen atoms, generating more stable and less toxic molecules [<xref rid="B13-biomolecules-11-00011" ref-type="bibr">13</xref>,<xref rid="B14-biomolecules-11-00011" ref-type="bibr">14</xref>,<xref rid="B15-biomolecules-11-00011" ref-type="bibr">15</xref>]. In addition, studies indicate that these compounds have anticancer [<xref rid="B16-biomolecules-11-00011" ref-type="bibr">16</xref>], anti-inflammatory [<xref rid="B17-biomolecules-11-00011" ref-type="bibr">17</xref>], antibacterial [<xref rid="B18-biomolecules-11-00011" ref-type="bibr">18</xref>], antifungal [<xref rid="B19-biomolecules-11-00011" ref-type="bibr">19</xref>] and antiviral [<xref rid="B20-biomolecules-11-00011" ref-type="bibr">20</xref>] properties.</p><p>Among the phenolic compounds that have antiviral activity are epigallocatechin gallate, which inhibits hepatitis B virus, influenza A and chikungunya virus [<xref rid="B21-biomolecules-11-00011" ref-type="bibr">21</xref>,<xref rid="B22-biomolecules-11-00011" ref-type="bibr">22</xref>,<xref rid="B23-biomolecules-11-00011" ref-type="bibr">23</xref>]; curcumin, which is bioactive against hepatitis C virus and human immunodeficiency virus [<xref rid="B24-biomolecules-11-00011" ref-type="bibr">24</xref>,<xref rid="B25-biomolecules-11-00011" ref-type="bibr">25</xref>]; resveratrol, which protects against Middle East respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus 2 [<xref rid="B26-biomolecules-11-00011" ref-type="bibr">26</xref>,<xref rid="B27-biomolecules-11-00011" ref-type="bibr">27</xref>]; nordihydroguaiaretic acid, which protects against Zika virus and West Nile virus [<xref rid="B28-biomolecules-11-00011" ref-type="bibr">28</xref>]; and punicalagin, which inhibits herpes simplex virus [<xref rid="B29-biomolecules-11-00011" ref-type="bibr">29</xref>].</p><p>For years, a wide variety of natural products have been the source for drug discovery due to their various structural characteristics. In this sense, compounds that have at least one phenolic group in their molecular structure represent great diversity, and most of them, including flavonoids, tannins, lignans and phenolic acids, are responsible for the antioxidant properties of many plants [<xref rid="B20-biomolecules-11-00011" ref-type="bibr">20</xref>]. Oxidative stress induced by viruses is well established. This disorder interferes with the body&#x02032;s important metabolic processes in addition to participating in the replication of the virus [<xref rid="B30-biomolecules-11-00011" ref-type="bibr">30</xref>]. Therefore, antioxidant phenolic compounds can be interesting pharmacological tools against several types of viruses. Thus, in the present review, 20 phenolic compounds were selected, and their actions against dengue virus and mechanisms of action are discussed. <xref ref-type="fig" rid="biomolecules-11-00011-f001">Figure 1</xref> illustrates the heteroside phenolic compounds discussed in this study; <xref ref-type="fig" rid="biomolecules-11-00011-f002">Figure 2</xref> shows the flavonoids, phenylpropanoids and derivatives, while <xref ref-type="fig" rid="biomolecules-11-00011-f003">Figure 3</xref> contains other types of phenolic compounds.</p></sec><sec id="sec2-biomolecules-11-00011"><title>2. Geraniin</title><p>Geraniin, an ellagitannin compound, has been obtained from different plants in multiple places principally in Asia, such as <italic>Geranuim thunbergii</italic> Siebold ex Lindl. &#x00026; Paxton (Geraniaceae) from Japan [<xref rid="B31-biomolecules-11-00011" ref-type="bibr">31</xref>] and <italic>Nephelium lappaceum</italic> L. (Sapindaceae) [<xref rid="B32-biomolecules-11-00011" ref-type="bibr">32</xref>] from Malaysia; it is the main polyphenolic component in both species and is also found in <italic>Dimocarpus longan</italic> Lour. and <italic>Euphoria longan</italic> (Lour.) Steud. from Thailand [<xref rid="B33-biomolecules-11-00011" ref-type="bibr">33</xref>] and in <italic>Phyllanthus myrtifolius</italic> (Wight) Mull. Arg. and <italic>P. urinaria</italic> L. (Euphorbiaceae) from Taiwan [<xref rid="B34-biomolecules-11-00011" ref-type="bibr">34</xref>], among others [<xref rid="B33-biomolecules-11-00011" ref-type="bibr">33</xref>,<xref rid="B35-biomolecules-11-00011" ref-type="bibr">35</xref>].</p><p>This compound has been related to multiple biological effects, such as immunomodulation induced by NF-<italic>&#x003ba;</italic>B activation and downregulation of Mcl-1 expression to suppress ovarian cancer growth [<xref rid="B36-biomolecules-11-00011" ref-type="bibr">36</xref>], anti-apoptosis effects caused by radiation damage and enhanced antioxidant enzymes in Chinese hamster lung fibroblasts (V79-4), a Hps90 ATPase inhibitor [<xref rid="B37-biomolecules-11-00011" ref-type="bibr">37</xref>] and anti-<italic>Plasmodium falciparum</italic> in vitro (IC<sub>50</sub>: 11.74 &#x000b5;M) [<xref rid="B36-biomolecules-11-00011" ref-type="bibr">36</xref>]. Antiviral in vitro effects of geraniin have also been reported against enterovirus 71 (EV71) (IC<sub>50</sub>: 10 &#x003bc;g/mL) [<xref rid="B38-biomolecules-11-00011" ref-type="bibr">38</xref>], herpes simplex virus type 2 (HSV-2) (IC<sub>50</sub>: 18.4 &#x000b1; 2.0 &#x000b5;M) [<xref rid="B39-biomolecules-11-00011" ref-type="bibr">39</xref>], human immunodeficiency virus (HIV) (IC<sub>50</sub>: 0.48&#x02013;6.28 &#x003bc;g/mL by multiple mechanisms of action) [<xref rid="B40-biomolecules-11-00011" ref-type="bibr">40</xref>], hepatitis B (HBV) (200 &#x003bc;g/mL, inhibition of HBsAg and HBeAg secretion, 85.8 &#x000b1; 7.3% and 63.7 &#x000b1; 6.8, respectively) [<xref rid="B41-biomolecules-11-00011" ref-type="bibr">41</xref>], Epstein&#x02013;Barr virus (EBV) (IC<sub>50</sub>: 15.7 &#x000b5;M, inhibition of DNA polymerase) [<xref rid="B42-biomolecules-11-00011" ref-type="bibr">42</xref>], and hepatitis C virus (HCV) (IC<sub>50</sub>: 8.91 &#x000b5;M, inhibition of NS3-4A protease) [<xref rid="B43-biomolecules-11-00011" ref-type="bibr">43</xref>].</p><sec><title>Anti-DENV Effect of Geraniin</title><p>Due to its antiviral properties, its effect on DENV-2 infection has been studied. The antiviral effect was evaluated using a cocktail compound of four aqueous extracts of different species of local Malaysian medicinal plants (<italic>Phyllanthus</italic> spp.: <italic>P. amarus</italic> Schum. &#x00026; Thonn., <italic>P. niruri</italic> L., <italic>P. urinaria</italic> and <italic>P. watsonii</italic> Airy Shaw) through three different strategies (pre-, trans- and post-treatment) onto confluent VERO cell monolayers. For all treatment strategies, the cultures were incubated for 24, 48 and 72 h. An antiviral effect was found in the trans-treatment (possible effect on viral particles) and pretreatment (possible effect on cellular proteins) strategies. Using a protein profiling assay, the study also demonstrated that pretreatment with <italic>Phyllanthus</italic> altered several cellular proteins involved in biological processes, including viral entry, viral transcription and translation regulation, cytoskeletal assembly, and cellular metabolism. Several bioactive compounds were identified in the pool, including gallic acid, syringin, corilagin, and geraniin, but the latter constituted the greatest amount in the extract. However, these components together could have had a synergistic anti-DENV effect in this study [<xref rid="B44-biomolecules-11-00011" ref-type="bibr">44</xref>].</p><p>On the other hand, a study in VERO cells showed that polyphenol geraniin obtained from the bark of the <italic>Nephelium lappaceum</italic> L. plant had a dose-dependent virucidal effect (<italic>trans</italic>-treatment), with an IC<sub>50</sub> of 1.75 &#x003bc;M. on DENV-2 [<xref rid="B45-biomolecules-11-00011" ref-type="bibr">45</xref>]. Additionally, through a viral attachment assay, this polyphenol at a concentration of 26.3 &#x003bc;M inhibited 100% of the formation of infectious viral particles, but when its effect was evaluated after the internalization of the virus, the inhibition was only 40%. Based on these results, an in silico study was performed by molecular docking, demonstrating that the binding affinity of geraniin to domain III of the viral envelope protein is favorable, with a free energy binding of &#x02212;9.8 kcal/mol. Finally, a recombinant rE-DIII protein was produced, and a competitive binding ELISA assay was performed to demonstrate that geraniin binds to this domain, avoiding viral particle adhesion to its cellular receptor [<xref rid="B45-biomolecules-11-00011" ref-type="bibr">45</xref>]. All of these findings allow us to conclude that the antiviral effect of geraniin is associated with the inhibition of early steps of virus replication [<xref rid="B45-biomolecules-11-00011" ref-type="bibr">45</xref>].</p><p>The anti-DENV effect of geraniin has also been demonstrated in vivo using a model of immunodeficient BALB/c mice, which develop liver damage due to infection with DENV-2 [<xref rid="B46-biomolecules-11-00011" ref-type="bibr">46</xref>]. The study demonstrated that polyphenol geraniin reduced viremia when administered to mice 72 h after infection (hpi) at a concentration of 131.30&#x02009;&#x003bc;M prepared in 100&#x02009;&#x003bc;L PBS. Additionally, histopathology showed that treatment with geraniin 24&#x02009;h prior to infection could prevent severe liver damage caused by DENV-2 [<xref rid="B47-biomolecules-11-00011" ref-type="bibr">47</xref>].</p></sec></sec><sec id="sec3-biomolecules-11-00011"><title>3. Chebulagic Acid and Punicalagin</title><p>Bioactive polyphenol compounds, such as chebulagic acid and punicalagin, are also hydrolyzable tannins, such as geraniin [<xref rid="B48-biomolecules-11-00011" ref-type="bibr">48</xref>], which was previously referenced in this review. Both chebulagic acid and punicalagin are simple ellagitannins that can cooccur in <italic>Terminalia</italic> species, but 1C4-glucopyranose core plus chebuloyl group compounds, such as chebulagic acid, have been found in the <italic>Geranium</italic> and <italic>Euphorbia</italic> genera [<xref rid="B49-biomolecules-11-00011" ref-type="bibr">49</xref>], while punicalagin is more related to <italic>Punica granatum</italic> L., the pomegranate, where it was first isolated [<xref rid="B49-biomolecules-11-00011" ref-type="bibr">49</xref>,<xref rid="B50-biomolecules-11-00011" ref-type="bibr">50</xref>].</p><p>The multiple biological activities related to these two compounds are anti-inflammatory effects [<xref rid="B51-biomolecules-11-00011" ref-type="bibr">51</xref>,<xref rid="B52-biomolecules-11-00011" ref-type="bibr">52</xref>], growth inhibition [<xref rid="B53-biomolecules-11-00011" ref-type="bibr">53</xref>], antimicrobial [<xref rid="B54-biomolecules-11-00011" ref-type="bibr">54</xref>,<xref rid="B55-biomolecules-11-00011" ref-type="bibr">55</xref>] and antiviral activity. The anti-HCV effect of chebulagic acid has been shown by NS3-4A protease and RNA replication inhibition (IC<sub>50</sub>: 9.03 &#x000b5;M and 22.25 &#x000b1; 8.70), with higher selectivity index (SI) than geraniin in Huh 7.5 cells (4.7 vs. 1.9) [<xref rid="B43-biomolecules-11-00011" ref-type="bibr">43</xref>]. In contrast, chebulagic acid inhibited EBV DNA polymerase <italic>&#x003b1;</italic> but at a higher concentration than geraniin (IC<sub>50</sub>: 18.6 &#x000b5;M) [<xref rid="B42-biomolecules-11-00011" ref-type="bibr">42</xref>]. Additionally, its anti-influenza A virus (IAV) effects, as a neuraminidase inhibitor, have been probed, even for oseltamivir-resistant IAV, showing viral release inhibition (IC<sub>50</sub>s of 1.36 &#x003bc;M) but no activity on other steps of the viral cycle, such as entry or RNA replication [<xref rid="B56-biomolecules-11-00011" ref-type="bibr">56</xref>]. In contrast, chebulagic acid and punicalagin inhibited HSV type 1 (HSV-1) entry and spread by acting as GAG-competitors (EC<sub>50:</sub> 17.02 &#x000b1; 2.82 and 10.25 &#x000b1; 1.13; SI: 18.62 and 31.11, respectively) [<xref rid="B57-biomolecules-11-00011" ref-type="bibr">57</xref>], as in human cytomegalovirus (HCMV) (EC<sub>50:</sub> 25.50 &#x000b1; 1.51; 16.76 &#x000b1; 0.88), measles virus (MV) (EC<sub>50:</sub> 34.42 &#x000b1; 4.35; 25.49 &#x000b1; 2.94), respiratory syncytial virus (RSV) (EC<sub>50:</sub> 0.38 &#x000b1; 0.05; 0.54 &#x000b1; 0.04) and HCV (EC<sub>50:</sub> 12.16 &#x000b1; 2.56; 16.72 &#x000b1; 2.55) in HeLa, CHO-SLAM, HEp-2 and Huh-7.5 cells, respectively [<xref rid="B58-biomolecules-11-00011" ref-type="bibr">58</xref>]. Therefore, their antiviral mechanism of action is dependent on the viral model used.</p><sec><title>Anti-DENV Effect of Chebulagic Acid and Punicalagin</title><p>Both molecules were evaluated against DENV-2 strain 16,681 infection in HeLa, VERO, A549 and HEp-2 cells. The effectiveness of these compounds at different concentrations (1&#x02013;10 and 100 &#x000b5;g/mL) was confirmed when prechilled monolayers at 4 &#x000b0;C were cotreated with DENV-2 at a multiplicity of infection (MOI) of five, at the same time demonstrating their effectiveness against infection. In this sense, there was a significant inhibition of viral particle adhesion and fusion to the cell membrane [<xref rid="B58-biomolecules-11-00011" ref-type="bibr">58</xref>]. The virus seems to bind to tannins, avoiding cellular receptors, likely with a similar mechanism of action as other viral models previously referenced.</p></sec></sec><sec id="sec4-biomolecules-11-00011"><title>4. Flavonoids</title><p>The flavanols catechin and epigallocatechin gallate (EGCG) and delphinidin and the flavanone naringin and the flavanols quercetin and fisetin are derived from the phenylpropanoid metabolic pathway [<xref rid="B59-biomolecules-11-00011" ref-type="bibr">59</xref>,<xref rid="B60-biomolecules-11-00011" ref-type="bibr">60</xref>] and belong to the large family of flavonoid compounds derived from shikimic acid metabolism.</p><p>Flavonoid compounds have been one of the most studied secondary plant metabolites in different health disorders. The phenolic hydroxyl groups present on the B ring are related to their antioxidant activity [<xref rid="B61-biomolecules-11-00011" ref-type="bibr">61</xref>], which could be associated with the wide spectrum of pharmacological activities of this group, including anti-inflammatory and antiallergic [<xref rid="B62-biomolecules-11-00011" ref-type="bibr">62</xref>,<xref rid="B63-biomolecules-11-00011" ref-type="bibr">63</xref>], neuroprotective [<xref rid="B61-biomolecules-11-00011" ref-type="bibr">61</xref>,<xref rid="B64-biomolecules-11-00011" ref-type="bibr">64</xref>], hepatoprotective [<xref rid="B65-biomolecules-11-00011" ref-type="bibr">65</xref>], nephroprotective [<xref rid="B66-biomolecules-11-00011" ref-type="bibr">66</xref>], anticancer [<xref rid="B60-biomolecules-11-00011" ref-type="bibr">60</xref>,<xref rid="B67-biomolecules-11-00011" ref-type="bibr">67</xref>] and antimicrobial [<xref rid="B68-biomolecules-11-00011" ref-type="bibr">68</xref>,<xref rid="B69-biomolecules-11-00011" ref-type="bibr">69</xref>,<xref rid="B70-biomolecules-11-00011" ref-type="bibr">70</xref>] effects. Additionally, many flavonoid compounds have been related to antiviral activity against many viruses, such as HIV, HSV, influenza virus (IV), RSV, severe acute respiratory syndrome coronavirus (SARS-CoV), measles, and rotavirus [<xref rid="B71-biomolecules-11-00011" ref-type="bibr">71</xref>]. This demonstrates that flavonoids could be one of the most active compounds against different types of viruses, with multiple mechanisms of action, such as the inhibition of adsorption, virus entry, virus binding, RTase, integrase, protease, replication inhibiting DNA and RNA polymerases, and protein complex formation [<xref rid="B71-biomolecules-11-00011" ref-type="bibr">71</xref>].</p><p>Specifically, quercetin showed activity against HBV by inhibiting mRNA in HuS-E/2 cells (50 &#x000b5;M: approx. 40%) [<xref rid="B72-biomolecules-11-00011" ref-type="bibr">72</xref>] and HBsAg secretion (36.1 &#x000b1; 7.6%), but not HBeAg, in HepG2 2.2.15 cells (25 &#x003bc;g/mL) [<xref rid="B41-biomolecules-11-00011" ref-type="bibr">41</xref>], against murine <italic>betacoronavirus</italic> and mouse hepatitis virus (MHV) CCL9.1 cells at low SI (IC<sub>50</sub> 125.0 &#x003bc;g/mL; SI: 0.93) [<xref rid="B73-biomolecules-11-00011" ref-type="bibr">73</xref>], against enterovirus 71 (EV71) strain Wuhan/3018/2010 in RD cells (50 &#x003bc;M) [<xref rid="B74-biomolecules-11-00011" ref-type="bibr">74</xref>], and against canine distemper virus (CDV) in VERO cells. However, naringenin [<xref rid="B75-biomolecules-11-00011" ref-type="bibr">75</xref>], the biosynthetic precursor of naringin, did not [<xref rid="B76-biomolecules-11-00011" ref-type="bibr">76</xref>].</p><p>Quercetin inhibited the entry of three strains of IAV into MDCK cells (IC<sub>50</sub>: 7.756 &#x000b1; 1.097, 6.225 &#x000b1; 0.467, and 2.738 &#x000b1; 1.931 &#x003bc;g/mL for strains A/Puerto Rico/8/34 (H1N1), A/FM-1/47/1 (H1N1), and A/Aichi/2/68 (H3N2), respectively). In the same cell model, posttreatment with quercetin and catechin hydrate, compounds present in bioactive extracts of <italic>Aloe vera</italic> L. (25 &#x003bc;g/mL), inhibited M2 viral mRNA synthesis and M2 protein expression of IAV (H1N1) strain A/PR/8/34 at an MOI of 1. An extract that contains both compounds inhibits autophagy induced by IAV infection [<xref rid="B77-biomolecules-11-00011" ref-type="bibr">77</xref>]. Quercetin also stimulates Na<sup>+</sup>&#x02013;K<sup>+</sup>&#x02013;2Cl<sup>&#x02212;</sup> cotransporter 1 (NKCC1) due to its chemical structure [<xref rid="B78-biomolecules-11-00011" ref-type="bibr">78</xref>], and these compounds could have activity as direct antivirals as well as a broad spectrum against other viruses.</p><p>On the other hand, other flavonoid compounds, such as fisetin, have Enterovirus A71 (EV-A71)-3C protease inhibition activity in HeLaG3CwtR cells (CI<sub>50</sub>: 142.8 &#x000b1; 0.7 &#x000b5;M) and can inhibit replication (84.5 &#x000b1; 0.3 &#x000b5;M) [<xref rid="B79-biomolecules-11-00011" ref-type="bibr">79</xref>]. Naringin inhibits herpes simplex type 1 (HSV-1) (cytopathic effect (CPE) inhibitory concentration: 1.6 &#x000b5;g/mL), parainfluenza type-3 (PI-3) (cytopathic effect (CPE) inhibitory concentration: 0.2 &#x000b5;g/mL) [<xref rid="B80-biomolecules-11-00011" ref-type="bibr">80</xref>], and rotavirus in MA-104 cells (IC<sub>50</sub>: 25 &#x000b5;M); catechin inhibits HBV-mRNA in HuS-E/2 cells (50 &#x000b5;M: more than 40%); and EGCG inhibits HBV entry (50 &#x003bc;M in HuS-E/2 cells) [<xref rid="B72-biomolecules-11-00011" ref-type="bibr">72</xref>], cccDNA, replicative intermediates of DNA (100 &#x003bc;M: 72.4% and 71.8%, respectively) and HBV-HBeAg (IC<sub>50</sub> of 39.4 &#x003bc;M) in HepG2.117 cells, but not HBsAg [<xref rid="B81-biomolecules-11-00011" ref-type="bibr">81</xref>]. This is in contrast to other studies showing inhibitions above 90% in HepG2-N10 cells of both Ag at 100 &#x003bc;M [<xref rid="B22-biomolecules-11-00011" ref-type="bibr">22</xref>]. It also has a modulatory effect on cellular processes that affect the HBV viral cycle, such as autophagy, which is necessary for replication [<xref rid="B82-biomolecules-11-00011" ref-type="bibr">82</xref>] and transcription in HepG2 cells [<xref rid="B22-biomolecules-11-00011" ref-type="bibr">22</xref>]. Additionally, EGCG inhibits vesicular stomatitis virus (VSV), IAV, HCV, Sindbis virus (SIN), reovirus (RV), HSV-1, HSV-2, murine cytomegalovirus (mCMV), vaccinia virus (VACV) and adenovirus type 5 (AdV) in VERO or MDCK cells (EC<sub>50</sub>, 3.3, 7.3 to 40.1, 2.6, 15.8, 4.3, 0.1, 2.6, 5.4, 7.1 to 7.7, and 17.7 &#x003bc;M, respectively) [<xref rid="B83-biomolecules-11-00011" ref-type="bibr">83</xref>]. Inhibition of HIV, human T-cell lymphotropic virus (HTLV), HCV, Chikungunya virus (CHIKV), Ebola virus (EBOV), viral hemorrhagic septicemia (VHSV), infectious hematopoietic necrosis virus (IHNV), spring viremia of carp (SVCV) and grass carp reovirus (GCRV), has also been reported [<xref rid="B84-biomolecules-11-00011" ref-type="bibr">84</xref>].</p><sec><title>Anti-DENV Effect of Flavonoids</title><p>Due to the antiviral reports of this compound, including activity against arboviruses and flaviviruses, flavonoids also have several reported anti-DENV effects with multiple mechanisms involved. Nonneutralizing heterotypic antibodies have been documented to induce antibody-dependent potentiation (ADE) in secondary DENV infection, leading to increased entry of infectious viral particles into phagocytes, cells that produce a series of proinflammatory cytokines involved in the immune response in severe dengue pathogenesis [<xref rid="B2-biomolecules-11-00011" ref-type="bibr">2</xref>]. In this context, a recent study evaluated the antiviral and immunomodulatory properties of polyphenols in U937-DC-SIGN cells (boosted or not with antibodies) infected with DENV-2 and DENV-3 at an MOI of 1. Only quercetin at 100 &#x000b5;M and fisetin at 40 &#x000b5;M showed activity (flavonoids that only differ in one hydroxyl group at carbon 5 of the A ring). Furthermore, DENV-2 induced more IL-6, IFN-&#x003b3;, and IL-10 than DENV-3, but both viruses induced similar amounts of TNF-&#x003b1; that were downregulated by the compounds [<xref rid="B85-biomolecules-11-00011" ref-type="bibr">85</xref>]. Additionally, quercetin and fisetin can also induce type 1 IFN, a cytokine mediated by the JAK-STAT route, modifying the signaling pathways involved in the innate response [<xref rid="B86-biomolecules-11-00011" ref-type="bibr">86</xref>].</p><p>Additionally, the antiviral effect of quercetin has been probed in different DENV-2 strains, such as the NG strain at an MOI of 1 in VERO cells (19.2 &#x003bc;g/mL; SI: 34.3) with pre- and post-treatment inhibition [<xref rid="B87-biomolecules-11-00011" ref-type="bibr">87</xref>]; the New Guinea C strain in BHK-21 cells but with a low selectivity index (IC<sub>50</sub> 176.76 &#x003bc;g/mL; SI: 0.88) [<xref rid="B73-biomolecules-11-00011" ref-type="bibr">73</xref>]; and the TR1751 strain with an MOI of 5 in BHK-21 cells, with inhibition percentages of 60.6% and 75.7% at concentrations of 1 &#x000b5;M and at 10 &#x000b5;M, respectively [<xref rid="B88-biomolecules-11-00011" ref-type="bibr">88</xref>]. The possible antiviral effect of quercetin and fisetin has even been reviewed with in silico methods, such as molecular docking, using different DENV viral proteins as possible pharmacological targets, and both could interact with glycoprotein E, glycoprotein NS1, protease NS3 and RdRP NS5. Therefore, it was assumed that polyphenols can have several mechanisms of action that inhibit different stages of the viral replicative cycle [<xref rid="B89-biomolecules-11-00011" ref-type="bibr">89</xref>,<xref rid="B90-biomolecules-11-00011" ref-type="bibr">90</xref>,<xref rid="B91-biomolecules-11-00011" ref-type="bibr">91</xref>]. Among six phenolic compounds, quercetin had the best favorable ligand&#x02013;enzyme consensus score (CScore) of 5.95 with DENV-2 NS2B-NS3 protease [<xref rid="B92-biomolecules-11-00011" ref-type="bibr">92</xref>], but it did not have the best binding energy among the other five phenolic compounds with DENV NS5 and envelope proteins [<xref rid="B87-biomolecules-11-00011" ref-type="bibr">87</xref>]. The inhibition and interaction of quercetin and DENV protease as important targets [<xref rid="B93-biomolecules-11-00011" ref-type="bibr">93</xref>,<xref rid="B94-biomolecules-11-00011" ref-type="bibr">94</xref>] could be related to their mechanism of action.</p><p>The flavonoids naringin and catechin also inhibited DENV-2 NG at MOI 1 in VERO cells (47.9 &#x003bc;g/mL; SI: 13.5; and 33.7 &#x003bc;g/mL; SI: 24.8, respectively), especially posttreatment (64.5% and 91.8% inhibition, respectively), and only catechin at pretreatment [<xref rid="B87-biomolecules-11-00011" ref-type="bibr">87</xref>]. Additionally, fisetin showed an anti-DENV-2 (NGC strain) effect in VERO cells treated previously (IC<sub>50</sub>: 43.12 &#x000b5;g/mL; SI: 5.72) and after infection (IC<sub>50</sub>: 55 &#x000b5;g/mL; SI: 4.49), with no direct virucide activity. However, naringenin, a naringin precursor, exhibited direct virucidal activity against DENV-2 (IC<sub>50</sub> = 52.64 &#x000b5;g/mL SI &#x0003c; 1) [<xref rid="B95-biomolecules-11-00011" ref-type="bibr">95</xref>], and the anti-adsorption effects of naringin against the DENV-2 New Guinea C strain have been probed in VERO cells (IC<sub>50</sub> = 168.2 &#x003bc;g/mL; SI: 1.3), reducing the viral genome (25.8%; 50 &#x003bc;g/mL) [<xref rid="B96-biomolecules-11-00011" ref-type="bibr">96</xref>].</p><p>Catechin, delphinidin, quercetin and EGCG were proven effective against DENV-2 (strain 00st-22A) at an MOI of 0.03 in VERO cells. The inhibition percentages of catechin and delphinidin were above 60%, but quercetin and EGCG showed approximately 90% inhibition at the same concentration (100 &#x003bc;M). In the same study, the antiviral effect of EGCG was probed against the four DENV serotypes, but not other flaviviruses (100 &#x003bc;M), and the possible mechanism of action showed better activity at pretreatment than at posttreatment (DENV-2 MOI of 3.60 &#x003bc;M) [<xref rid="B97-biomolecules-11-00011" ref-type="bibr">97</xref>].</p><p>The antiviral effects of the polyphenols delphinidin and EGCG in three different flaviviruses (DENV, West Nile virus (WNV) and Zika virus (ZIKV)) were evaluated. In those studies, the infection was reduced, likely by affecting virus internalization [<xref rid="B72-biomolecules-11-00011" ref-type="bibr">72</xref>] or modulating endosomal pH [<xref rid="B82-biomolecules-11-00011" ref-type="bibr">82</xref>], which can affect pH-dependent viral fusion. According to these results, another study determined that both phenolic compounds, delphinidin and EGCG at 10 &#x003bc;M, have anti-flavivirus effects in DENV, WNV and ZIKV models when added at the first steps of infection in VERO cells. The mechanism of action could act directly on the viral particle [<xref rid="B98-biomolecules-11-00011" ref-type="bibr">98</xref>]. Other flavonoid compounds have shown similar mechanisms of action, such as baicalein, which exhibits virucidal and anti-adsorption activities against DENV and Japanese encephalitis virus (JEV) [<xref rid="B99-biomolecules-11-00011" ref-type="bibr">99</xref>,<xref rid="B100-biomolecules-11-00011" ref-type="bibr">100</xref>].</p></sec></sec><sec id="sec5-biomolecules-11-00011"><title>5. Resveratrol</title><p>Resveratrol, a natural oligomeric stilbene, is a phytoalexin principally derived from grapes, berries, peanuts, and other plant sources as one of the defense mechanisms against infection and stress and is a widely known anti-inflammatory and antioxidant agent [<xref rid="B101-biomolecules-11-00011" ref-type="bibr">101</xref>]. Oligomeric stilbenes are distributed in more than 15 families of plant species [<xref rid="B102-biomolecules-11-00011" ref-type="bibr">102</xref>]. Resveratrol can be found in two stereoisomeric forms, <italic>trans-</italic> or <italic>cis-3</italic>,5,4&#x02032;-trihydroxystilbene, but the <italic>trans</italic>-isomer changes into the <italic>cis</italic>-isomer in the presence of ultraviolet light. These differences could impact the different biological properties [<xref rid="B103-biomolecules-11-00011" ref-type="bibr">103</xref>,<xref rid="B104-biomolecules-11-00011" ref-type="bibr">104</xref>,<xref rid="B105-biomolecules-11-00011" ref-type="bibr">105</xref>].</p><p>Similar to other phenolic compounds, the antiviral effect of resveratrol has been tested in models, such as IAV in MDCK cells, EBV in Raji and human B cells, HSV in VERO and MRC-5 cells, RSV in lung epithelial cells, and HIV-1 in primary peripheral blood lymphocytes [<xref rid="B106-biomolecules-11-00011" ref-type="bibr">106</xref>]. The anti-flavivirus activity of resveratrol was proven against ZIKV in Huh7 cells, and the mechanisms were related to postentry and virucidal activity and adsorption inhibition (MOI 1; 80 &#x000b5;M) [<xref rid="B107-biomolecules-11-00011" ref-type="bibr">107</xref>]. Anti-HCV activity could not be proven, and treatment with resveratrol even enhanced replication in OR6 cells [<xref rid="B108-biomolecules-11-00011" ref-type="bibr">108</xref>].</p><sec><title>Anti-DENV Effect of Resveratrol</title><p>A recent study evaluated five natural compounds and found that, among the tested compounds, only resveratrol had an antiviral effect against DENV-2/16681 in HEK293T/17 cells, but not in HepG2 cells, after viral entry. Additionally, a dose-dependent effect was observed (EC<sub>50</sub>: 11.37 &#x003bc;M) when cells were infected at a low MOI of 0.01, while the dose-dependent effect was not evident at a higher MOI of 2 (EC<sub>50</sub>: 24.37 &#x003bc;M) [<xref rid="B109-biomolecules-11-00011" ref-type="bibr">109</xref>]. However, in that study, it was not possible to elucidate a specific mechanism of action that could explain these results.</p><p>A study found that resveratrol can inhibit DENV-2 infection in Huh7 cells, inducing HMGB1 protein accumulation. Resveratrol increases the amount of nuclear HMGB1 and improves the production of genes stimulated by interferon (ISG), leading to a more efficient innate immune response inside the cell, which is crucial to restrict virus replication and infection [<xref rid="B110-biomolecules-11-00011" ref-type="bibr">110</xref>]. The inhibitory effect of resveratrol on the translocation of HMGB1 outside the nucleus also suggests the possibility that treatment may negatively regulate the proinflammatory genes associated with DENV disease pathogenesis [<xref rid="B111-biomolecules-11-00011" ref-type="bibr">111</xref>].</p><p>Although the mechanism of action has been more elucidated for some compounds, the question remains whether structural analogs have similar properties or whether apparently small differences in the chemical structure could modify the inhibition percentages obtained and could even have a completely different mechanism of action. For these reasons, two resveratrol analogs, PNR-4-44 and PNR-5-02, were evaluated in Huh7 cells infected with DENV-2/NG, demonstrating a reduction in the cytopathic effect of the virus in a dose-dependent manner. Furthermore, both analogs had an effect at 12 h postinfection in an addition time assay, inhibiting the viral genome but not affecting the viral polymerase [<xref rid="B112-biomolecules-11-00011" ref-type="bibr">112</xref>]. The study suggests that the decrease in the viral genome can be attributed to other nonviral factors, since it is known that viral replication requires the presence of cellular molecules that can be altered in the presence of analogs [<xref rid="B113-biomolecules-11-00011" ref-type="bibr">113</xref>]. Because of these factors, the cellular components that intervene in the replicative cycle of the virus offer a possible therapeutic route in which they can be considered treatment targets. Although both resveratrol phenolic analogs were shown to be active in events after virus entry, only PNR-5-02 had partial inhibition in stages prior to viral entry by inhibiting replication by 34%, indicating that it may have an additional effect on cellular factors in host cells, as reported in other studies [<xref rid="B114-biomolecules-11-00011" ref-type="bibr">114</xref>].</p></sec></sec><sec id="sec6-biomolecules-11-00011"><title>6. Nordihydroguaiaretic Acid</title><p>Phenolic lignan, nordihydroguaiaretic acid (NDGA), has been isolated from leaves of <italic>Larrea tridentate</italic> (DC.) Coville found in Mexico and USA deserts. NGDA is approximately 5 to 10% of the leaf dry weight (80% of all phenolic compounds in the resin). The catechol rings present in their structure confer antioxidant and anti-inflammatory properties to this hypolipidemic agent [<xref rid="B115-biomolecules-11-00011" ref-type="bibr">115</xref>]. NDGA is also known for its cytoprotective effects in nontumor cells and its proapoptotic activity in malignant cells. These facts make NDGA a promising antitumor compound that regulates several signaling pathways and controls cellular damage by reactive oxygen species (ROS) [<xref rid="B116-biomolecules-11-00011" ref-type="bibr">116</xref>,<xref rid="B117-biomolecules-11-00011" ref-type="bibr">117</xref>].</p><p>It is well known that viruses can regulate cellular metabolism and pathways to develop and improve their viral replication cycle [<xref rid="B118-biomolecules-11-00011" ref-type="bibr">118</xref>]. The modulatory properties of NDGA could inhibit changes in the cell after viral infection. According to this, NDGA can inhibit HIV-Tat-regulated secreted alkaline phosphatase (IC<sub>50</sub> = 20 &#x000b5;M) [<xref rid="B119-biomolecules-11-00011" ref-type="bibr">119</xref>], DNA fragmentation by apoptosis, ROS production induced by IAV (Puerto Rico/8/34; H1N1) infection (76% in human fetal membrane chorion cells) [<xref rid="B120-biomolecules-11-00011" ref-type="bibr">120</xref>], and lipid metabolic pathways necessary for HCV replication in Huh7.5.1 cells (EC<sub>50</sub>: 30 &#x003bc;M) [<xref rid="B121-biomolecules-11-00011" ref-type="bibr">121</xref>]. Similar regulatory mechanisms could be related to NDGA activity against arboviruses.</p><sec><title>Anti-DENV Effect of NDGA</title><p>A study evaluated the effect of NDGA against DENV-2/NG and DENV-4 infection in Huh-7, U937 and VERO cells. This study concluded that posttreatment with NDGA significantly inhibited DENV replication, causing a reduction in the amount of lipid droplets (neutral lipid storage organelles involved in DENV morphogenesis that increase during infection and are necessary for exocytosis of cellular metabolites and viral proteins, such as NS1) [<xref rid="B122-biomolecules-11-00011" ref-type="bibr">122</xref>]. Another study showed that treatment with NDGA (100 &#x000b5;M) reduced secreted DENV-NS1 in Huh-7 cells by 92%; furthermore, treatment with NDGA caused dissociation of the structural protein capsid (C) from the lipid droplets, preventing the correct assembly of the DENV viral particle [<xref rid="B123-biomolecules-11-00011" ref-type="bibr">123</xref>]. The requirement of protein C binding to the periphery of lipid droplets for the assembly of the virus has been described [<xref rid="B124-biomolecules-11-00011" ref-type="bibr">124</xref>]; additionally, the possible inhibition of virus assembly has already been reported with other hypolipemiant drugs, such as statins [<xref rid="B125-biomolecules-11-00011" ref-type="bibr">125</xref>]. These observations may confirm that viral assembly can be affected by NDGA treatment.</p><p>Considering that flaviviruses need cellular lipids to complete the replicative cycle [<xref rid="B126-biomolecules-11-00011" ref-type="bibr">126</xref>,<xref rid="B127-biomolecules-11-00011" ref-type="bibr">127</xref>] and that DENV infection modulates the synthesis of cholesterol and fatty acids, when generating a lipid-rich cellular environment that is necessary for viral replication [<xref rid="B126-biomolecules-11-00011" ref-type="bibr">126</xref>], compounds able to modify the metabolic pathways of lipids may be an appropriate strategy to interrupt the replicative cycle of flaviviruses.</p><p>The sterol regulatory element binding protein (SREBP) pathway is another proposed mechanism even when the antiviral effect of NDGA (10 &#x000b5;M or 35 &#x000b5;M) was demonstrated in other flaviviruses, with ZIKV and WNV at an MOI of 1 in VERO-CCL81 and HeLa3-WNV cells (cells that express the structural proteins C, prM and E of WNV) [<xref rid="B28-biomolecules-11-00011" ref-type="bibr">28</xref>,<xref rid="B128-biomolecules-11-00011" ref-type="bibr">128</xref>]. This shows that the same compound can inhibit several viruses and has multiple mechanisms of action, making it a broad-spectrum candidate.</p></sec></sec><sec id="sec7-biomolecules-11-00011"><title>7. Curcumin</title><p>Curcumin or diferuloylmethane, derived from the phenylpropanoid pathway, is a linear diphenylheptanoid and a tautomeric compound with enol, keto and enol&#x02013;keto forms; it depends on dilution in solvents that can influence its activities [<xref rid="B129-biomolecules-11-00011" ref-type="bibr">129</xref>,<xref rid="B130-biomolecules-11-00011" ref-type="bibr">130</xref>].</p><p>This natural compound is present in <italic>Curcuma</italic> species, especially <italic>Curcuma longa</italic> L., and has multiple reported anti-inflammatory, antioxidant, anticarcinogenic, antiangiogenic, antiplatelet aggregation, skin regeneration, antimicrobial and antiviral properties [<xref rid="B131-biomolecules-11-00011" ref-type="bibr">131</xref>]. Many of these activities have been related to cellular pathways and enzyme modulation, including the transcription factor NF-<italic>&#x003ba;</italic>B, phospholipases, cyclo-oxygenases and lipoxygenases, metalloproteinases, superoxide dismutase, catalase, glutathione peroxidase, cytochrome P450, JNK, and MAPKs, among others [<xref rid="B132-biomolecules-11-00011" ref-type="bibr">132</xref>].</p><p>The antiviral activity of curcumin has been proven against many enveloped viruses, since this compound is able to modify the lipid bilayer and influences the function of the membrane protein [<xref rid="B133-biomolecules-11-00011" ref-type="bibr">133</xref>]. The curcumin antiviral effect was confirmed for HBV inhibition of mRNA in HuS-E/2 (50 &#x000b5;M: more than 40%) [<xref rid="B72-biomolecules-11-00011" ref-type="bibr">72</xref>]; for coxsackie virus (CVB3) in HeLa cells (MOI of 10; 30 &#x000b5;M) [<xref rid="B134-biomolecules-11-00011" ref-type="bibr">134</xref>] and JEV in Neuro2a cells (MOI of 5; 5 and 10 &#x003bc;M) [<xref rid="B135-biomolecules-11-00011" ref-type="bibr">135</xref>], acting as a host-target antiviral agent for both of these viruses by modulating ubiquitin&#x02013;proteasome system; HSV-1 in pretreated VERO cells (MOI of 1; 10 &#x003bc;M) [<xref rid="B136-biomolecules-11-00011" ref-type="bibr">136</xref>]; HIV by different mechanisms [<xref rid="B137-biomolecules-11-00011" ref-type="bibr">137</xref>]; HCV entry in Huh-7.5 cells and primary human hepatocytes (IC<sub>50</sub> 8.46 &#x000b1; 1.27 mM in Huh-7.5 and 12.5 &#x000b5;M in PHH) [<xref rid="B138-biomolecules-11-00011" ref-type="bibr">138</xref>]; and arboviruses like ZIKV and CHIKV in pretreated HeLa cells, inhibiting both infectious particle and viral-RNA (MOI of 0.1; IC<sub>50</sub>: 1.90 and 3.89 &#x003bc;M, respectively) [<xref rid="B139-biomolecules-11-00011" ref-type="bibr">139</xref>].</p><sec><title>Anti-DENV Effect of Curcumin</title><p>As described above for CVB3 and JEV, the importance of curcumin in modulating cellular systems, such as the ubiquitin&#x02013;proteasome, leads to an antiviral effect. In the case of DENV, it has been described that the ubiquitin&#x02013;proteasome system decreases the concentration of structural E-protein that could affect DENV infection [<xref rid="B140-biomolecules-11-00011" ref-type="bibr">140</xref>]. According to this, a study concluded that curcumin at different concentrations (10, 15, and 20 &#x003bc;M) caused intracellular accumulation of viral proteins and promoted the accumulation of ubiquitin-conjugated proteins, causing decreased DENV infection. However, the mechanism by which this system affects the replicative cycle has not yet been established [<xref rid="B141-biomolecules-11-00011" ref-type="bibr">141</xref>].</p><p>The antiviral effect of curcumin against many enveloped viruses was described above. Continuing with this, a study determined that this compound completely cleared DENV-2 and another flavivirus, JEV, during the <italic>trans</italic>-treatment strategy. However, the antiviral effect was not evidenced when curcumin was added to the cells after infection. Consequently, these studies concluded that curcumin can act as a direct antiviral or host-target antiviral agent [<xref rid="B142-biomolecules-11-00011" ref-type="bibr">142</xref>]. Due to the broad spectrum of this phenolic compound, the structural core of curcumin could be used to develop new molecules with enhanced antiviral effects.</p><p>Despite the promising effects of curcumin, its obtainment from <italic>Curcuma longa</italic> is limited; moreover, the extraction of the compound in large masses is not entirely feasible, and the processes are often carried out in the presence of toxic solvents, such as methanol. The aqueous extraction of <italic>Curcuma</italic> was evaluated as an easier process to perform, and curcumin was found to be the major component in more than 80% of the samples, followed by two remaining analogs, demethoxycurcumin and bisdemethoxycurcumin [<xref rid="B143-biomolecules-11-00011" ref-type="bibr">143</xref>]. Then, a study evaluated the inhibition of DENV-4 protease activity from the recombinant protein NS2B-NS3 and determined the water soluble extracts prepared with this acid or steviol glycosides with primary inhibitory activity against the viral protease [<xref rid="B142-biomolecules-11-00011" ref-type="bibr">142</xref>]. It was concluded that the glucosides used in the aqueous extraction process, stevioside (Ste), rebaudioside A (RebA), or steviol glucosides (SG), were able to maintain the biological activities of the evaluated compounds, making the extraction process easier and less toxic to obtain compounds with promising activity. In this context, Ste, RebA, and SG showed inhibitory activity against NS2B-NS3pro of DENV4, with IC<sub>50</sub> values of 14.1 &#x000b1; 0.2, 24.0 &#x000b1; 0.4, and 15.3 &#x000b1; 0.4 &#x003bc;g/mL, respectively [<xref rid="B143-biomolecules-11-00011" ref-type="bibr">143</xref>]. However, it is important to note that, in studies using extracts, the effect cannot be attributed to a single compound and is probably due to the result of synergy between the mixture of molecules present in the extract.</p></sec></sec><sec id="sec8-biomolecules-11-00011"><title>8. Salidroside</title><p>Salidroside, also known as rhodioloside, rhodosin, tyrosol 8-<italic>O</italic>-glucoside or <italic>p</italic>-hydroxyphenethyl glucopyranoside, is a bioactive phenolic compound tyrosine derived from <italic>Rhodiola</italic> genus plants [<xref rid="B144-biomolecules-11-00011" ref-type="bibr">144</xref>]. One of the principal biological activities related to <italic>Rhodiola rosea</italic> L. and salidroside is their activity in the pathogenic conditions of the central nervous system [<xref rid="B145-biomolecules-11-00011" ref-type="bibr">145</xref>], osteoarthritis rat models inhibiting synovial inflammation [<xref rid="B146-biomolecules-11-00011" ref-type="bibr">146</xref>] and alleviating cartilage degeneration [<xref rid="B147-biomolecules-11-00011" ref-type="bibr">147</xref>], diabetic nephropathy in rats [<xref rid="B148-biomolecules-11-00011" ref-type="bibr">148</xref>] and anticancer in vitro [<xref rid="B149-biomolecules-11-00011" ref-type="bibr">149</xref>].</p><p>The antiviral effect of salidroside has also been reported against RSV in HEp-2 cells (MOI of 0.01; IC<sub>50</sub>: 10.3 &#x000b1; 1.50 &#x003bc;g/mL) [<xref rid="B150-biomolecules-11-00011" ref-type="bibr">150</xref>] and CVB3 in vitro in myocytes and in vivo in BALB/c mice (IC<sub>50</sub>: 39.0 &#x000b1; 1.2 mg/L; 20 and 40 mg/kg at days 7 and 14) [<xref rid="B151-biomolecules-11-00011" ref-type="bibr">151</xref>].</p><sec><title>Anti-DENV Effect of Salidroside</title><p>Studies evaluating compounds with mechanisms of action on the immune system are important due to the immunopathological nature of DENV [<xref rid="B152-biomolecules-11-00011" ref-type="bibr">152</xref>]. Among these compounds is salidroside, which has neuroprotective, anti-inflammatory and antiviral properties [<xref rid="B153-biomolecules-11-00011" ref-type="bibr">153</xref>,<xref rid="B154-biomolecules-11-00011" ref-type="bibr">154</xref>]. This compound is derived from the plant <italic>Rhodiola rosea</italic>. Anti-DENV-2 activity in vitro has been demonstrated in THP-1 cells infected with DENV-2 (MOI 3) and incubated for 48 h after infection with salidroside (166 &#x000b5;M). The effect was determined by evaluating DENV envelope protein expression by Western blotting, and the density ratio of viral protein and salidroside-treated cells to beta actin decreased more than ten-fold in comparison to virus-infected cells without salidroside treatment [<xref rid="B155-biomolecules-11-00011" ref-type="bibr">155</xref>]. It was also postulated that the mechanism of action of salidroside is related to the increased expression of RIG-I, which specifically recognizes viral RNA [<xref rid="B156-biomolecules-11-00011" ref-type="bibr">156</xref>], initiating a downstream signaling cascade that induces positive regulation of IRF-3 and IRF-7, which limit initial stages of DENV infection [<xref rid="B157-biomolecules-11-00011" ref-type="bibr">157</xref>]. On the other hand, salidroside increases the expression of PKR and P-eIF2<italic>&#x003b1;</italic>, which restricts the synthesis of viral proteins, decreasing the expression of NF-<italic>&#x003ba;</italic>B [<xref rid="B158-biomolecules-11-00011" ref-type="bibr">158</xref>]. Another effect is the increase in IFN-&#x003b1; and NK cells observed in human peripheral blood mononuclear cells (hPBMCs), which helps reduce viral replication during the early stages of DENV infection and therefore limits subsequent pathogenesis [<xref rid="B159-biomolecules-11-00011" ref-type="bibr">159</xref>]. These results indicate that the phenolic glycoside salidroside could be considered for the development of an effective therapeutic multitherapeutic agent against DENV infection [<xref rid="B155-biomolecules-11-00011" ref-type="bibr">155</xref>].</p></sec></sec><sec id="sec9-biomolecules-11-00011"><title>9. Verbascoside and Caffeoylcalleryanin</title><p>Verbascosides, also known as actosides and caffeoylcalleryanins, are polyphenolic catechols. They have been isolated from multiple plant families, such as Bignoniaceae [<xref rid="B43-biomolecules-11-00011" ref-type="bibr">43</xref>], Lamiaceae [<xref rid="B160-biomolecules-11-00011" ref-type="bibr">160</xref>], Scrophulariaceae [<xref rid="B161-biomolecules-11-00011" ref-type="bibr">161</xref>], and species such as <italic>Arrabidaea</italic> spp. and <italic>Cuspidaria pulchra</italic> (Cham.) L.G. Lohmann. These tropical plants have been used for medical purposes, such as the treatment of skin effects, leukemia, anemia, colic, and diarrhea, because of their anti-inflammatory and astringent effects [<xref rid="B162-biomolecules-11-00011" ref-type="bibr">162</xref>].</p><p>The leaves of <italic>Arrabidaea chica</italic> (Humb. &#x00026; Bonpl.) B. Verlt have antifungal and trypanocidal activities [<xref rid="B162-biomolecules-11-00011" ref-type="bibr">162</xref>]. Moreover, the ethanolic extracts of <italic>Arrabidaea samydoides</italic> (Cham.) Sandw. leaves and stems have shown antiviral effects against HHV-1 (EC<sub>50</sub> 40.6 &#x000b1; 1.6 &#x003bc;g/mL and 218.1 &#x000b1; 3.4 &#x003bc;g/mL, respectively), encephalomyocarditis virus (EMCV) (EC<sub>50</sub> 323.4 &#x000b1; 5.6 and 377.2 &#x000b1; 17.7 &#x003bc;g/mL, respectively) and VACV (EC<sub>50</sub> 37.13 &#x000b1; 1.3 and 45.5 &#x000b1; 2.8 &#x003bc;g/mL, respectively) [<xref rid="B163-biomolecules-11-00011" ref-type="bibr">163</xref>].</p><p>Moreover, caffeoylcalleryanin has anti-inflammatory effects, showing a significant inhibitory effect on NF-<italic>&#x003ba;</italic>B activity at 100 &#x003bc;g/mL [<xref rid="B164-biomolecules-11-00011" ref-type="bibr">164</xref>]. Meanwhile, purified verbascoside has demonstrated inhibition of HSV-1 and HSV-2 in VERO cells, with a virus-dependent antiviral effect (200 &#x003bc;g/mL), since the viricidal effect was the principal mechanism of action for HSV-1, and entry inhibition of HSV-2 [<xref rid="B164-biomolecules-11-00011" ref-type="bibr">164</xref>].</p><sec><title>Anti-DENV Effect of Verbascoside and Caffeoylcalleryanin</title><p>The antiviral activity of both compounds against DENV-2 was proven in VERO and LLCMK2 cells treated with caffeoylcalleryanin and verbascoside for 48 h (EC<sub>50</sub>: 2.8 &#x000b1; 0.4 &#x003bc;g/mL, SI: 20.0 and 3.4 &#x000b1; 0.4 &#x003bc;g/mL, SI: 3.8, respectively) [<xref rid="B165-biomolecules-11-00011" ref-type="bibr">165</xref>], but the mechanism of action was not elucidated. However, this kind of catechol compound, such as dicaffeoylquinic acid (DCQA) and related dicaffeoyltartaric acid, <italic>L</italic>-chicoric acid, has been shown to be involved in HIV-RT polymerase inhibition (IC<sub>50</sub>: 7&#x02013;107 &#x000b5;M and 17 &#x000b5;M, respectively), HIV integrase inhibition (IC<sub>50</sub>: 7&#x02013;107 &#x000b5;M and 17 &#x000b5;M, respectively) [<xref rid="B166-biomolecules-11-00011" ref-type="bibr">166</xref>], and HCV replication inhibition by 3,5-DCQA (100 &#x000b5;M, 53%) [<xref rid="B167-biomolecules-11-00011" ref-type="bibr">167</xref>].</p></sec></sec><sec id="sec10-biomolecules-11-00011"><title>10. Sodium Salicylate</title><p>The drug sodium salicylate (NaSal) (sodium 2-hydroxybenzoate) is classified by the WHO in the ATC system N02BA04, which is other analgesics and antipyretics, salicylic acid and derivatives, a group of compounds first discovered in willow trees. The extract obtained from this tree has been used as a natural anti-inflammatory medicine for centuries. NaSal belongs to a large group of compounds known as nonsteroidal anti-inflammatory drugs (NSAIDs), exerting its mechanism of action by decreasing prostaglandin E2 by inhibiting cyclooxygenase enzyme (COX) and inhibiting NF-&#x003ba;B activation [<xref rid="B168-biomolecules-11-00011" ref-type="bibr">168</xref>,<xref rid="B169-biomolecules-11-00011" ref-type="bibr">169</xref>]. This immunomodulatory effect is related to the antiviral effect of sodium salicylate against RSV infection in A549 cells [<xref rid="B170-biomolecules-11-00011" ref-type="bibr">170</xref>], CMV in human coronary artery smooth muscle cells (SMCs) (2.0 mmol/L) [<xref rid="B171-biomolecules-11-00011" ref-type="bibr">171</xref>], and the flavivirus JEV in neuronal and nonneuronal cells (N18 and BHK21 cells; 5 mM) [<xref rid="B172-biomolecules-11-00011" ref-type="bibr">172</xref>].</p><sec><title>Anti- Dengue Activity of Sodium Salicylate</title><p>The effect of sodium salicylate in cultures infected with JEV or DENV-2 at an MOI 5 in a posttreatment assay in BHK-21 and N18 cells concluded that both compounds inhibit infectious viral particles in a dose-dependent manner and block virus-induced apoptosis [<xref rid="B173-biomolecules-11-00011" ref-type="bibr">173</xref>]. This inhibition is probably not mediated by blocking COX activities or NF-<italic>&#x003ba;</italic>B activation but may involve p38 MAPK activity, which plays an essential role in apoptosis activation [<xref rid="B174-biomolecules-11-00011" ref-type="bibr">174</xref>]. Although the in vitro results are promising, it should be noted that salicylates are known for antiplatelet function, a situation that can be extremely dangerous in the development of severe forms of DENV [<xref rid="B175-biomolecules-11-00011" ref-type="bibr">175</xref>].</p></sec></sec><sec id="sec11-biomolecules-11-00011"><title>11. Cardol Triene</title><p>A compound obtained from the nutshell of <italic>Anacardium occidentale</italic> L., cardol triene (5-[(8<italic>Z</italic>,11<italic>Z</italic>)-pentadeca-8,11,14-trienyl]benzene-1,3-diol) is a phenolic lipid with three double bonds [<xref rid="B176-biomolecules-11-00011" ref-type="bibr">176</xref>]. Cardol triene has been described as a potent mushroom tyrosinase inhibitor [<xref rid="B177-biomolecules-11-00011" ref-type="bibr">177</xref>]. Additionally, cardol triene has antiparasitic activity against <italic>Schistosoma mansoni</italic> worms (IC<sub>50</sub>: 192.6 &#x000b1; 6.0 &#x000b5;M) [<xref rid="B176-biomolecules-11-00011" ref-type="bibr">176</xref>] and against <italic>Trypanosoma cruzi</italic> amastigotes (11.75 &#x000b1; 0.40 &#x000b5;M) and trypomastigotes (IC<sub>50</sub>: 23.36 &#x000b1; 0.12 &#x000b5;M) [<xref rid="B178-biomolecules-11-00011" ref-type="bibr">178</xref>].</p><sec><title>Anti-DENV Effect of Cardol Triene</title><p>The compound cardol triene also showed in vitro anti-<italic>DENV</italic> activity when added to VERO cells 48 h before the infection; it was able to inhibit cell membrane fusion with the viral envelope protein of DENV-2/NG (10 &#x000b5;M; MOI of 1). The results also showed that the major inhibition of intracellular RNA and infectious virions was observed after infection (87.00 &#x000b1; 6.43% and 91.73 &#x000b1; 4.53%, respectively), and even cardol triene exhibited broad spectrum inhibition against all dengue virus serotypes (DENV 1&#x02013;4; EC<sub>50</sub> = 5.35 &#x000b5;M, 7.13 &#x000b5;M, 8.98 &#x000b5;M and 8.21 &#x000b5;M, respectively). A predicted in silico mechanism of action by molecular docking was made. Then, it was postulated that this compound has a high affinity (energy scored between &#x02212;41.44 and &#x02212;50.47 kcal/mol) for the kl loops of the DENV E protein, and this complex was demonstrated to be stable by molecular dynamics (300 ns of simulation) [<xref rid="B179-biomolecules-11-00011" ref-type="bibr">179</xref>].</p></sec></sec><sec id="sec12-biomolecules-11-00011"><title>12. Policresulen</title><p>Policresulen is also known as formaldehyde-<italic>meta</italic>-cresolsulfonic acid. This drug has been classified by those in the ATC systems as D08AE02 (dermatological, antiseptic and disinfectants) and G01AX03 (gynecological anti-infectives and antiseptics). This drug is approved by the EMA Committee for Veterinary Medicinal Products for topical use and has been commercialized in several countries as Albothyl or Lotagen<sup>&#x000ae;</sup> as a hemostatic [<xref rid="B180-biomolecules-11-00011" ref-type="bibr">180</xref>] and antimicrobial agent [<xref rid="B181-biomolecules-11-00011" ref-type="bibr">181</xref>,<xref rid="B182-biomolecules-11-00011" ref-type="bibr">182</xref>].</p><sec><title>Anti-DENV Effect of Policresulen</title><p>Viral proteases are an interesting target for the development of antivirals for DENV [<xref rid="B183-biomolecules-11-00011" ref-type="bibr">183</xref>]. As a viral protease complex, NS2B/NS3 cleaves various sites of the viral polyprotein to allow the conformation of both structural and nonstructural proteins; therefore, the inhibition of NS2B/NS3 leads to a clear interruption of the replicative cycle [<xref rid="B184-biomolecules-11-00011" ref-type="bibr">184</xref>].</p><p>A study performed with a recombinant viral protease found that the compound policresulen is a potent inhibitor of DENV-2 NS2B/NS3, acting as a competitive protease inhibitor, affecting its stability and efficiently decreasing virus replication [<xref rid="B185-biomolecules-11-00011" ref-type="bibr">185</xref>]. To understand the interaction between this phenolic compound and the viral protease, tests were carried out based on biophysical technology, molecular coupling and directed mutagenesis. The results showed that policresulen interacts with the Gln106 and Arg133 residues of the protease through hydrogen bonds. This finding differs from previously described interactions with other DENV protease inhibitors that bind to catalytic triad residues (His51, Asp75, and Ser135), offering a new target site for the protease [<xref rid="B186-biomolecules-11-00011" ref-type="bibr">186</xref>].</p></sec></sec><sec id="sec13-biomolecules-11-00011"><title>13. GW5074</title><p>GW5074 ((3<italic>Z</italic>)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1<italic>H</italic>-indol-2-one) is a 3&#x02032; substituted indolone. This structure has been related to neuroprotective activities, since this chemical core has been used and improved, and this biological activity remains [<xref rid="B187-biomolecules-11-00011" ref-type="bibr">187</xref>] and even is related to the capability of this compound to cross the blood&#x02013;brain barrier (BBB). GW5074 has been reported as a potent in vitro inhibitor of the kinase c-Raf [<xref rid="B188-biomolecules-11-00011" ref-type="bibr">188</xref>], but in neurons and in in vivo models, it has the opposite action, activating B-Raf and C-Raf, which are mainly responsible for the neuroprotective effect [<xref rid="B189-biomolecules-11-00011" ref-type="bibr">189</xref>,<xref rid="B190-biomolecules-11-00011" ref-type="bibr">190</xref>].</p><p>The principal biological effects reported for this compound are related to its capability to modulate signaling pathways [<xref rid="B191-biomolecules-11-00011" ref-type="bibr">191</xref>,<xref rid="B192-biomolecules-11-00011" ref-type="bibr">192</xref>], but the antiviral activity reported against poliovirus (PV) and enterovirus 71 (EV71) in RD cells (IC<sub>50</sub> of 2.7 SI: 63; IC<sub>50</sub>: 2.0 SI: 85) was not related to c-Raf, B-Raf or IFN response [<xref rid="B193-biomolecules-11-00011" ref-type="bibr">193</xref>].</p><sec><title>Anti-DENV Effect of GW5074</title><p>Among the articles that included the evaluation of antivirals targeting cell targets, a small molecule, GW5074, blocks the entry of RNA-dependent RNA polymerase (RdRp) into the cell nucleus [<xref rid="B194-biomolecules-11-00011" ref-type="bibr">194</xref>]. VERO cells were treated with or without GW5074 (20 &#x000b5;M) 2 h prior to infection with DENV-2 strain NGC at an MOI of 4. The results showed a marked reduction in NS5 nuclear localization of 2an by immunofluorescence. The mechanism of action indicates that GW5074 interferes with binding to the IMP&#x003b1;/&#x003b2;1 heterodimer, a nuclear transport protein involved in the import of NS5 into the nucleus and thus with the depletion of the subsequent impact of the antiviral response by the cell [<xref rid="B194-biomolecules-11-00011" ref-type="bibr">194</xref>].</p></sec></sec><sec id="sec14-biomolecules-11-00011"><title>14. Honokiol</title><p>Honokiol is a lignan biphenol derived from the shikimic acid pathway. This compound can be obtained from the <italic>Magnolia</italic> Tree and is regularly used for the relief of anxiety and as analgesic in Korean, Chinese and Japanese traditional medicine [<xref rid="B195-biomolecules-11-00011" ref-type="bibr">195</xref>]. This compound has shown anti-inflammatory [<xref rid="B196-biomolecules-11-00011" ref-type="bibr">196</xref>], antithrombotic [<xref rid="B197-biomolecules-11-00011" ref-type="bibr">197</xref>], and antioxidant activities that could be used in dermatological [<xref rid="B198-biomolecules-11-00011" ref-type="bibr">198</xref>], cardiac [<xref rid="B199-biomolecules-11-00011" ref-type="bibr">199</xref>] and neurological disorders [<xref rid="B200-biomolecules-11-00011" ref-type="bibr">200</xref>]. Honokiol also induced apoptosis and reduced the proliferation index in implanted human prostate cancer cell (PC-3) tumors in mice [<xref rid="B201-biomolecules-11-00011" ref-type="bibr">201</xref>] and had antitumoral effects against angiosarcoma implanted in mice in vivo and as an angiogenesis inhibitor in vitro [<xref rid="B202-biomolecules-11-00011" ref-type="bibr">202</xref>,<xref rid="B203-biomolecules-11-00011" ref-type="bibr">203</xref>]. Its antimicrobial activities include reported antibacterial effects against methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) [<xref rid="B204-biomolecules-11-00011" ref-type="bibr">204</xref>] and as an antiviral inhibitor of HSV-1 DNA replication and virus production [<xref rid="B205-biomolecules-11-00011" ref-type="bibr">205</xref>] and HCV entry, replication and protein translation (SI: 5.4) [<xref rid="B206-biomolecules-11-00011" ref-type="bibr">206</xref>].</p><sec><title>Anti-DENV Effect of Honokiol</title><p>DENV-2 strain PL046 infection in BHK and Huh-7 cells (MOI 0.1 and 1, respectively) was inhibited by honokiol posttreatment (48 h; 10 &#x000b5;M and 20 &#x000b5;M) by more than 90%. The possible mechanisms of action in both cellular models, BHK and Huh-7 cells treated with 10 and 20 &#x000b5;M honokiol, respectively, included viral protein expression reduction (NS1 and NS3; <italic>p</italic> &#x0003c; 0.001) and viral replication inhibition (intermediate, double-stranded RNA&#x02014;dsARN&#x02014;reduction; <italic>p</italic> &#x0003c; 0.01). Additionally, it was demonstrated that honokiol could inhibit the early steps of DENV infection, suppressing the upregulation of early endosomes, but it did not affect the attachment of the virus in Huh-7 cells (MOI of 10; 10 &#x000b5;M and 20 &#x000b5;M honokiol posttreatment) [<xref rid="B207-biomolecules-11-00011" ref-type="bibr">207</xref>]. This lignan inhibits infection by different mechanisms in different viruses. <xref rid="biomolecules-11-00011-t001" ref-type="table">Table 1</xref> shows the anti-dengue activity of phenolic compounds, while <xref ref-type="fig" rid="biomolecules-11-00011-f004">Figure 4</xref> illustrates the activities of these compounds against dengue virus.</p></sec></sec><sec id="sec15-biomolecules-11-00011"><title>15. Materials and Methods</title><p>The present study was carried out based on a search of the literature on phenolic compounds and dengue virus. The search, performed in the PubMed database, included studies published from 2010 until March 2020 and used the following keywords: dengue virus, phenol, polyphenol, phenol compounds, phenolic compounds, flavonoid, quercetin, tannins and lignans. Scientific publications were selected from studies published in English.</p></sec><sec sec-type="conclusions" id="sec16-biomolecules-11-00011"><title>16. Conclusions</title><p>The results discussed in this review show the clinical potential of phenolic compounds as antiviral agents, especially against dengue virus. Some of the compounds are widely found in medicinal plants and foods or are drugs used for other clinical purposes; thus, they may have greater toxicological safety for use in humans as anti-dengue drugs. Despite the structural diversity of bioactive compounds, it is not possible to establish a structure&#x02013;antiviral activity relationship. However, the presence of phenolic hydroxyl groups in chemical structures should have an important contribution to antiviral action and should be investigated for the development of synthetic derivatives with therapeutic applications against dengue infection.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Writing&#x02014;original draft preparation, V.L.-C., L.M.M.-E. and C.d.S.M.B.F.; writing&#x02014;review and editing, and supervision, M.M.-G.; methodology, writing&#x02014;review and editing, funding acquisition, and supervision, D.P.d.S.; All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research was supported by the National Council for Scientific and Technological Development (CNPq), the Coordination for the Improvement of Higher Education Personnel (CAPES), and the Departamento Administrativo de Ciencia, Tecnolog&#x000ed;a e Investigaci&#x000f3;n&#x02014;COLCIENCIAS [Administrative Department of Science, Technology and Research]. Project No. 141577757439).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>No potential conflict of interest were reported by the authors.</p></notes><glossary><title>Abbreviation</title><array orientation="portrait"><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ADE</td><td align="left" valign="middle" rowspan="1" colspan="1">Antibody-dependent potentiation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AdV</td><td align="left" valign="middle" rowspan="1" colspan="1">Adenovirus type 5</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BBB</td><td align="left" valign="middle" rowspan="1" colspan="1">Blood&#x02013;brain barrier</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CDV</td><td align="left" valign="middle" rowspan="1" colspan="1">Canine Distemper Virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CHIKV</td><td align="left" valign="middle" rowspan="1" colspan="1">Chikungunya virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">COX</td><td align="left" valign="middle" rowspan="1" colspan="1">Cyclo-oxygenase enzyme</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CPE</td><td align="left" valign="middle" rowspan="1" colspan="1">Cytopathic effect</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Cscore</td><td align="left" valign="middle" rowspan="1" colspan="1">Ligand&#x02013;enzyme consensus score</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CVB3</td><td align="left" valign="middle" rowspan="1" colspan="1">Coxsackie virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">DENV</td><td align="left" valign="middle" rowspan="1" colspan="1">Dengue virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EBOV</td><td align="left" valign="middle" rowspan="1" colspan="1">Ebola virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EBV</td><td align="left" valign="middle" rowspan="1" colspan="1">Epstein Barr virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EGCG</td><td align="left" valign="middle" rowspan="1" colspan="1">Epigallocatechin gallate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EMCV</td><td align="left" valign="middle" rowspan="1" colspan="1">Encephalomyocarditis virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">EVA71</td><td align="left" valign="middle" rowspan="1" colspan="1">Enterovirus A71</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">GCRV</td><td align="left" valign="middle" rowspan="1" colspan="1">Grass carp reovirus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HBV</td><td align="left" valign="middle" rowspan="1" colspan="1">Hepatitis B</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HCMV</td><td align="left" valign="middle" rowspan="1" colspan="1">Human cytomegalovirus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HCV</td><td align="left" valign="middle" rowspan="1" colspan="1">Hepatitis C virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HIV</td><td align="left" valign="middle" rowspan="1" colspan="1">Human immunodeficiency virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HSV</td><td align="left" valign="middle" rowspan="1" colspan="1">Herpes simplex virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">HTLV</td><td align="left" valign="middle" rowspan="1" colspan="1">Human t-cell lymphotropic virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IAV</td><td align="left" valign="middle" rowspan="1" colspan="1">Influenza A virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IHNV</td><td align="left" valign="middle" rowspan="1" colspan="1">Infectious hematopoietic necrosis virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ISG</td><td align="left" valign="middle" rowspan="1" colspan="1">Stimulated by interferon</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IV</td><td align="left" valign="middle" rowspan="1" colspan="1">Influenza virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">JEV</td><td align="left" valign="middle" rowspan="1" colspan="1">Japanese encephalitis virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">mCMV</td><td align="left" valign="middle" rowspan="1" colspan="1">Murine cytomegalovirus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MHV</td><td align="left" valign="middle" rowspan="1" colspan="1">Mouse hepatitis virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MOI</td><td align="left" valign="middle" rowspan="1" colspan="1">Multiplicity of infection</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MRSA</td><td align="left" valign="middle" rowspan="1" colspan="1">Methicillin-resistant Staphylococcus aureus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">MV</td><td align="left" valign="middle" rowspan="1" colspan="1">Measles virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NaSal</td><td align="left" valign="middle" rowspan="1" colspan="1">Sodium salicylate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NDGA</td><td align="left" valign="middle" rowspan="1" colspan="1">Nordihydroguaiaretic acid</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NKCC1</td><td align="left" valign="middle" rowspan="1" colspan="1">Na<sup>+</sup>&#x02013;K<sup>+</sup>&#x02013;2Cl<sup>&#x02212;</sup> cotransporter 1</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">NSAIDs</td><td align="left" valign="middle" rowspan="1" colspan="1">Nonsteroidal anti-inflammatory drugs</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PI-3</td><td align="left" valign="middle" rowspan="1" colspan="1">Parainfluenza type-3</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PV</td><td align="left" valign="middle" rowspan="1" colspan="1">Poliovirus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RebA</td><td align="left" valign="middle" rowspan="1" colspan="1">Rebaudioside A</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ROS</td><td align="left" valign="middle" rowspan="1" colspan="1">Reactive oxygen species</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RSV</td><td align="left" valign="middle" rowspan="1" colspan="1">Respiratory syncytial virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RV</td><td align="left" valign="middle" rowspan="1" colspan="1">Reovirus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SARS-CoV</td><td align="left" valign="middle" rowspan="1" colspan="1">Severe acute respiratory syndrome-coronavirus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SG</td><td align="left" valign="middle" rowspan="1" colspan="1">Steviol glucosides</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SIN</td><td align="left" valign="middle" rowspan="1" colspan="1">Sindbis virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SREBP</td><td align="left" valign="middle" rowspan="1" colspan="1">Sterol regulatory element binding protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Ste</td><td align="left" valign="middle" rowspan="1" colspan="1">Extraction process stevioside</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SVCV</td><td align="left" valign="middle" rowspan="1" colspan="1">Spring viraemia of carp</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VACV</td><td align="left" valign="middle" rowspan="1" colspan="1">Vaccinia virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VHSV</td><td align="left" valign="middle" rowspan="1" colspan="1">Viral hemorrhagic septicemia</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">VSV</td><td align="left" valign="middle" rowspan="1" colspan="1">Vesicular stomatitis virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">WNV</td><td align="left" valign="middle" rowspan="1" colspan="1">West Nile virus</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ZIKV</td><td align="left" valign="middle" rowspan="1" colspan="1">Zika virus</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-biomolecules-11-00011"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uno</surname><given-names>N.</given-names></name><name><surname>Ross</surname><given-names>T.M.</given-names></name></person-group><article-title>Dengue virus and the host innate immune response</article-title><source>Emerg. Microbes Infect.</source><year>2018</year><volume>7</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41426-018-0168-0</pub-id><?supplied-pmid 30301880?><pub-id pub-id-type="pmid">29323102</pub-id></element-citation></ref><ref id="B2-biomolecules-11-00011"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martina</surname><given-names>B.E.E.</given-names></name><name><surname>Koraka</surname><given-names>P.</given-names></name><name><surname>Osterhaus</surname><given-names>A.D.M.E.</given-names></name></person-group><article-title>Dengue virus pathogenesis: An integrated view</article-title><source>Clin. Microbiol. Rev.</source><year>2009</year><volume>22</volume><fpage>564</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1128/CMR.00035-09</pub-id><?supplied-pmid 19822889?><pub-id pub-id-type="pmid">19822889</pub-id></element-citation></ref><ref id="B3-biomolecules-11-00011"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandoval</surname><given-names>E.</given-names></name><name><surname>T&#x000e9;llez</surname><given-names>Y.</given-names></name><name><surname>Harris</surname><given-names>E.</given-names></name><name><surname>Videa</surname><given-names>E.</given-names></name><name><surname>Amador</surname><given-names>J.J.</given-names></name><name><surname>Gonzalez</surname><given-names>A.</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>L.</given-names></name><name><surname>Campo</surname><given-names>L.A.</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>M.L.</given-names></name><name><surname>Cuadra</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua</article-title><source>Am. J. Trop. Med. Hyg.</source><year>2000</year><volume>63</volume><fpage>5</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.4269/ajtmh.2000.63.5</pub-id><pub-id pub-id-type="pmid">11357995</pub-id></element-citation></ref><ref id="B4-biomolecules-11-00011"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Screaton</surname><given-names>G.</given-names></name><name><surname>Mongkolsapaya</surname><given-names>J.</given-names></name><name><surname>Yacoub</surname><given-names>S.</given-names></name><name><surname>Roberts</surname><given-names>C.</given-names></name></person-group><article-title>New insights into the immunopathology and control of dengue virus infection</article-title><source>Nat. Rev. Immunol.</source><year>2015</year><volume>15</volume><fpage>745</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1038/nri3916</pub-id><?supplied-pmid 26603900?><pub-id pub-id-type="pmid">26603900</pub-id></element-citation></ref><ref id="B5-biomolecules-11-00011"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodr&#x000ed;guez-P&#x000e9;rez</surname><given-names>C.</given-names></name><name><surname>Segura-Carretero</surname><given-names>A.</given-names></name><name><surname>del Mar Contreras</surname><given-names>M.</given-names></name></person-group><article-title>Phenolic compounds as natural and multifunctional anti-obesity agents: A review</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2019</year><volume>59</volume><fpage>1212</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1080/10408398.2017.1399859</pub-id><pub-id pub-id-type="pmid">29156939</pub-id></element-citation></ref><ref id="B6-biomolecules-11-00011"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thitilertdecha</surname><given-names>N.</given-names></name><name><surname>Teerawutgulrag</surname><given-names>A.</given-names></name><name><surname>Kilburn</surname><given-names>J.D.</given-names></name><name><surname>Rakariyatham</surname><given-names>N.</given-names></name></person-group><article-title>Identification of major Phenolic compounds from <italic>Nephelium lappaceum</italic> L. and their antioxidant activities</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>1453</fpage><lpage>1465</lpage><pub-id pub-id-type="doi">10.3390/molecules15031453</pub-id><?supplied-pmid 20335993?><pub-id pub-id-type="pmid">20335993</pub-id></element-citation></ref><ref id="B7-biomolecules-11-00011"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000e1;ez</surname><given-names>V.</given-names></name><name><surname>Pastene</surname><given-names>E.</given-names></name><name><surname>Vergara</surname><given-names>C.</given-names></name><name><surname>Mardones</surname><given-names>C.</given-names></name><name><surname>Hermos&#x000ed;n-Guti&#x000e9;rrez</surname><given-names>I.</given-names></name><name><surname>G&#x000f3;mez-Alonso</surname><given-names>S.</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>M.V.</given-names></name><name><surname>Theoduloz</surname><given-names>C.</given-names></name><name><surname>Riquelme</surname><given-names>S.</given-names></name><name><surname>von Baer</surname><given-names>D.</given-names></name></person-group><article-title>Oligostilbenoids in Vitis vinifera L. Pinot Noir grape cane extract: Isolation, characterization, in vitro antioxidant capacity and anti-proliferative effect on cancer cells</article-title><source>Food Chem.</source><year>2018</year><volume>265</volume><fpage>101</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2018.05.050</pub-id><pub-id pub-id-type="pmid">29884360</pub-id></element-citation></ref><ref id="B8-biomolecules-11-00011"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batall&#x000e1;n</surname><given-names>G.</given-names></name><name><surname>Torre</surname><given-names>R.</given-names></name><name><surname>Flores</surname><given-names>F.</given-names></name><name><surname>Konigheim</surname><given-names>B.</given-names></name><name><surname>Ludue&#x000f1;a-Almeida</surname><given-names>F.</given-names></name><name><surname>Tonn</surname><given-names>C.</given-names></name><name><surname>Contigiani</surname><given-names>M.</given-names></name><name><surname>Almir&#x000f3;n</surname><given-names>W.</given-names></name></person-group><article-title>Larvicidal activity of crude extracts from Larrea cuneifolia (Zygophyllaceae) and of its metabolite nordihydroguaiaretic acid against the vector Culex quinquefasciatus (Diptera: Culicidae)</article-title><source>Rev. Soc. Bras. Med. Trop.</source><year>2013</year><volume>46</volume><fpage>84</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1590/0037-868211392013</pub-id><pub-id pub-id-type="pmid">23563831</pub-id></element-citation></ref><ref id="B9-biomolecules-11-00011"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolff</surname><given-names>T.</given-names></name><name><surname>Berrueta</surname><given-names>L.A.</given-names></name><name><surname>Valente</surname><given-names>L.M.M.</given-names></name><name><surname>Barboza</surname><given-names>R.S.</given-names></name><name><surname>Neris</surname><given-names>R.L.S.</given-names></name><name><surname>Guimar&#x000e3;es-Andrade</surname><given-names>I.P.</given-names></name><name><surname>Assun&#x000e7;&#x000e3;o-Miranda</surname><given-names>I.</given-names></name><name><surname>Nascimento</surname><given-names>A.C.</given-names></name><name><surname>Gomes</surname><given-names>M.</given-names></name><name><surname>Gallo</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Comprehensive characterisation of polyphenols in leaves and stems of three anti-dengue virus type-2 active Brazilian <italic>Faramea</italic> species (Rubiaceae) by HPLC-DAD-ESI-MS/MS</article-title><source>Phytochem. Anal.</source><year>2019</year><volume>30</volume><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1002/pca.2790</pub-id><pub-id pub-id-type="pmid">30191624</pub-id></element-citation></ref><ref id="B10-biomolecules-11-00011"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H.</given-names></name><name><surname>He</surname><given-names>Y.</given-names></name><name><surname>She</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><name><surname>Ren</surname><given-names>J.H.</given-names></name><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Shao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Abd El-Aty</surname><given-names>A.M.</given-names></name><etal/></person-group><article-title>Preparation of molecularly imprinted polymers coupled with high-performance liquid chromatography for the selective extraction of salidroside from Rhodiola crenulata</article-title><source>J. Chromatogr. B</source><year>2019</year><volume>1118&#x02013;1119</volume><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.jchromb.2019.04.004</pub-id></element-citation></ref><ref id="B11-biomolecules-11-00011"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbieri</surname><given-names>M.</given-names></name><name><surname>Heard</surname><given-names>C.M.</given-names></name></person-group><article-title>Isolation of punicalagin from Punica granatum rind extract using mass-directed semi-preparative ESI-AP single quadrupole LC-MS</article-title><source>J. Pharm. Biomed. Anal.</source><year>2019</year><volume>166</volume><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.jpba.2018.12.033</pub-id><?supplied-pmid 30639933?><pub-id pub-id-type="pmid">30639933</pub-id></element-citation></ref><ref id="B12-biomolecules-11-00011"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000c7;evik</surname><given-names>D.</given-names></name><name><surname>Kan</surname><given-names>Y.</given-names></name><name><surname>K&#x00131;rm&#x00131;z&#x00131;bekmez</surname><given-names>H.</given-names></name></person-group><article-title>Mechanisms of action of cytotoxic phenolic compounds from Glycyrrhiza iconica roots</article-title><source>Phytomedicine</source><year>2019</year><volume>58</volume><fpage>152872</fpage><pub-id pub-id-type="doi">10.1016/j.phymed.2019.152872</pub-id><?supplied-pmid 30826527?><pub-id pub-id-type="pmid">30826527</pub-id></element-citation></ref><ref id="B13-biomolecules-11-00011"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cianciosi</surname><given-names>D.</given-names></name><name><surname>Forbes-Hern&#x000e1;ndez</surname><given-names>T.</given-names></name><name><surname>Afrin</surname><given-names>S.</given-names></name><name><surname>Gasparrini</surname><given-names>M.</given-names></name><name><surname>Reboredo-Rodriguez</surname><given-names>P.</given-names></name><name><surname>Manna</surname><given-names>P.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Bravo Lamas</surname><given-names>L.</given-names></name><name><surname>Mart&#x000ed;nez Fl&#x000f3;rez</surname><given-names>S.</given-names></name><name><surname>Agudo Toyos</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Phenolic compounds in honey and their associated health benefits: A review</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>2322</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23092322</pub-id><?supplied-pmid 30208664?><pub-id pub-id-type="pmid">30208664</pub-id></element-citation></ref><ref id="B14-biomolecules-11-00011"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname><given-names>J.</given-names></name><name><surname>Apea-Bah</surname><given-names>F.B.</given-names></name><name><surname>Ndolo</surname><given-names>V.U.</given-names></name><name><surname>Katundu</surname><given-names>M.C.</given-names></name><name><surname>Beta</surname><given-names>T.</given-names></name></person-group><article-title>Profile of phenolic compounds and antioxidant activity of finger millet varieties</article-title><source>Food Chem.</source><year>2019</year><volume>275</volume><fpage>361</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2018.09.120</pub-id><?supplied-pmid 30724208?><pub-id pub-id-type="pmid">30724208</pub-id></element-citation></ref><ref id="B15-biomolecules-11-00011"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice-Evans</surname><given-names>C.A.</given-names></name><name><surname>Miller</surname><given-names>N.J.</given-names></name></person-group><article-title>Antioxidant activities of flavonoids as bioactive components of food</article-title><source>Biochem. Soc. Trans.</source><year>1996</year><volume>24</volume><fpage>790</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1042/bst0240790</pub-id><pub-id pub-id-type="pmid">8878849</pub-id></element-citation></ref><ref id="B16-biomolecules-11-00011"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saud</surname><given-names>S.M.</given-names></name><name><surname>Li</surname><given-names>W.</given-names></name><name><surname>Morris</surname><given-names>N.L.</given-names></name><name><surname>Matter</surname><given-names>M.S.</given-names></name><name><surname>Colburn</surname><given-names>N.H.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Young</surname><given-names>M.R.</given-names></name></person-group><article-title>Resveratrol prevents tumorigenesis in mouse model of Kras activated sporadic colorectal cancer by suppressing oncogenic Kras expression</article-title><source>Carcinogenesis</source><year>2014</year><volume>35</volume><fpage>2778</fpage><lpage>2786</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgu209</pub-id><pub-id pub-id-type="pmid">25280562</pub-id></element-citation></ref><ref id="B17-biomolecules-11-00011"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boakye</surname><given-names>Y.D.</given-names></name><name><surname>Agyare</surname><given-names>C.</given-names></name><name><surname>Abotsi</surname><given-names>W.K.M.</given-names></name><name><surname>Ayande</surname><given-names>P.G.</given-names></name><name><surname>Ossei</surname><given-names>P.P.S.</given-names></name></person-group><article-title>Anti-inflammatory activity of aqueous leaf extract of Phyllanthus muellerianus (Kuntze) Exell. and its major constituent, geraniin</article-title><source>J. Ethnopharmacol.</source><year>2016</year><volume>187</volume><fpage>17</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2016.04.020</pub-id><pub-id pub-id-type="pmid">27103113</pub-id></element-citation></ref><ref id="B18-biomolecules-11-00011"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Izui</surname><given-names>S.</given-names></name><name><surname>Sekine</surname><given-names>S.</given-names></name><name><surname>Maeda</surname><given-names>K.</given-names></name><name><surname>Kuboniwa</surname><given-names>M.</given-names></name><name><surname>Takada</surname><given-names>A.</given-names></name><name><surname>Amano</surname><given-names>A.</given-names></name><name><surname>Nagata</surname><given-names>H.</given-names></name></person-group><article-title>Antibacterial activity of curcumin against Periodontopathic bacteria</article-title><source>J. Periodontol.</source><year>2016</year><volume>87</volume><fpage>83</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1902/jop.2015.150260</pub-id><pub-id pub-id-type="pmid">26447754</pub-id></element-citation></ref><ref id="B19-biomolecules-11-00011"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>J.T.</given-names></name><name><surname>Fantini de Figueiredo</surname><given-names>G.</given-names></name><name><surname>Cruz</surname><given-names>L.F.</given-names></name><name><surname>Eliza de Morais</surname><given-names>S.</given-names></name><name><surname>Souza</surname><given-names>C.D.F.</given-names></name><name><surname>Pinto</surname><given-names>F.C.H.</given-names></name><name><surname>Ferreira</surname><given-names>J.M.S.</given-names></name><name><surname>de Freitas Ara&#x000fa;jo</surname><given-names>M.G.</given-names></name></person-group><article-title>Efficacy of curcumin in the treatment of experimental vulvovaginal candidiasis</article-title><source>Rev. Iberoam. Micol.</source><year>2019</year><volume>36</volume><fpage>192</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1016/j.riam.2019.01.003</pub-id><pub-id pub-id-type="pmid">31757595</pub-id></element-citation></ref><ref id="B20-biomolecules-11-00011"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.-L.</given-names></name><name><surname>Guo</surname><given-names>Y.-S.</given-names></name><name><surname>Wang</surname><given-names>C.-H.</given-names></name><name><surname>Li</surname><given-names>G.-Q.</given-names></name><name><surname>Xu</surname><given-names>J.-J.</given-names></name><name><surname>Chung</surname><given-names>H.Y.</given-names></name><name><surname>Ye</surname><given-names>W.-C.</given-names></name><name><surname>Li</surname><given-names>Y.-L.</given-names></name><name><surname>Wang</surname><given-names>G.-C.</given-names></name></person-group><article-title>Phenolic compounds from Origanum vulgare and their antioxidant and antiviral activities</article-title><source>Food Chem.</source><year>2014</year><volume>152</volume><fpage>300</fpage><lpage>306</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2013.11.153</pub-id><pub-id pub-id-type="pmid">24444941</pub-id></element-citation></ref><ref id="B21-biomolecules-11-00011"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>C.</given-names></name><name><surname>Sliva</surname><given-names>K.</given-names></name><name><surname>von Rhein</surname><given-names>C.</given-names></name><name><surname>K&#x000fc;mmerer</surname><given-names>B.M.</given-names></name><name><surname>Schnierle</surname><given-names>B.S.</given-names></name></person-group><article-title>The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection</article-title><source>Antiviral Res.</source><year>2015</year><volume>113</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2014.11.001</pub-id><?supplied-pmid 25446334?><pub-id pub-id-type="pmid">25446334</pub-id></element-citation></ref><ref id="B22-biomolecules-11-00011"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Gu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Xing</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name></person-group><article-title>Epigallocatechin gallate inhibits hepatitis B virus via farnesoid X receptor alpha</article-title><source>J. Nat. Med.</source><year>2016</year><volume>70</volume><fpage>584</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1007/s11418-016-0980-6</pub-id><?supplied-pmid 26968537?><pub-id pub-id-type="pmid">26968537</pub-id></element-citation></ref><ref id="B23-biomolecules-11-00011"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z.-F.</given-names></name><name><surname>Bai</surname><given-names>L.-P.</given-names></name><name><surname>Huang</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>X.-Z.</given-names></name><name><surname>Zhao</surname><given-names>S.-S.</given-names></name><name><surname>Zhong</surname><given-names>N.-S.</given-names></name><name><surname>Jiang</surname><given-names>Z.-H.</given-names></name></person-group><article-title>Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure&#x02013;activity relationship analysis</article-title><source>Fitoterapia</source><year>2014</year><volume>93</volume><fpage>47</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2013.12.011</pub-id><?supplied-pmid 24370660?><pub-id pub-id-type="pmid">24370660</pub-id></element-citation></ref><ref id="B24-biomolecules-11-00011"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>S.</given-names></name><name><surname>Tyagi</surname><given-names>A.K.</given-names></name></person-group><article-title>Curcumin and its analogues: A potential natural compound against HIV infection and AIDS</article-title><source>Food Funct.</source><year>2015</year><volume>6</volume><fpage>3412</fpage><lpage>3419</lpage><pub-id pub-id-type="doi">10.1039/C5FO00485C</pub-id><pub-id pub-id-type="pmid">26404185</pub-id></element-citation></ref><ref id="B25-biomolecules-11-00011"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Kim</surname><given-names>K.H.</given-names></name><name><surname>Kim</surname><given-names>H.Y.</given-names></name><name><surname>Cho</surname><given-names>H.K.</given-names></name><name><surname>Sakamoto</surname><given-names>N.</given-names></name><name><surname>Cheong</surname><given-names>J.</given-names></name></person-group><article-title>Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway</article-title><source>FEBS Lett.</source><year>2010</year><volume>584</volume><fpage>707</fpage><lpage>712</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2009.12.019</pub-id><pub-id pub-id-type="pmid">20026048</pub-id></element-citation></ref><ref id="B26-biomolecules-11-00011"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horne</surname><given-names>J.R.</given-names></name><name><surname>Vohl</surname><given-names>M.-C.</given-names></name></person-group><article-title>Biological plausibility for interactions between dietary fat, resveratrol, <italic>ACE2</italic>, and SARS-CoV illness severity</article-title><source>Am. J. Physiol. Metab.</source><year>2020</year><volume>318</volume><fpage>E830</fpage><lpage>E833</lpage><pub-id pub-id-type="doi">10.1152/ajpendo.00150.2020</pub-id></element-citation></ref><ref id="B27-biomolecules-11-00011"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>S.-C.</given-names></name><name><surname>Ho</surname><given-names>C.-T.</given-names></name><name><surname>Chuo</surname><given-names>W.-H.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>T.T.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name></person-group><article-title>Effective inhibition of MERS-CoV infection by resveratrol</article-title><source>BMC Infect. Dis.</source><year>2017</year><volume>17</volume><elocation-id>144</elocation-id><pub-id pub-id-type="doi">10.1186/s12879-017-2253-8</pub-id><pub-id pub-id-type="pmid">28193191</pub-id></element-citation></ref><ref id="B28-biomolecules-11-00011"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merino-Ramos</surname><given-names>T.</given-names></name><name><surname>Jim&#x000e9;nez de Oya</surname><given-names>N.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name></person-group><article-title>Antiviral activity of Nordihydroguaiaretic acid and its derivative Tetra-O-Methyl Nordihydroguaiaretic acid against West Nile Virus and Zika Virus</article-title><source>Antimicrob. Agents Chemother.</source><year>2017</year><volume>61</volume><pub-id pub-id-type="doi">10.1128/AAC.00376-17</pub-id></element-citation></ref><ref id="B29-biomolecules-11-00011"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houston</surname><given-names>D.M.J.</given-names></name><name><surname>Bugert</surname><given-names>J.J.</given-names></name><name><surname>Denyer</surname><given-names>S.P.</given-names></name><name><surname>Heard</surname><given-names>C.M.</given-names></name></person-group><article-title>Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0179291</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0179291</pub-id><pub-id pub-id-type="pmid">28665969</pub-id></element-citation></ref><ref id="B30-biomolecules-11-00011"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krylova</surname><given-names>N.V.</given-names></name><name><surname>Popov</surname><given-names>A.M.</given-names></name><name><surname>Leonova</surname><given-names>G.N.</given-names></name></person-group><article-title>Antioxidants as potential antiviral agents for Flavivirus Infections</article-title><source>Antibiot. khimioterapiia = Antibiot. Chemoterapy [sic]</source><year>2016</year><volume>61</volume><fpage>25</fpage><lpage>31</lpage></element-citation></ref><ref id="B31-biomolecules-11-00011"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamada</surname><given-names>H.</given-names></name><name><surname>Wakamori</surname><given-names>S.</given-names></name><name><surname>Hirokane</surname><given-names>T.</given-names></name><name><surname>Ikeuchi</surname><given-names>K.</given-names></name><name><surname>Matsumoto</surname><given-names>S.</given-names></name></person-group><article-title>Structural revisions in Natural Ellagitannins</article-title><source>Molecules</source><year>2018</year><volume>23</volume><elocation-id>1901</elocation-id><pub-id pub-id-type="doi">10.3390/molecules23081901</pub-id><?supplied-pmid 30061530?><pub-id pub-id-type="pmid">30061530</pub-id></element-citation></ref><ref id="B32-biomolecules-11-00011"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elendran</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>L.W.</given-names></name><name><surname>Prankerd</surname><given-names>R.</given-names></name><name><surname>Palanisamy</surname><given-names>U.D.</given-names></name></person-group><article-title>The physicochemical properties of geraniin, a potential antihyperglycemic agent</article-title><source>Pharm. Biol.</source><year>2015</year><volume>53</volume><fpage>1719</fpage><lpage>1726</lpage><pub-id pub-id-type="doi">10.3109/13880209.2014.1003356</pub-id><?supplied-pmid 25853977?><pub-id pub-id-type="pmid">25853977</pub-id></element-citation></ref><ref id="B33-biomolecules-11-00011"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudjaroen</surname><given-names>Y.</given-names></name><name><surname>Hull</surname><given-names>W.E.</given-names></name><name><surname>Erben</surname><given-names>G.</given-names></name><name><surname>W&#x000fc;rtele</surname><given-names>G.</given-names></name><name><surname>Changbumrung</surname><given-names>S.</given-names></name><name><surname>Ulrich</surname><given-names>C.M.</given-names></name><name><surname>Owen</surname><given-names>R.W.</given-names></name></person-group><article-title>Isolation and characterization of ellagitannins as the major polyphenolic components of Longan (Dimocarpus longan Lour) seeds</article-title><source>Phytochemistry</source><year>2012</year><volume>77</volume><fpage>226</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1016/j.phytochem.2011.12.008</pub-id><?supplied-pmid 22277734?><pub-id pub-id-type="pmid">22277734</pub-id></element-citation></ref><ref id="B34-biomolecules-11-00011"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Jiang</surname><given-names>Z.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Ping</surname><given-names>F.</given-names></name></person-group><article-title>Geraniin suppresses ovarian cancer growth through inhibition of NF-&#x003ba;B activation and downregulation of Mcl-1 expression</article-title><source>J. Biochem. Mol. Toxicol.</source><year>2017</year><volume>31</volume><fpage>e21929</fpage><pub-id pub-id-type="doi">10.1002/jbt.21929</pub-id><?supplied-pmid 28590547?><pub-id pub-id-type="pmid">28590547</pub-id></element-citation></ref><ref id="B35-biomolecules-11-00011"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipi&#x00144;ska</surname><given-names>L.</given-names></name><name><surname>Klewicka</surname><given-names>E.</given-names></name><name><surname>S&#x000f3;jka</surname><given-names>M.</given-names></name></person-group><article-title>The structure, occurrence and biological activity of ellagitannins: A general review</article-title><source>Acta Sci. Pol. Technol. Aliment.</source><year>2014</year><volume>13</volume><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.17306/J.AFS.2014.3.7</pub-id><pub-id pub-id-type="pmid">24887944</pub-id></element-citation></ref><ref id="B36-biomolecules-11-00011"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ndjonka</surname><given-names>D.</given-names></name><name><surname>Bergmann</surname><given-names>B.</given-names></name><name><surname>Agyare</surname><given-names>C.</given-names></name><name><surname>Zimbres</surname><given-names>F.M.</given-names></name><name><surname>L&#x000fc;ersen</surname><given-names>K.</given-names></name><name><surname>Hensel</surname><given-names>A.</given-names></name><name><surname>Wrenger</surname><given-names>C.</given-names></name><name><surname>Liebau</surname><given-names>E.</given-names></name></person-group><article-title>In vitro activity of extracts and isolated polyphenols from West African medicinal plants against Plasmodium falciparum</article-title><source>Parasitol. Res.</source><year>2012</year><volume>111</volume><fpage>827</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1007/s00436-012-2905-y</pub-id><pub-id pub-id-type="pmid">22476602</pub-id></element-citation></ref><ref id="B37-biomolecules-11-00011"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vassallo</surname><given-names>A.</given-names></name><name><surname>Vaccaro</surname><given-names>M.C.</given-names></name><name><surname>De Tommasi</surname><given-names>N.</given-names></name><name><surname>Dal Piaz</surname><given-names>F.</given-names></name><name><surname>Leone</surname><given-names>A.</given-names></name></person-group><article-title>Identification of the plant compound Geraniin as a novel Hsp90 inhibitor</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e74266</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0074266</pub-id><pub-id pub-id-type="pmid">24066128</pub-id></element-citation></ref><ref id="B38-biomolecules-11-00011"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Fan</surname><given-names>X.</given-names></name><name><surname>Qin</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name></person-group><article-title>Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2012</year><volume>22</volume><fpage>2209</fpage><lpage>2211</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2012.01.102</pub-id><pub-id pub-id-type="pmid">22342145</pub-id></element-citation></ref><ref id="B39-biomolecules-11-00011"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C.-M.</given-names></name><name><surname>Cheng</surname><given-names>H.-Y.</given-names></name><name><surname>Lin</surname><given-names>T.-C.</given-names></name><name><surname>Chiang</surname><given-names>L.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name></person-group><article-title>The in vitro activity of geraniin and 1,3,4,6-tetra-O-galloyl-&#x003b2;-d-glucose isolated from Phyllanthus urinaria against herpes simplex virus type 1 and type 2 infection</article-title><source>J. Ethnopharmacol.</source><year>2007</year><volume>110</volume><fpage>555</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2006.09.039</pub-id><pub-id pub-id-type="pmid">17113739</pub-id></element-citation></ref><ref id="B40-biomolecules-11-00011"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Notka</surname><given-names>F.</given-names></name><name><surname>Meier</surname><given-names>G.</given-names></name><name><surname>Wagner</surname><given-names>R.</given-names></name></person-group><article-title>Inhibition of wild-type human immunodeficiency virus and reverse transcriptase inhibitor-resistant variants by Phyllanthus amarus</article-title><source>Antivir. Res.</source><year>2003</year><volume>58</volume><fpage>175</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/S0166-3542(02)00213-9</pub-id><pub-id pub-id-type="pmid">12742578</pub-id></element-citation></ref><ref id="B41-biomolecules-11-00011"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Feng</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>P.</given-names></name></person-group><article-title>In vitro and in vivo anti-hepatitis B virus activities of a plant extract from <italic>Geranium carolinianum</italic> L.</article-title><source>Antivir. Res.</source><year>2008</year><volume>79</volume><fpage>114</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2008.03.001</pub-id><pub-id pub-id-type="pmid">18423640</pub-id></element-citation></ref><ref id="B42-biomolecules-11-00011"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen Liu</surname><given-names>K.C.S.</given-names></name><name><surname>Lin</surname><given-names>M.-T.</given-names></name><name><surname>Lee</surname><given-names>S.-S.</given-names></name><name><surname>Chiou</surname><given-names>J.-F.</given-names></name><name><surname>Ren</surname><given-names>S.</given-names></name><name><surname>Lien</surname><given-names>E.J.</given-names></name></person-group><article-title>Antiviral Tannins from two Phyllanthus species</article-title><source>Planta Med.</source><year>1999</year><volume>65</volume><fpage>043</fpage><lpage>046</lpage><pub-id pub-id-type="doi">10.1055/s-1999-13960</pub-id><?supplied-pmid 10083844?><pub-id pub-id-type="pmid">10083844</pub-id></element-citation></ref><ref id="B43-biomolecules-11-00011"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>D.</given-names></name><name><surname>Proksch</surname><given-names>P.</given-names></name><name><surname>Lin</surname><given-names>W.</given-names></name></person-group><article-title>Inhibitory effects of polyphenols toward HCV from the mangrove plant <italic>Excoecaria agallocha</italic> L.</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2012</year><volume>22</volume><fpage>1099</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2011.11.109</pub-id><?supplied-pmid 22196120?><pub-id pub-id-type="pmid">22196120</pub-id></element-citation></ref><ref id="B44-biomolecules-11-00011"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.H.</given-names></name><name><surname>Tang</surname><given-names>Y.Q.</given-names></name><name><surname>Rathkrishnan</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>S.M.</given-names></name><name><surname>Ong</surname><given-names>K.C.</given-names></name><name><surname>Manikam</surname><given-names>R.</given-names></name><name><surname>Payne</surname><given-names>B.J.</given-names></name><name><surname>Jaganath</surname><given-names>I.B.</given-names></name><name><surname>Sekaran</surname><given-names>S.D.</given-names></name></person-group><article-title>Effects of cocktail of four local Malaysian medicinal plants (Phyllanthus spp.) against dengue virus 2</article-title><source>BMC Complement Altern. Med.</source><year>2013</year><volume>13</volume><elocation-id>192</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-13-192</pub-id><?supplied-pmid 23889893?><pub-id pub-id-type="pmid">23889893</pub-id></element-citation></ref><ref id="B45-biomolecules-11-00011"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul Ahmad</surname><given-names>S.A.</given-names></name><name><surname>Palanisamy</surname><given-names>U.D.</given-names></name><name><surname>Tejo</surname><given-names>B.A.</given-names></name><name><surname>Chew</surname><given-names>M.F.</given-names></name><name><surname>Tham</surname><given-names>H.W.</given-names></name><name><surname>Syed Hassan</surname><given-names>S.</given-names></name></person-group><article-title>Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication</article-title><source>Virol. J.</source><year>2017</year><volume>14</volume><fpage>229</fpage><pub-id pub-id-type="doi">10.1186/s12985-017-0895-1</pub-id><?supplied-pmid 29162124?><pub-id pub-id-type="pmid">29162124</pub-id></element-citation></ref><ref id="B46-biomolecules-11-00011"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paes</surname><given-names>M.V.</given-names></name><name><surname>Pinh&#x000e3;o</surname><given-names>A.T.</given-names></name><name><surname>Barreto</surname><given-names>D.F.</given-names></name><name><surname>Costa</surname><given-names>S.M.</given-names></name><name><surname>Oliveira</surname><given-names>M.P.</given-names></name><name><surname>Nogueira</surname><given-names>A.C.</given-names></name><name><surname>Takiya</surname><given-names>C.M.</given-names></name><name><surname>Farias-Filho</surname><given-names>J.C.</given-names></name><name><surname>Schatzmayr</surname><given-names>H.G.</given-names></name><name><surname>Alves</surname><given-names>A.M.B.</given-names></name><etal/></person-group><article-title>Liver injury and viremia in mice infected with dengue-2 virus</article-title><source>Virology</source><year>2005</year><volume>338</volume><fpage>236</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2005.04.042</pub-id><?supplied-pmid 15961136?><pub-id pub-id-type="pmid">15961136</pub-id></element-citation></ref><ref id="B47-biomolecules-11-00011"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul Ahmad</surname><given-names>S.A.</given-names></name><name><surname>Palanisamy</surname><given-names>U.D.</given-names></name><name><surname>Khoo</surname><given-names>J.J.</given-names></name><name><surname>Dhanoa</surname><given-names>A.</given-names></name><name><surname>Syed Hassan</surname><given-names>S.</given-names></name></person-group><article-title>Efficacy of geraniin on dengue virus type-2 infected BALB/c mice</article-title><source>Virol. J.</source><year>2019</year><volume>16</volume><fpage>26</fpage><pub-id pub-id-type="doi">10.1186/s12985-019-1127-7</pub-id><pub-id pub-id-type="pmid">30813954</pub-id></element-citation></ref><ref id="B48-biomolecules-11-00011"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Tang</surname><given-names>Q.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><name><surname>Bian</surname><given-names>K.</given-names></name><name><surname>Seeram</surname><given-names>N.P.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name></person-group><article-title>Hydrolyzable Tannins are iron chelators that inhibit DNA repair enzyme ALKBH2</article-title><source>Chem. Res. Toxicol.</source><year>2019</year><volume>32</volume><fpage>1082</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrestox.8b00398</pub-id><pub-id pub-id-type="pmid">31088072</pub-id></element-citation></ref><ref id="B49-biomolecules-11-00011"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>T.</given-names></name><name><surname>Amakura</surname><given-names>Y.</given-names></name><name><surname>Yoshimura</surname><given-names>M.</given-names></name></person-group><article-title>Structural features and biological properties of Ellagitannins in some plant families of the order Myrtales</article-title><source>Int. J. Mol. Sci.</source><year>2010</year><volume>11</volume><fpage>79</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.3390/ijms11010079</pub-id><pub-id pub-id-type="pmid">20162003</pub-id></element-citation></ref><ref id="B50-biomolecules-11-00011"><label>50.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Heber</surname><given-names>D.</given-names></name></person-group><article-title>Pomegranate ellagitannins</article-title><source>Herbal Medicine: Biomolecular and Clinical Aspects</source><edition>2nd ed.</edition><publisher-name>CRC Press/Taylor &#x00026; Francis</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2011</year></element-citation></ref><ref id="B51-biomolecules-11-00011"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>D.B.</given-names></name><name><surname>Reddanna</surname><given-names>P.</given-names></name></person-group><article-title>Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-&#x003ba;B and MAPK activation in RAW 264.7 macrophages</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2009</year><volume>381</volume><fpage>112</fpage><lpage>117</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2009.02.022</pub-id><pub-id pub-id-type="pmid">19351605</pub-id></element-citation></ref><ref id="B52-biomolecules-11-00011"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dell&#x02019;Agli</surname><given-names>M.</given-names></name><name><surname>Galli</surname><given-names>G.V.</given-names></name><name><surname>Bulgari</surname><given-names>M.</given-names></name><name><surname>Basilico</surname><given-names>N.</given-names></name><name><surname>Romeo</surname><given-names>S.</given-names></name><name><surname>Bhattacharya</surname><given-names>D.</given-names></name><name><surname>Taramelli</surname><given-names>D.</given-names></name><name><surname>Bosisio</surname><given-names>E.</given-names></name></person-group><article-title>Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria</article-title><source>Malar. J.</source><year>2010</year><volume>9</volume><fpage>208</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-9-208</pub-id><?supplied-pmid 20642847?><pub-id pub-id-type="pmid">20642847</pub-id></element-citation></ref><ref id="B53-biomolecules-11-00011"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adaramoye</surname><given-names>O.</given-names></name><name><surname>Erguen</surname><given-names>B.</given-names></name><name><surname>Nitzsche</surname><given-names>B.</given-names></name><name><surname>H&#x000f6;pfner</surname><given-names>M.</given-names></name><name><surname>Jung</surname><given-names>K.</given-names></name><name><surname>Rabien</surname><given-names>A.</given-names></name></person-group><article-title>Punicalagin, a polyphenol from pomegranate fruit, induces growth inhibition and apoptosis in human PC-3 and LNCaP cells</article-title><source>Chem. Biol. Interact.</source><year>2017</year><volume>274</volume><fpage>100</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1016/j.cbi.2017.07.009</pub-id><?supplied-pmid 28709945?><pub-id pub-id-type="pmid">28709945</pub-id></element-citation></ref><ref id="B54-biomolecules-11-00011"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>O.</given-names></name><name><surname>Viegas</surname><given-names>S.</given-names></name><name><surname>de Mello-Sampayo</surname><given-names>C.</given-names></name><name><surname>Costa</surname><given-names>M.J.P.</given-names></name><name><surname>Serrano</surname><given-names>R.</given-names></name><name><surname>Cabrita</surname><given-names>J.</given-names></name><name><surname>Gomes</surname><given-names>E.T.</given-names></name></person-group><article-title>Anti-Helicobacter pylori activity of Terminalia macroptera root</article-title><source>Fitoterapia</source><year>2012</year><volume>83</volume><fpage>872</fpage><lpage>876</lpage><pub-id pub-id-type="doi">10.1016/j.fitote.2012.03.019</pub-id><?supplied-pmid 22465506?><pub-id pub-id-type="pmid">22465506</pub-id></element-citation></ref><ref id="B55-biomolecules-11-00011"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>E.H.</given-names></name><name><surname>Garcia Cortez</surname><given-names>D.A.</given-names></name><name><surname>Ueda-Nakamura</surname><given-names>T.</given-names></name><name><surname>Nakamura</surname><given-names>C.V.</given-names></name><name><surname>Dias Filho</surname><given-names>B.P.</given-names></name></person-group><article-title>Potent antifungal activity of extracts and pure compound isolated from pomegranate peels and synergism with fluconazole against Candida albicans</article-title><source>Res. Microbiol.</source><year>2010</year><volume>161</volume><fpage>534</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1016/j.resmic.2010.05.002</pub-id><pub-id pub-id-type="pmid">20541606</pub-id></element-citation></ref><ref id="B56-biomolecules-11-00011"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>P.</given-names></name><name><surname>Du</surname><given-names>R.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Hou</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>X.</given-names></name><name><surname>Zhan</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Rong</surname><given-names>L.</given-names></name><name><surname>Cui</surname><given-names>Q.</given-names></name></person-group><article-title>Identification of Chebulinic Acid and Chebulagic Acid as novel Influenza Viral Neuraminidase inhibitors</article-title><source>Front. Microbiol.</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.3389/fmicb.2020.00182</pub-id></element-citation></ref><ref id="B57-biomolecules-11-00011"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L.-T.</given-names></name><name><surname>Chen</surname><given-names>T.-Y.</given-names></name><name><surname>Chung</surname><given-names>C.-Y.</given-names></name><name><surname>Noyce</surname><given-names>R.S.</given-names></name><name><surname>Grindley</surname><given-names>T.B.</given-names></name><name><surname>McCormick</surname><given-names>C.</given-names></name><name><surname>Lin</surname><given-names>T.-C.</given-names></name><name><surname>Wang</surname><given-names>G.-H.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name><name><surname>Richardson</surname><given-names>C.D.</given-names></name></person-group><article-title>Hydrolyzable Tannins (Chebulagic Acid and Punicalagin) target viral Glycoprotein-Glycosaminoglycan interactions to inhibit herpes simplex Virus 1 entry and cell-to-cell spread</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>4386</fpage><lpage>4398</lpage><pub-id pub-id-type="doi">10.1128/JVI.01492-10</pub-id><pub-id pub-id-type="pmid">21307190</pub-id></element-citation></ref><ref id="B58-biomolecules-11-00011"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>L.-T.</given-names></name><name><surname>Chen</surname><given-names>T.-Y.</given-names></name><name><surname>Lin</surname><given-names>S.-C.</given-names></name><name><surname>Chung</surname><given-names>C.-Y.</given-names></name><name><surname>Lin</surname><given-names>T.-C.</given-names></name><name><surname>Wang</surname><given-names>G.-H.</given-names></name><name><surname>Anderson</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>C.-C.</given-names></name><name><surname>Richardson</surname><given-names>C.D.</given-names></name></person-group><article-title>Broad-spectrum antiviral activity of chebulagic acid and punicalagin against viruses that use glycosaminoglycans for entry</article-title><source>BMC Microbiol.</source><year>2013</year><volume>13</volume><elocation-id>187</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-13-187</pub-id><pub-id pub-id-type="pmid">23924316</pub-id></element-citation></ref><ref id="B59-biomolecules-11-00011"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>E.</given-names></name><name><surname>Sabetta</surname><given-names>W.</given-names></name><name><surname>Danzi</surname><given-names>D.</given-names></name><name><surname>Negro</surname><given-names>D.</given-names></name><name><surname>Passeri</surname><given-names>V.</given-names></name><name><surname>De Lisi</surname><given-names>A.</given-names></name><name><surname>Paolocci</surname><given-names>F.</given-names></name><name><surname>Sonnante</surname><given-names>G.</given-names></name></person-group><article-title>Isolation and characterization of the flavonol regulator CcMYB12 From the Globe Artichoke [Cynara cardunculus var. scolymus (L.) Fiori]</article-title><source>Front. Plant Sci.</source><year>2018</year><volume>9</volume><pub-id pub-id-type="doi">10.3389/fpls.2018.00941</pub-id></element-citation></ref><ref id="B60-biomolecules-11-00011"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravishankar</surname><given-names>D.</given-names></name><name><surname>Rajora</surname><given-names>A.K.</given-names></name><name><surname>Greco</surname><given-names>F.</given-names></name><name><surname>Osborn</surname><given-names>H.M.I.</given-names></name></person-group><article-title>Flavonoids as prospective compounds for anti-cancer therapy</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2013</year><volume>45</volume><fpage>2821</fpage><lpage>2831</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2013.10.004</pub-id><pub-id pub-id-type="pmid">24128857</pub-id></element-citation></ref><ref id="B61-biomolecules-11-00011"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Airoldi</surname><given-names>C.</given-names></name><name><surname>La Ferla</surname><given-names>B.</given-names></name><name><surname>D&#x02018;Orazio</surname><given-names>G.</given-names></name><name><surname>Ciaramelli</surname><given-names>C.</given-names></name><name><surname>Palmioli</surname><given-names>A.</given-names></name></person-group><article-title>Flavonoids in the treatment of Alzheimer&#x02019;s and other neurodegenerative diseases</article-title><source>Curr. Med. Chem.</source><year>2018</year><volume>25</volume><fpage>3228</fpage><lpage>3246</lpage><pub-id pub-id-type="doi">10.2174/0929867325666180209132125</pub-id><pub-id pub-id-type="pmid">29424298</pub-id></element-citation></ref><ref id="B62-biomolecules-11-00011"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>P.</given-names></name><name><surname>Zhao</surname><given-names>T.</given-names></name><name><surname>Che</surname><given-names>D.</given-names></name><name><surname>Cao</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>R.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Quercetin as a Lyn kinase inhibitor inhibits IgE-mediated allergic conjunctivitis</article-title><source>Food Chem. Toxicol.</source><year>2020</year><volume>135</volume><fpage>110924</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110924</pub-id><?supplied-pmid 31672514?><pub-id pub-id-type="pmid">31672514</pub-id></element-citation></ref><ref id="B63-biomolecules-11-00011"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goh</surname><given-names>F.Y.</given-names></name><name><surname>Upton</surname><given-names>N.</given-names></name><name><surname>Guan</surname><given-names>S.</given-names></name><name><surname>Cheng</surname><given-names>C.</given-names></name><name><surname>Shanmugam</surname><given-names>M.K.</given-names></name><name><surname>Sethi</surname><given-names>G.</given-names></name><name><surname>Leung</surname><given-names>B.P.</given-names></name><name><surname>Wong</surname><given-names>W.S.F.</given-names></name></person-group><article-title>Fisetin, a bioactive flavonol, attenuates allergic airway inflammation through negative regulation of NF-&#x003ba;B</article-title><source>Eur. J. Pharmacol.</source><year>2012</year><volume>679</volume><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="doi">10.1016/j.ejphar.2012.01.002</pub-id><?supplied-pmid 22290391?><pub-id pub-id-type="pmid">22290391</pub-id></element-citation></ref><ref id="B64-biomolecules-11-00011"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name><name><surname>Kandhare</surname><given-names>A.D.</given-names></name><name><surname>Mukherjee-Kandhare</surname><given-names>A.A.</given-names></name><name><surname>Bodhankar</surname><given-names>S.L.</given-names></name></person-group><article-title>Neuroprotective effect of naringin, a flavone glycoside in quinolinic acid-induced neurotoxicity: Possible role of PPAR-&#x003b3;, Bax/Bcl-2, and caspase-3</article-title><source>Food Chem. Toxicol.</source><year>2018</year><volume>121</volume><fpage>95</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2018.08.028</pub-id><?supplied-pmid 30130594?><pub-id pub-id-type="pmid">30130594</pub-id></element-citation></ref><ref id="B65-biomolecules-11-00011"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pingili</surname><given-names>R.B.</given-names></name><name><surname>Challa</surname><given-names>S.R.</given-names></name><name><surname>Pawar</surname><given-names>A.K.</given-names></name><name><surname>Toleti</surname><given-names>V.</given-names></name><name><surname>Kodali</surname><given-names>T.</given-names></name><name><surname>Koppula</surname><given-names>S.</given-names></name></person-group><article-title>A systematic review on hepatoprotective activity of quercetin against various drugs and toxic agents: Evidence from preclinical studies</article-title><source>Phyther. Res.</source><year>2020</year><volume>34</volume><fpage>5</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1002/ptr.6503</pub-id><?supplied-pmid 31617262?><pub-id pub-id-type="pmid">31617262</pub-id></element-citation></ref><ref id="B66-biomolecules-11-00011"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vicente-Vicente</surname><given-names>L.</given-names></name><name><surname>Gonz&#x000e1;lez-Calle</surname><given-names>D.</given-names></name><name><surname>Casanova</surname><given-names>A.G.</given-names></name><name><surname>Hern&#x000e1;ndez-S&#x000e1;nchez</surname><given-names>M.T.</given-names></name><name><surname>Prieto</surname><given-names>M.</given-names></name><name><surname>Rama-Merch&#x000e1;n</surname><given-names>J.C.</given-names></name><name><surname>Mart&#x000ed;n-Moreiras</surname><given-names>J.</given-names></name><name><surname>Mart&#x000ed;n-Herrero</surname><given-names>F.</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>P.L.</given-names></name><name><surname>L&#x000f3;pez-Hern&#x000e1;ndez</surname><given-names>F.J.</given-names></name><etal/></person-group><article-title>Quercetin, a promising clinical candidate for the prevention of contrast-induced Nephropathy</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>4961</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20194961</pub-id><?supplied-pmid 31597315?><pub-id pub-id-type="pmid">31597315</pub-id></element-citation></ref><ref id="B67-biomolecules-11-00011"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezzati</surname><given-names>M.</given-names></name><name><surname>Yousefi</surname><given-names>B.</given-names></name><name><surname>Velaei</surname><given-names>K.</given-names></name><name><surname>Safa</surname><given-names>A.</given-names></name></person-group><article-title>A review on anti-cancer properties of Quercetin in breast cancer</article-title><source>Life Sci.</source><year>2020</year><volume>248</volume><fpage>117463</fpage><pub-id pub-id-type="doi">10.1016/j.lfs.2020.117463</pub-id><pub-id pub-id-type="pmid">32097663</pub-id></element-citation></ref><ref id="B68-biomolecules-11-00011"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>J.</given-names></name><name><surname>Chaudry</surname><given-names>M.T.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Xiao</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Yin</surname><given-names>W.</given-names></name></person-group><article-title>Bacteriostatic effect of Quercetin as an Antibiotic Alternative in vivo and its antibacterial mechanism in vitro</article-title><source>J. Food Prot.</source><year>2018</year><volume>81</volume><fpage>68</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.4315/0362-028X.JFP-17-214</pub-id><pub-id pub-id-type="pmid">29271686</pub-id></element-citation></ref><ref id="B69-biomolecules-11-00011"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pal</surname><given-names>A.</given-names></name><name><surname>Tripathi</surname><given-names>A.</given-names></name></person-group><article-title>Quercetin potentiates meropenem activity among pathogenic carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> and <italic>Acinetobacter baumannii</italic></article-title><source>J. Appl. Microbiol.</source><year>2019</year><volume>127</volume><fpage>1038</fpage><lpage>1047</lpage><pub-id pub-id-type="doi">10.1111/jam.14388</pub-id><pub-id pub-id-type="pmid">31319012</pub-id></element-citation></ref><ref id="B70-biomolecules-11-00011"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pendota</surname><given-names>S.C.</given-names></name><name><surname>Aderogba</surname><given-names>M.A.</given-names></name><name><surname>Ndhlala</surname><given-names>A.R.</given-names></name><name><surname>Van Staden</surname><given-names>J.</given-names></name></person-group><article-title>Antimicrobial and acetylcholinesterase inhibitory activities of Buddleja salviifolia (L.) Lam. leaf extracts and isolated compounds</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>148</volume><fpage>515</fpage><lpage>520</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2013.04.047</pub-id><pub-id pub-id-type="pmid">23665162</pub-id></element-citation></ref><ref id="B71-biomolecules-11-00011"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chattopadhyay</surname><given-names>D.</given-names></name><name><surname>Naik</surname><given-names>T.</given-names></name></person-group><article-title>Antivirals of ethnomedicinal origin: Structure-activity relationship and scope</article-title><source>Mini-Reviews Med. Chem.</source><year>2007</year><volume>7</volume><fpage>275</fpage><lpage>301</lpage><pub-id pub-id-type="doi">10.2174/138955707780059844</pub-id></element-citation></ref><ref id="B72-biomolecules-11-00011"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>H.-C.</given-names></name><name><surname>Tao</surname><given-names>M.-H.</given-names></name><name><surname>Hung</surname><given-names>T.-M.</given-names></name><name><surname>Chen</surname><given-names>J.-C.</given-names></name><name><surname>Lin</surname><given-names>Z.-J.</given-names></name><name><surname>Huang</surname><given-names>C.</given-names></name></person-group><article-title>(&#x02212;)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes</article-title><source>Antivir. Res.</source><year>2014</year><volume>111</volume><fpage>100</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2014.09.009</pub-id><?supplied-pmid 25260897?><pub-id pub-id-type="pmid">25260897</pub-id></element-citation></ref><ref id="B73-biomolecules-11-00011"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiow</surname><given-names>K.H.</given-names></name><name><surname>Phoon</surname><given-names>M.C.</given-names></name><name><surname>Putti</surname><given-names>T.</given-names></name><name><surname>Tan</surname><given-names>B.K.H.</given-names></name><name><surname>Chow</surname><given-names>V.T.</given-names></name></person-group><article-title>Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection</article-title><source>Asian Pac. J. Trop. Med.</source><year>2016</year><volume>9</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/j.apjtm.2015.12.002</pub-id><?supplied-pmid 26851778?><pub-id pub-id-type="pmid">26851778</pub-id></element-citation></ref><ref id="B74-biomolecules-11-00011"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>C.</given-names></name><name><surname>Xi</surname><given-names>C.</given-names></name><name><surname>Hu</surname><given-names>K.</given-names></name><name><surname>Gao</surname><given-names>W.</given-names></name><name><surname>Cai</surname><given-names>X.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Lv</surname><given-names>S.</given-names></name><name><surname>Du</surname><given-names>C.</given-names></name><name><surname>Wei</surname><given-names>Y.</given-names></name></person-group><article-title>Inhibition of enterovirus 71 replication and viral 3C protease by quercetin</article-title><source>Virol. J.</source><year>2018</year><volume>15</volume><fpage>116</fpage><pub-id pub-id-type="doi">10.1186/s12985-018-1023-6</pub-id><?supplied-pmid 30064445?><pub-id pub-id-type="pmid">30064445</pub-id></element-citation></ref><ref id="B75-biomolecules-11-00011"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Gonz&#x000e1;lez-B&#x000fa;rquez</surname><given-names>M.J.</given-names></name><name><surname>Gonz&#x000e1;lez-D&#x000ed;az</surname><given-names>F.R.</given-names></name><name><surname>Garc&#x000ed;a-Tovar</surname><given-names>C.G.</given-names></name><name><surname>Carrillo-Miranda</surname><given-names>L.</given-names></name><name><surname>Soto-Z&#x000e1;rate</surname><given-names>C.I.</given-names></name><name><surname>Canales-Mart&#x000ed;nez</surname><given-names>M.M.</given-names></name><name><surname>Penieres-Carrillo</surname><given-names>J.G.</given-names></name><name><surname>Cr&#x000fa;z-S&#x000e1;nchez</surname><given-names>T.A.</given-names></name><name><surname>Fonseca-Coronado</surname><given-names>S.</given-names></name></person-group><article-title>Comparison between in vitro antiviral effect of Mexican propolis and three commercial Flavonoids against Canine Distemper Virus</article-title><source>Evid. Based Complement. Altern. Med.</source><year>2018</year><volume>2018</volume><fpage>7092416</fpage><pub-id pub-id-type="doi">10.1155/2018/7092416</pub-id></element-citation></ref><ref id="B76-biomolecules-11-00011"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salehi</surname><given-names>B.</given-names></name><name><surname>Fokou</surname><given-names>P.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>M.</given-names></name><name><surname>Zucca</surname><given-names>P.</given-names></name><name><surname>Pezzani</surname><given-names>R.</given-names></name><name><surname>Martins</surname><given-names>N.</given-names></name><name><surname>Sharifi-Rad</surname><given-names>J.</given-names></name></person-group><article-title>The therapeutic potential of Naringenin: A review of clinical trials</article-title><source>Pharmaceuticals</source><year>2019</year><volume>12</volume><elocation-id>11</elocation-id><pub-id pub-id-type="doi">10.3390/ph12010011</pub-id></element-citation></ref><ref id="B77-biomolecules-11-00011"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>J.-G.</given-names></name><name><surname>Lee</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y.S.</given-names></name><name><surname>Hwang</surname><given-names>Y.-H.</given-names></name><name><surname>Oh</surname><given-names>Y.-C.</given-names></name><name><surname>Lee</surname><given-names>B.</given-names></name><name><surname>Moon</surname><given-names>K.M.</given-names></name><name><surname>Cho</surname><given-names>W.-K.</given-names></name><name><surname>Ma</surname><given-names>J.Y.</given-names></name></person-group><article-title><italic>Aloe vera</italic> and its components inhibit influenza a virus-induced autophagy and replication</article-title><source>Am. J. Chin. Med.</source><year>2019</year><volume>47</volume><fpage>1307</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1142/S0192415X19500678</pub-id><pub-id pub-id-type="pmid">31505936</pub-id></element-citation></ref><ref id="B78-biomolecules-11-00011"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marunaka</surname><given-names>Y.</given-names></name></person-group><article-title>Actions of quercetin, a flavonoid, on ion transporters: Its physiological roles</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2017</year><volume>1398</volume><fpage>142</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1111/nyas.13361</pub-id><pub-id pub-id-type="pmid">28574574</pub-id></element-citation></ref><ref id="B79-biomolecules-11-00011"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.-J.</given-names></name><name><surname>Chang</surname><given-names>Y.-C.</given-names></name><name><surname>Hsiao</surname><given-names>N.-W.</given-names></name><name><surname>Hsieh</surname><given-names>J.-L.</given-names></name><name><surname>Wang</surname><given-names>C.-Y.</given-names></name><name><surname>Kung</surname><given-names>S.-H.</given-names></name><name><surname>Tsai</surname><given-names>F.-J.</given-names></name><name><surname>Lan</surname><given-names>Y.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-W.</given-names></name></person-group><article-title>Fisetin and rutin as 3C protease inhibitors of enterovirus A71</article-title><source>J. Virol. Methods</source><year>2012</year><volume>182</volume><fpage>93</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.jviromet.2012.03.020</pub-id><pub-id pub-id-type="pmid">22465253</pub-id></element-citation></ref><ref id="B80-biomolecules-11-00011"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d6;z&#x000e7;elik</surname><given-names>B.</given-names></name><name><surname>Kartal</surname><given-names>M.</given-names></name><name><surname>Orhan</surname><given-names>I.</given-names></name></person-group><article-title>Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids</article-title><source>Pharm. Biol.</source><year>2011</year><volume>49</volume><fpage>396</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.3109/13880209.2010.519390</pub-id><pub-id pub-id-type="pmid">21391841</pub-id></element-citation></ref><ref id="B81-biomolecules-11-00011"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W.</given-names></name></person-group><article-title>Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication&#x02014;inducible cell line</article-title><source>World J. Gastroenterol.</source><year>2011</year><volume>17</volume><fpage>1507</fpage><pub-id pub-id-type="doi">10.3748/wjg.v17.i11.1507</pub-id><pub-id pub-id-type="pmid">21472112</pub-id></element-citation></ref><ref id="B82-biomolecules-11-00011"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>L.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Shu</surname><given-names>W.</given-names></name><name><surname>Gao</surname><given-names>B.</given-names></name><name><surname>Xiong</surname><given-names>S.</given-names></name></person-group><article-title>Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication</article-title><source>Cell Death Dis.</source><year>2015</year><volume>6</volume><fpage>e1770</fpage><pub-id pub-id-type="doi">10.1038/cddis.2015.136</pub-id><?supplied-pmid 25996297?><pub-id pub-id-type="pmid">25996297</pub-id></element-citation></ref><ref id="B83-biomolecules-11-00011"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colpitts</surname><given-names>C.C.</given-names></name><name><surname>Schang</surname><given-names>L.M.</given-names></name></person-group><article-title>A Small molecule inhibits virion attachment to Heparan Sulfate- or Sialic Acid-containing Glycans</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>7806</fpage><lpage>7817</lpage><pub-id pub-id-type="doi">10.1128/JVI.00896-14</pub-id><?supplied-pmid 24789779?><pub-id pub-id-type="pmid">24789779</pub-id></element-citation></ref><ref id="B84-biomolecules-11-00011"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>Z.</given-names></name><name><surname>Zheng</surname><given-names>W.</given-names></name></person-group><article-title>A review of the antiviral role of green tea catechins</article-title><source>Molecules</source><year>2017</year><volume>22</volume><elocation-id>1337</elocation-id><pub-id pub-id-type="doi">10.3390/molecules22081337</pub-id></element-citation></ref><ref id="B85-biomolecules-11-00011"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jasso-Miranda</surname><given-names>C.</given-names></name><name><surname>Herrera-Camacho</surname><given-names>I.</given-names></name><name><surname>Flores-Mendoza</surname><given-names>L.K.</given-names></name><name><surname>Dominguez</surname><given-names>F.</given-names></name><name><surname>Vallejo-Ruiz</surname><given-names>V.</given-names></name><name><surname>Sanchez-Burgos</surname><given-names>G.G.</given-names></name><name><surname>Pando-Robles</surname><given-names>V.</given-names></name><name><surname>Santos-Lopez</surname><given-names>G.</given-names></name><name><surname>Reyes-Leyva</surname><given-names>J.</given-names></name></person-group><article-title>Antiviral and immunomodulatory effects of polyphenols on macrophages infected with dengue virus serotypes 2 and 3 enhanced or not with antibodies</article-title><source>Infect. Drug Resist.</source><year>2019</year><volume>12</volume><fpage>1833</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.2147/IDR.S210890</pub-id><?supplied-pmid 31303775?><pub-id pub-id-type="pmid">31303775</pub-id></element-citation></ref><ref id="B86-biomolecules-11-00011"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Igbe</surname><given-names>I.</given-names></name><name><surname>Shen</surname><given-names>X.-F.</given-names></name><name><surname>Jiao</surname><given-names>W.</given-names></name><name><surname>Qiang</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>W.-L.</given-names></name><name><surname>Liu</surname><given-names>H.-W.</given-names></name><name><surname>Zhang</surname><given-names>G.-L.</given-names></name><name><surname>Wang</surname><given-names>F.</given-names></name></person-group><article-title>Dietary quercetin potentiates the antiproliferative effect of interferon-&#x003b1; in hepatocellular carcinoma cells through activation of JAK/STAT pathway signaling by inhibition of SHP2 phosphatase</article-title><source>Oncotarget</source><year>2017</year><volume>8</volume><fpage>113734</fpage><lpage>113748</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.22556</pub-id><pub-id pub-id-type="pmid">29371942</pub-id></element-citation></ref><ref id="B87-biomolecules-11-00011"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trujillo-Correa</surname><given-names>A.I.</given-names></name><name><surname>Quintero-Gil</surname><given-names>D.C.</given-names></name><name><surname>Diaz-Castillo</surname><given-names>F.</given-names></name><name><surname>Qui&#x000f1;ones</surname><given-names>W.</given-names></name><name><surname>Robledo</surname><given-names>S.M.</given-names></name><name><surname>Martinez-Gutierrez</surname><given-names>M.</given-names></name></person-group><article-title>In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting</article-title><source>BMC Complement. Altern. Med.</source><year>2019</year><volume>19</volume><elocation-id>298</elocation-id><pub-id pub-id-type="doi">10.1186/s12906-019-2695-1</pub-id><?supplied-pmid 31694638?><pub-id pub-id-type="pmid">31694638</pub-id></element-citation></ref><ref id="B88-biomolecules-11-00011"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dwivedi</surname><given-names>V.D.</given-names></name><name><surname>Bharadwaj</surname><given-names>S.</given-names></name><name><surname>Afroz</surname><given-names>S.</given-names></name><name><surname>Khan</surname><given-names>N.</given-names></name><name><surname>Ansari</surname><given-names>M.A.</given-names></name><name><surname>Yadava</surname><given-names>U.</given-names></name><name><surname>Tripathi</surname><given-names>R.C.</given-names></name><name><surname>Tripathi</surname><given-names>I.P.</given-names></name><name><surname>Mishra</surname><given-names>S.K.</given-names></name><name><surname>Kang</surname><given-names>S.G.</given-names></name></person-group><article-title>Anti-dengue infectivity evaluation of bioflavonoid from <italic>Azadirachta indica</italic> by dengue virus serine protease inhibition</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1734485</pub-id></element-citation></ref><ref id="B89-biomolecules-11-00011"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ismail</surname><given-names>N.A.</given-names></name><name><surname>Jusoh</surname><given-names>S.A.</given-names></name></person-group><article-title>Molecular docking and molecular dynamics simulation studies to predict flavonoid binding on the surface of DENV2 E protein</article-title><source>Interdiscip. Sci. Comput. Life Sci.</source><year>2017</year><volume>9</volume><fpage>499</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1007/s12539-016-0157-8</pub-id></element-citation></ref><ref id="B90-biomolecules-11-00011"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qamar</surname><given-names>M.</given-names></name><name><surname>Mumtaz</surname><given-names>A.</given-names></name><name><surname>Naseem</surname><given-names>R.</given-names></name><name><surname>Ali</surname><given-names>A.</given-names></name><name><surname>Fatima</surname><given-names>T.</given-names></name><name><surname>Jabbar</surname><given-names>T.</given-names></name><name><surname>Ahmad</surname><given-names>Z.</given-names></name><name><surname>Ashfaq</surname><given-names>U.A.</given-names></name></person-group><article-title>Molecular docking based screening of plant flavonoids as Dengue NS1 inhibitors</article-title><source>Bioinformation</source><year>2014</year><volume>10</volume><fpage>460</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.6026/97320630010460</pub-id><pub-id pub-id-type="pmid">25187688</pub-id></element-citation></ref><ref id="B91-biomolecules-11-00011"><label>91.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Sousa</surname><given-names>L.R.F.</given-names></name><name><surname>Wu</surname><given-names>H.</given-names></name><name><surname>Nebo</surname><given-names>L.</given-names></name><name><surname>Fernandes</surname><given-names>J.B.</given-names></name><name><surname>das Gra&#x000e7;as Fernandes da Silva</surname><given-names>M.F.</given-names></name><name><surname>Kiefer</surname><given-names>W.</given-names></name><name><surname>Kanitz</surname><given-names>M.</given-names></name><name><surname>Bodem</surname><given-names>J.</given-names></name><name><surname>Diederich</surname><given-names>W.E.</given-names></name><name><surname>Schirmeister</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Flavonoids as noncompetitive inhibitors of Dengue virus NS2B-NS3 protease: Inhibition kinetics and docking studies</article-title><source>Bioorg. Med. Chem.</source><year>2015</year><volume>23</volume><fpage>466</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.bmc.2014.12.015</pub-id><pub-id pub-id-type="pmid">25564380</pub-id></element-citation></ref><ref id="B92-biomolecules-11-00011"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senthilvel</surname><given-names>P.</given-names></name><name><surname>Lavanya</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>K.M.</given-names></name><name><surname>Swetha</surname><given-names>R.</given-names></name><name><surname>Anitha</surname><given-names>P.</given-names></name><name><surname>Bag</surname><given-names>S.</given-names></name><name><surname>Sarveswari</surname><given-names>S.</given-names></name><name><surname>Vijayakumar</surname><given-names>V.</given-names></name><name><surname>Ramaiah</surname><given-names>S.</given-names></name><name><surname>Anbarasu</surname><given-names>A.</given-names></name></person-group><article-title>Flavonoid from Carica papaya inhibits NS2B-NS3 protease and prevents Dengue 2 viral assembly</article-title><source>Bioinformation</source><year>2013</year><volume>9</volume><fpage>889</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.6026/97320630009889</pub-id><pub-id pub-id-type="pmid">24307765</pub-id></element-citation></ref><ref id="B93-biomolecules-11-00011"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chappell</surname><given-names>K.</given-names></name><name><surname>Stoermer</surname><given-names>M.</given-names></name><name><surname>Fairlie</surname><given-names>D.</given-names></name><name><surname>Young</surname><given-names>P.</given-names></name></person-group><article-title>West Nile Virus NS2B/NS3 protease as an antiviral target</article-title><source>Curr. Med. Chem.</source><year>2008</year><volume>15</volume><fpage>2771</fpage><lpage>2784</lpage><pub-id pub-id-type="doi">10.2174/092986708786242804</pub-id><pub-id pub-id-type="pmid">18991636</pub-id></element-citation></ref><ref id="B94-biomolecules-11-00011"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.M.</given-names></name><name><surname>Gayen</surname><given-names>S.</given-names></name><name><surname>Kang</surname><given-names>C.</given-names></name><name><surname>Joy</surname><given-names>J.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>A.S.</given-names></name><name><surname>Wee</surname><given-names>J.L.K.</given-names></name><name><surname>Ang</surname><given-names>M.J.Y.</given-names></name><name><surname>Lim</surname><given-names>H.A.</given-names></name><name><surname>Hung</surname><given-names>A.W.</given-names></name><etal/></person-group><article-title>NMR Analysis of a novel enzymatically active unlinked Dengue NS2B-NS3 protease complex</article-title><source>J. Biol. Chem.</source><year>2013</year><volume>288</volume><fpage>12891</fpage><lpage>12900</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.442723</pub-id><pub-id pub-id-type="pmid">23511634</pub-id></element-citation></ref><ref id="B95-biomolecules-11-00011"><label>95.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keivan</surname><given-names>Z.</given-names></name><name><surname>Teoh</surname><given-names>B.-T.</given-names></name><name><surname>Sam</surname><given-names>S.-S.</given-names></name><name><surname>Wong</surname><given-names>P.-F.</given-names></name><name><surname>Mustafa</surname><given-names>M.R.</given-names></name><name><surname>AbuBakar</surname><given-names>S.</given-names></name></person-group><article-title>In vitro antiviral activity of fisetin, rutin and naringenin against dengue virus type-2</article-title><source>J. Med. Plants Res.</source><year>2011</year><volume>5</volume><fpage>5534</fpage><lpage>5539</lpage></element-citation></ref><ref id="B96-biomolecules-11-00011"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zandi</surname><given-names>K.</given-names></name><name><surname>Teoh</surname><given-names>B.-T.</given-names></name><name><surname>Sam</surname><given-names>S.-S.</given-names></name><name><surname>Wong</surname><given-names>P.-F.</given-names></name><name><surname>Mustafa</surname><given-names>M.</given-names></name><name><surname>AbuBakar</surname><given-names>S.</given-names></name></person-group><article-title>Antiviral activity of four types of bioflavonoid against dengue virus type-2</article-title><source>Virol. J.</source><year>2011</year><volume>8</volume><fpage>560</fpage><pub-id pub-id-type="doi">10.1186/1743-422X-8-560</pub-id><?supplied-pmid 22201648?><pub-id pub-id-type="pmid">22201648</pub-id></element-citation></ref><ref id="B97-biomolecules-11-00011"><label>97.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raekiansyah</surname><given-names>M.</given-names></name><name><surname>Buerano</surname><given-names>C.C.</given-names></name><name><surname>Luz</surname><given-names>M.A.D.</given-names></name><name><surname>Morita</surname><given-names>K.</given-names></name></person-group><article-title>Inhibitory effect of the green tea molecule EGCG against dengue virus infection</article-title><source>Arch. Virol.</source><year>2018</year><volume>163</volume><fpage>1649</fpage><lpage>1655</lpage><pub-id pub-id-type="doi">10.1007/s00705-018-3769-y</pub-id><?supplied-pmid 29429035?><pub-id pub-id-type="pmid">29429035</pub-id></element-citation></ref><ref id="B98-biomolecules-11-00011"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>V&#x000e1;zquez-Calvo</surname><given-names>&#x000c1;.</given-names></name><name><surname>Jim&#x000e9;nez de Oya</surname><given-names>N.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name><name><surname>Garcia-Moruno</surname><given-names>E.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name></person-group><article-title>Antiviral properties of the natural Polyphenols Delphinidin and Epigallocatechin Gallate against the Flaviviruses West Nile Virus, Zika Virus, and Dengue Virus</article-title><source>Front. Microbiol.</source><year>2017</year><volume>8</volume><pub-id pub-id-type="doi">10.3389/fmicb.2017.01314</pub-id><?supplied-pmid 28744282?><pub-id pub-id-type="pmid">28744282</pub-id></element-citation></ref><ref id="B99-biomolecules-11-00011"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johari</surname><given-names>J.</given-names></name><name><surname>Kianmehr</surname><given-names>A.</given-names></name><name><surname>Mustafa</surname><given-names>M.</given-names></name><name><surname>Abubakar</surname><given-names>S.</given-names></name><name><surname>Zandi</surname><given-names>K.</given-names></name></person-group><article-title>Antiviral activity of Baicalein and Quercetin against the Japanese Encephalitis Virus</article-title><source>Int. J. Mol. Sci.</source><year>2012</year><volume>13</volume><fpage>16785</fpage><lpage>16795</lpage><pub-id pub-id-type="doi">10.3390/ijms131216785</pub-id><pub-id pub-id-type="pmid">23222683</pub-id></element-citation></ref><ref id="B100-biomolecules-11-00011"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zandi</surname><given-names>K.</given-names></name><name><surname>Teoh</surname><given-names>B.-T.</given-names></name><name><surname>Sam</surname><given-names>S.-S.</given-names></name><name><surname>Wong</surname><given-names>P.-F.</given-names></name><name><surname>Mustafa</surname><given-names>M.R.</given-names></name><name><surname>AbuBakar</surname><given-names>S.</given-names></name></person-group><article-title>Novel antiviral activity of baicalein against dengue virus</article-title><source>BMC Complement. Altern. Med.</source><year>2012</year><volume>12</volume><elocation-id>1185</elocation-id><pub-id pub-id-type="doi">10.1186/1472-6882-12-214</pub-id></element-citation></ref><ref id="B101-biomolecules-11-00011"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shukla</surname><given-names>Y.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name></person-group><article-title>Resveratrol and cellular mechanisms of cancer prevention</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2011</year><volume>1215</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2010.05870.x</pub-id><pub-id pub-id-type="pmid">21261635</pub-id></element-citation></ref><ref id="B102-biomolecules-11-00011"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>X.-N.</given-names></name><name><surname>Lou</surname><given-names>H.-X.</given-names></name></person-group><article-title>Natural stilbenes: An overview</article-title><source>Nat. Prod. Rep.</source><year>2009</year><volume>26</volume><fpage>916</fpage><pub-id pub-id-type="doi">10.1039/b905960a</pub-id><?supplied-pmid 19554241?><pub-id pub-id-type="pmid">19554241</pub-id></element-citation></ref><ref id="B103-biomolecules-11-00011"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T.</given-names></name></person-group><article-title>Resveratrol oligomer structure in Dipterocarpaceaeous plants</article-title><source>J. Nat. Med.</source><year>2020</year><volume>74</volume><fpage>619</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1007/s11418-020-01412-x</pub-id><?supplied-pmid 32356240?><pub-id pub-id-type="pmid">32356240</pub-id></element-citation></ref><ref id="B104-biomolecules-11-00011"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nawaz</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>Z.</given-names></name><name><surname>Deng</surname><given-names>S.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Ma</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Shu</surname><given-names>X.</given-names></name></person-group><article-title>Therapeutic versatility of resveratrol derivatives</article-title><source>Nutrients</source><year>2017</year><volume>9</volume><elocation-id>1188</elocation-id><pub-id pub-id-type="doi">10.3390/nu9111188</pub-id><?supplied-pmid 29109374?><pub-id pub-id-type="pmid">29109374</pub-id></element-citation></ref><ref id="B105-biomolecules-11-00011"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thapa</surname><given-names>S.B.</given-names></name><name><surname>Pandey</surname><given-names>R.P.</given-names></name><name><surname>Park</surname><given-names>Y.</given-names><suffix>II</suffix></name><name><surname>Sohng</surname><given-names>J.K.</given-names></name></person-group><article-title>Biotechnological advances in resveratrol production and its chemical diversity</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>2571</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24142571</pub-id><?supplied-pmid 31311182?><pub-id pub-id-type="pmid">31311182</pub-id></element-citation></ref><ref id="B106-biomolecules-11-00011"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abba</surname><given-names>Y.</given-names></name><name><surname>Hassim</surname><given-names>H.</given-names></name><name><surname>Hamzah</surname><given-names>H.</given-names></name><name><surname>Noordin</surname><given-names>M.M.</given-names></name></person-group><article-title>Antiviral activity of resveratrol against human and animal viruses</article-title><source>Adv. Virol.</source><year>2015</year><volume>2015</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1155/2015/184241</pub-id><?supplied-pmid 26693226?><pub-id pub-id-type="pmid">26693226</pub-id></element-citation></ref><ref id="B107-biomolecules-11-00011"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohd</surname><given-names>A.</given-names></name><name><surname>Zainal</surname><given-names>N.</given-names></name><name><surname>Tan</surname><given-names>K.-K.</given-names></name><name><surname>AbuBakar</surname><given-names>S.</given-names></name></person-group><article-title>Resveratrol affects Zika virus replication in vitro</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>14336</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-50674-3</pub-id><pub-id pub-id-type="pmid">31586088</pub-id></element-citation></ref><ref id="B108-biomolecules-11-00011"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>M.</given-names></name></person-group><article-title>An antioxidant resveratrol significantly enhanced replication of hepatitis C virus</article-title><source>World J. Gastroenterol.</source><year>2010</year><volume>16</volume><fpage>184</fpage><pub-id pub-id-type="doi">10.3748/wjg.v16.i2.184</pub-id><pub-id pub-id-type="pmid">20066737</pub-id></element-citation></ref><ref id="B109-biomolecules-11-00011"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paemanee</surname><given-names>A.</given-names></name><name><surname>Hitakarun</surname><given-names>A.</given-names></name><name><surname>Roytrakul</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>D.R.</given-names></name></person-group><article-title>Screening of melatonin, &#x003b1;-tocopherol, folic acid, acetyl-l-carnitine and resveratrol for anti-dengue 2 virus activity</article-title><source>BMC Res. Notes</source><year>2018</year><volume>11</volume><elocation-id>307</elocation-id><pub-id pub-id-type="doi">10.1186/s13104-018-3417-3</pub-id><pub-id pub-id-type="pmid">29769094</pub-id></element-citation></ref><ref id="B110-biomolecules-11-00011"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zainal</surname><given-names>N.</given-names></name><name><surname>Chang</surname><given-names>C.-P.</given-names></name><name><surname>Cheng</surname><given-names>Y.-L.</given-names></name><name><surname>Wu</surname><given-names>Y.-W.</given-names></name><name><surname>Anderson</surname><given-names>R.</given-names></name><name><surname>Wan</surname><given-names>S.-W.</given-names></name><name><surname>Chen</surname><given-names>C.-L.</given-names></name><name><surname>Ho</surname><given-names>T.-S.</given-names></name><name><surname>AbuBakar</surname><given-names>S.</given-names></name><name><surname>Lin</surname><given-names>Y.-S.</given-names></name></person-group><article-title>Resveratrol treatment reveals a novel role for HMGB1 in regulation of the type 1 interferon response in dengue virus infection</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>42998</fpage><pub-id pub-id-type="doi">10.1038/srep42998</pub-id><pub-id pub-id-type="pmid">28216632</pub-id></element-citation></ref><ref id="B111-biomolecules-11-00011"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>S.P.</given-names></name><name><surname>Lee</surname><given-names>L.M.</given-names></name><name><surname>Leong</surname><given-names>Y.F.I.</given-names></name><name><surname>Ng</surname><given-names>M.L.</given-names></name><name><surname>Chu</surname><given-names>J.J.H.</given-names></name></person-group><article-title>Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in Endothelial cells</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e41932</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0041932</pub-id><pub-id pub-id-type="pmid">22860034</pub-id></element-citation></ref><ref id="B112-biomolecules-11-00011"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>Y.-S.</given-names></name><name><surname>Penthala</surname><given-names>N.R.</given-names></name><name><surname>Oliveira</surname><given-names>M.</given-names></name><name><surname>Mespl&#x000e8;de</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Quan</surname><given-names>Y.</given-names></name><name><surname>Crooks</surname><given-names>P.A.</given-names></name><name><surname>Wainberg</surname><given-names>M.A.</given-names></name></person-group><article-title>Identification of resveratrol analogs as potent anti-dengue agents using a cell-based assay</article-title><source>J. Med. Virol.</source><year>2017</year><volume>89</volume><fpage>397</fpage><lpage>407</lpage><pub-id pub-id-type="doi">10.1002/jmv.24660</pub-id><?supplied-pmid 27509184?><pub-id pub-id-type="pmid">27509184</pub-id></element-citation></ref><ref id="B113-biomolecules-11-00011"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname><given-names>M.</given-names></name><name><surname>Garcia-Blanco</surname><given-names>M.</given-names></name></person-group><article-title>Targeting host factors to treat west Nile and Dengue Viral infections</article-title><source>Viruses</source><year>2014</year><volume>6</volume><fpage>683</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.3390/v6020683</pub-id><?supplied-pmid 24517970?><pub-id pub-id-type="pmid">24517970</pub-id></element-citation></ref><ref id="B114-biomolecules-11-00011"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Wispelaere</surname><given-names>M.</given-names></name><name><surname>LaCroix</surname><given-names>A.J.</given-names></name><name><surname>Yang</surname><given-names>P.L.</given-names></name></person-group><article-title>The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn Kinase</article-title><source>J. Virol.</source><year>2013</year><volume>87</volume><fpage>7367</fpage><lpage>7381</lpage><pub-id pub-id-type="doi">10.1128/JVI.00632-13</pub-id><?supplied-pmid 23616652?><pub-id pub-id-type="pmid">23616652</pub-id></element-citation></ref><ref id="B115-biomolecules-11-00011"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x000fc;</surname><given-names>J.-M.</given-names></name><name><surname>Nurko</surname><given-names>J.</given-names></name><name><surname>Weakley</surname><given-names>S.M.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Kougias</surname><given-names>P.</given-names></name><name><surname>Lin</surname><given-names>P.H.</given-names></name><name><surname>Yao</surname><given-names>Q.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name></person-group><article-title>Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: An update</article-title><source>Med. Sci. Monit. Int. Med. J. Exp. Clin. Res.</source><year>2010</year><volume>16</volume><fpage>RA93</fpage></element-citation></ref><ref id="B116-biomolecules-11-00011"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manda</surname><given-names>G.</given-names></name><name><surname>Rojo</surname><given-names>A.I.</given-names></name><name><surname>Mart&#x000ed;nez-Klimova</surname><given-names>E.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name><name><surname>Cuadrado</surname><given-names>A.</given-names></name></person-group><article-title>Nordihydroguaiaretic Acid: From herbal medicine to clinical development for cancer and chronic diseases</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>11</volume><pub-id pub-id-type="doi">10.3389/fphar.2020.00151</pub-id></element-citation></ref><ref id="B117-biomolecules-11-00011"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hern&#x000e1;ndez-Dami&#x000e1;n</surname><given-names>J.</given-names></name><name><surname>And&#x000e9;rica-Romero</surname><given-names>A.C.</given-names></name><name><surname>Pedraza-Chaverri</surname><given-names>J.</given-names></name></person-group><article-title>Paradoxical cellular effects and biological role of the multifaceted compound Nordihydroguaiaretic Acid</article-title><source>Arch. Pharm. (Weinheim)</source><year>2014</year><volume>347</volume><fpage>685</fpage><lpage>697</lpage><pub-id pub-id-type="doi">10.1002/ardp.201400159</pub-id><pub-id pub-id-type="pmid">25100573</pub-id></element-citation></ref><ref id="B118-biomolecules-11-00011"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iranpour</surname><given-names>M.</given-names></name><name><surname>Moghadam</surname><given-names>A.R.</given-names></name><name><surname>Yazdi</surname><given-names>M.</given-names></name><name><surname>Ande</surname><given-names>S.R.</given-names></name><name><surname>Alizadeh</surname><given-names>J.</given-names></name><name><surname>Wiechec</surname><given-names>E.</given-names></name><name><surname>Lindsay</surname><given-names>R.</given-names></name><name><surname>Drebot</surname><given-names>M.</given-names></name><name><surname>Coombs</surname><given-names>K.M.</given-names></name><name><surname>Ghavami</surname><given-names>S.</given-names></name></person-group><article-title>Apoptosis, autophagy and unfolded protein response pathways in Arbovirus replication and pathogenesis</article-title><source>Expert Rev. Mol. Med.</source><year>2016</year><volume>18</volume><fpage>e1</fpage><pub-id pub-id-type="doi">10.1017/erm.2015.19</pub-id><pub-id pub-id-type="pmid">26781343</pub-id></element-citation></ref><ref id="B119-biomolecules-11-00011"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hwu</surname><given-names>J.R.</given-names></name><name><surname>Hsu</surname><given-names>M.-H.</given-names></name><name><surname>Huang</surname><given-names>R.C.C.</given-names></name></person-group><article-title>New nordihydroguaiaretic acid derivatives as anti-HIV agents</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2008</year><volume>18</volume><fpage>1884</fpage><lpage>1888</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2008.02.018</pub-id><pub-id pub-id-type="pmid">18321703</pub-id></element-citation></ref><ref id="B120-biomolecules-11-00011"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uchide</surname><given-names>N.</given-names></name><name><surname>Ohyama</surname><given-names>K.</given-names></name><name><surname>Bessho</surname><given-names>T.</given-names></name><name><surname>Toyoda</surname><given-names>H.</given-names></name></person-group><article-title>Inhibition of Influenza-Virus-Induced Apoptosis in Chorion cells of human fetal membranes by Nordihydroguaiaretic Acid</article-title><source>Intervirology</source><year>2005</year><volume>48</volume><fpage>336</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1159/000085103</pub-id><pub-id pub-id-type="pmid">15956802</pub-id></element-citation></ref><ref id="B121-biomolecules-11-00011"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname><given-names>G.H.</given-names></name><name><surname>Siddiqui</surname><given-names>A.</given-names></name></person-group><article-title>Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus</article-title><source>Hepatology</source><year>2011</year><volume>54</volume><fpage>1936</fpage><lpage>1946</lpage><pub-id pub-id-type="doi">10.1002/hep.24619</pub-id><pub-id pub-id-type="pmid">21858850</pub-id></element-citation></ref><ref id="B122-biomolecules-11-00011"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samsa</surname><given-names>M.M.</given-names></name><name><surname>Mondotte</surname><given-names>J.A.</given-names></name><name><surname>Iglesias</surname><given-names>N.G.</given-names></name><name><surname>Assun&#x000e7;&#x000e3;o-Miranda</surname><given-names>I.</given-names></name><name><surname>Barbosa-Lima</surname><given-names>G.</given-names></name><name><surname>Da Poian</surname><given-names>A.T.</given-names></name><name><surname>Bozza</surname><given-names>P.T.</given-names></name><name><surname>Gamarnik</surname><given-names>A.V.</given-names></name></person-group><article-title>Dengue virus Capsid protein usurps lipid droplets for viral particle formation</article-title><source>PLoS Pathog.</source><year>2009</year><volume>5</volume><elocation-id>e1000632</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1000632</pub-id><?supplied-pmid 19851456?><pub-id pub-id-type="pmid">19851456</pub-id></element-citation></ref><ref id="B123-biomolecules-11-00011"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto-Acosta</surname><given-names>R.</given-names></name><name><surname>Bautista-Carbajal</surname><given-names>P.</given-names></name><name><surname>Syed</surname><given-names>G.H.</given-names></name><name><surname>Siddiqui</surname><given-names>A.</given-names></name><name><surname>Del Angel</surname><given-names>R.M.</given-names></name></person-group><article-title>Nordihydroguaiaretic acid (NDGA) inhibits replication and viral morphogenesis of Dengue virus</article-title><source>Antivir. Res.</source><year>2014</year><volume>109</volume><fpage>132</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2014.07.002</pub-id><?supplied-pmid 25017471?><pub-id pub-id-type="pmid">25017471</pub-id></element-citation></ref><ref id="B124-biomolecules-11-00011"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carvalho</surname><given-names>F.A.</given-names></name><name><surname>Carneiro</surname><given-names>F.A.</given-names></name><name><surname>Martins</surname><given-names>I.C.</given-names></name><name><surname>Assuncao-Miranda</surname><given-names>I.</given-names></name><name><surname>Faustino</surname><given-names>A.F.</given-names></name><name><surname>Pereira</surname><given-names>R.M.</given-names></name><name><surname>Bozza</surname><given-names>P.T.</given-names></name><name><surname>Castanho</surname><given-names>M.A.R.B.</given-names></name><name><surname>Mohana-Borges</surname><given-names>R.</given-names></name><name><surname>Da Poian</surname><given-names>A.T.</given-names></name><etal/></person-group><article-title>Dengue Virus Capsid protein binding to Hepatic Lipid Droplets (LD) is Potassium Ion dependent and is mediated by LD surface proteins</article-title><source>J. Virol.</source><year>2012</year><volume>86</volume><fpage>2096</fpage><lpage>2108</lpage><pub-id pub-id-type="doi">10.1128/JVI.06796-11</pub-id><?supplied-pmid 22130547?><pub-id pub-id-type="pmid">22130547</pub-id></element-citation></ref><ref id="B125-biomolecules-11-00011"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez-Gutierrez</surname><given-names>M.</given-names></name><name><surname>Castellanos</surname><given-names>J.E.</given-names></name><name><surname>Gallego-G&#x000f3;mez</surname><given-names>J.C.</given-names></name></person-group><article-title>Statins reduce Dengue virus production via decreased Virion assembly</article-title><source>Intervirology</source><year>2011</year><volume>54</volume><fpage>202</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1159/000321892</pub-id><?supplied-pmid 21293097?><pub-id pub-id-type="pmid">21293097</pub-id></element-citation></ref><ref id="B126-biomolecules-11-00011"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name><name><surname>V&#x000e1;zquez-Calvo</surname><given-names>&#x000c1;.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name></person-group><article-title>Lipids and flaviviruses, present and future perspectives for the control of dengue, Zika, and West Nile viruses</article-title><source>Prog. Lipid Res.</source><year>2016</year><volume>64</volume><fpage>123</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1016/j.plipres.2016.09.005</pub-id><?supplied-pmid 27702593?><pub-id pub-id-type="pmid">27702593</pub-id></element-citation></ref><ref id="B127-biomolecules-11-00011"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Villareal</surname><given-names>V.A.</given-names></name><name><surname>Rodgers</surname><given-names>M.A.</given-names></name><name><surname>Costello</surname><given-names>D.A.</given-names></name><name><surname>Yang</surname><given-names>P.L.</given-names></name></person-group><article-title>Targeting host lipid synthesis and metabolism to inhibit dengue and hepatitis C viruses</article-title><source>Antivir. Res.</source><year>2015</year><volume>124</volume><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2015.10.013</pub-id><pub-id pub-id-type="pmid">26526588</pub-id></element-citation></ref><ref id="B128-biomolecules-11-00011"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merino-Ramos</surname><given-names>T.</given-names></name><name><surname>Bl&#x000e1;zquez</surname><given-names>A.-B.</given-names></name><name><surname>Escribano-Romero</surname><given-names>E.</given-names></name><name><surname>Ca&#x000f1;as-Arranz</surname><given-names>R.</given-names></name><name><surname>Sobrino</surname><given-names>F.</given-names></name><name><surname>Saiz</surname><given-names>J.-C.</given-names></name><name><surname>Mart&#x000ed;n-Acebes</surname><given-names>M.A.</given-names></name></person-group><article-title>Protection of a single dose West Nile Virus recombinant subviral particle vaccine against Lineage 1 or 2 strains and analysis of the cross-reactivity with Usutu virus</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e108056</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0108056</pub-id><?supplied-pmid 25229345?><pub-id pub-id-type="pmid">25229345</pub-id></element-citation></ref><ref id="B129-biomolecules-11-00011"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manolova</surname><given-names>Y.</given-names></name><name><surname>Deneva</surname><given-names>V.</given-names></name><name><surname>Antonov</surname><given-names>L.</given-names></name><name><surname>Drakalska</surname><given-names>E.</given-names></name><name><surname>Momekova</surname><given-names>D.</given-names></name><name><surname>Lambov</surname><given-names>N.</given-names></name></person-group><article-title>The effect of the water on the curcumin tautomerism: A quantitative approach</article-title><source>Spectrochim. Acta Part A Mol. Biomol. Spectrosc.</source><year>2014</year><volume>132</volume><fpage>815</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1016/j.saa.2014.05.096</pub-id><?supplied-pmid 24973669?><pub-id pub-id-type="pmid">24973669</pub-id></element-citation></ref><ref id="B130-biomolecules-11-00011"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuyama</surname><given-names>Y.</given-names></name><name><surname>Kita</surname><given-names>T.</given-names></name><name><surname>Funa</surname><given-names>N.</given-names></name><name><surname>Horinouchi</surname><given-names>S.</given-names></name></person-group><article-title>Curcuminoid Biosynthesis by two type III Polyketide Synthases in the Herb <italic>Curcuma longa</italic></article-title><source>J. Biol. Chem.</source><year>2009</year><volume>284</volume><fpage>11160</fpage><lpage>11170</lpage><pub-id pub-id-type="doi">10.1074/jbc.M900070200</pub-id><pub-id pub-id-type="pmid">19258320</pub-id></element-citation></ref><ref id="B131-biomolecules-11-00011"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kocaadam</surname><given-names>B.</given-names></name><name><surname>&#x0015e;anlier</surname><given-names>N.</given-names></name></person-group><article-title>Curcumin, an active component of turmeric ( <italic>Curcuma longa</italic> ), and its effects on health</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2017</year><volume>57</volume><fpage>2889</fpage><lpage>2895</lpage><pub-id pub-id-type="doi">10.1080/10408398.2015.1077195</pub-id><?supplied-pmid 26528921?><pub-id pub-id-type="pmid">26528921</pub-id></element-citation></ref><ref id="B132-biomolecules-11-00011"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joe</surname><given-names>B.</given-names></name><name><surname>Vijaykumar</surname><given-names>M.</given-names></name><name><surname>Lokesh</surname><given-names>B.R.</given-names></name></person-group><article-title>Biological properties of curcumin-cellular and molecular mechanisms of action</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2004</year><volume>44</volume><fpage>97</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1080/10408690490424702</pub-id><?supplied-pmid 15116757?><pub-id pub-id-type="pmid">15116757</pub-id></element-citation></ref><ref id="B133-biomolecules-11-00011"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ingolfsson</surname><given-names>H.I.</given-names></name><name><surname>Koeppe</surname><given-names>R.E.</given-names></name><name><surname>Andersen</surname><given-names>O.S.</given-names></name></person-group><article-title>Curcumin is a modulator of Bilayer material properties <sup>&#x02020;</sup></article-title><source>Biochemistry</source><year>2007</year><volume>46</volume><fpage>10384</fpage><lpage>10391</lpage><pub-id pub-id-type="doi">10.1021/bi701013n</pub-id><?supplied-pmid 17705403?><pub-id pub-id-type="pmid">17705403</pub-id></element-citation></ref><ref id="B134-biomolecules-11-00011"><label>134.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Si</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wong</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>McManus</surname><given-names>B.M.</given-names></name><name><surname>Luo</surname><given-names>H.</given-names></name></person-group><article-title>Dysregulation of the Ubiquitin-Proteasome system by curcumin suppresses Coxsackievirus B3 replication</article-title><source>J. Virol.</source><year>2007</year><volume>81</volume><fpage>3142</fpage><lpage>3150</lpage><pub-id pub-id-type="doi">10.1128/JVI.02028-06</pub-id><?supplied-pmid 17229707?><pub-id pub-id-type="pmid">17229707</pub-id></element-citation></ref><ref id="B135-biomolecules-11-00011"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>K.</given-names></name><name><surname>Ghosh</surname><given-names>D.</given-names></name><name><surname>Basu</surname><given-names>A.</given-names></name></person-group><article-title>Curcumin protects neuronal cells from Japanese Encephalitis Virus-mediated cell death and also inhibits infective viral particle formation by Dysregulation of Ubiquitin&#x02013;Proteasome system</article-title><source>J. Neuroimmune Pharmacol.</source><year>2009</year><volume>4</volume><fpage>328</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1007/s11481-009-9158-2</pub-id><pub-id pub-id-type="pmid">19434500</pub-id></element-citation></ref><ref id="B136-biomolecules-11-00011"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kutluay</surname><given-names>S.B.</given-names></name><name><surname>Doroghazi</surname><given-names>J.</given-names></name><name><surname>Roemer</surname><given-names>M.E.</given-names></name><name><surname>Triezenberg</surname><given-names>S.J.</given-names></name></person-group><article-title>Curcumin inhibits herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity</article-title><source>Virology</source><year>2008</year><volume>373</volume><fpage>239</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1016/j.virol.2007.11.028</pub-id><pub-id pub-id-type="pmid">18191976</pub-id></element-citation></ref><ref id="B137-biomolecules-11-00011"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>X.</given-names></name><name><surname>Ammosova</surname><given-names>T.</given-names></name><name><surname>Kumari</surname><given-names>N.</given-names></name><name><surname>Nekhai</surname><given-names>S.</given-names></name></person-group><article-title>Protein Phosphatase-1 &#x02013;targeted small molecules, Iron Chelators and Curcumin analogs as HIV-1 antivirals</article-title><source>Curr. Pharm. Des.</source><year>2017</year><volume>23</volume><pub-id pub-id-type="doi">10.2174/1381612823666170704123620</pub-id></element-citation></ref><ref id="B138-biomolecules-11-00011"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anggakusuma</surname></name><name><surname>Colpitts</surname><given-names>C.C.</given-names></name><name><surname>Schang</surname><given-names>L.M.</given-names></name><name><surname>Rachmawati</surname><given-names>H.</given-names></name><name><surname>Frentzen</surname><given-names>A.</given-names></name><name><surname>Pfaender</surname><given-names>S.</given-names></name><name><surname>Behrendt</surname><given-names>P.</given-names></name><name><surname>Brown</surname><given-names>R.J.P.</given-names></name><name><surname>Bankwitz</surname><given-names>D.</given-names></name><name><surname>Steinmann</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells</article-title><source>Gut</source><year>2014</year><volume>63</volume><fpage>1137</fpage><lpage>1149</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2012-304299</pub-id><pub-id pub-id-type="pmid">23903236</pub-id></element-citation></ref><ref id="B139-biomolecules-11-00011"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mounce</surname><given-names>B.C.</given-names></name><name><surname>Cesaro</surname><given-names>T.</given-names></name><name><surname>Carrau</surname><given-names>L.</given-names></name><name><surname>Vallet</surname><given-names>T.</given-names></name><name><surname>Vignuzzi</surname><given-names>M.</given-names></name></person-group><article-title>Curcumin inhibits Zika and chikungunya virus infection by inhibiting cell binding</article-title><source>Antivir. Res.</source><year>2017</year><volume>142</volume><fpage>148</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2017.03.014</pub-id><pub-id pub-id-type="pmid">28343845</pub-id></element-citation></ref><ref id="B140-biomolecules-11-00011"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Garcia</surname><given-names>M.-D.</given-names></name><name><surname>Meertens</surname><given-names>L.</given-names></name><name><surname>Bonazzi</surname><given-names>M.</given-names></name><name><surname>Cossart</surname><given-names>P.</given-names></name><name><surname>Arenzana-Seisdedos</surname><given-names>F.</given-names></name><name><surname>Amara</surname><given-names>A.</given-names></name></person-group><article-title>Appraising the roles of CBLL1 and the Ubiquitin/Proteasome system for Flavivirus entry and replication</article-title><source>J. Virol.</source><year>2011</year><volume>85</volume><fpage>2980</fpage><lpage>2989</lpage><pub-id pub-id-type="doi">10.1128/JVI.02483-10</pub-id><pub-id pub-id-type="pmid">21191016</pub-id></element-citation></ref><ref id="B141-biomolecules-11-00011"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padilla-S</surname><given-names>L.</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>A.</given-names></name><name><surname>Gonzales</surname><given-names>M.M.</given-names></name><name><surname>Gallego-G</surname><given-names>J.C.</given-names></name><name><surname>Casta&#x000f1;o-O</surname><given-names>J.C.</given-names></name></person-group><article-title>Inhibitory effects of curcumin on dengue virus type 2-infected cells in vitro</article-title><source>Arch. Virol.</source><year>2014</year><volume>159</volume><fpage>573</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1007/s00705-013-1849-6</pub-id><pub-id pub-id-type="pmid">24081825</pub-id></element-citation></ref><ref id="B142-biomolecules-11-00011"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>T.-Y.</given-names></name><name><surname>Chen</surname><given-names>D.-Y.</given-names></name><name><surname>Wen</surname><given-names>H.-W.</given-names></name><name><surname>Ou</surname><given-names>J.-L.</given-names></name><name><surname>Chiou</surname><given-names>S.-S.</given-names></name><name><surname>Chen</surname><given-names>J.-M.</given-names></name><name><surname>Wong</surname><given-names>M.-L.</given-names></name><name><surname>Hsu</surname><given-names>W.-L.</given-names></name></person-group><article-title>Inhibition of enveloped viruses infectivity by Curcumin</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><elocation-id>e62482</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0062482</pub-id><?supplied-pmid 23658730?><pub-id pub-id-type="pmid">23658730</pub-id></element-citation></ref><ref id="B143-biomolecules-11-00011"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>T.T.H.</given-names></name><name><surname>Si</surname><given-names>J.</given-names></name><name><surname>Kang</surname><given-names>C.</given-names></name><name><surname>Chung</surname><given-names>B.</given-names></name><name><surname>Chung</surname><given-names>D.</given-names></name><name><surname>Kim</surname><given-names>D.</given-names></name></person-group><article-title>Facile preparation of water soluble curcuminoids extracted from turmeric ( Curcuma longa L.) powder by using steviol glucosides</article-title><source>Food Chem.</source><year>2017</year><volume>214</volume><fpage>366</fpage><lpage>373</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2016.07.102</pub-id><?supplied-pmid 27507487?><pub-id pub-id-type="pmid">27507487</pub-id></element-citation></ref><ref id="B144-biomolecules-11-00011"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrens-Spence</surname><given-names>M.P.</given-names></name><name><surname>Pluskal</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>F.-S.</given-names></name><name><surname>Carballo</surname><given-names>V.</given-names></name><name><surname>Weng</surname><given-names>J.-K.</given-names></name></person-group><article-title>Complete pathway elucidation and heterologous reconstitution of Rhodiola Salidroside biosynthesis</article-title><source>Mol. Plant</source><year>2018</year><volume>11</volume><fpage>205</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.molp.2017.12.007</pub-id><?supplied-pmid 29277428?><pub-id pub-id-type="pmid">29277428</pub-id></element-citation></ref><ref id="B145-biomolecules-11-00011"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>Z.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Xiao</surname><given-names>Q.</given-names></name><name><surname>Hu</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name></person-group><article-title>Pharmacological activities, mechanisms of action, and safety of salidroside in the central nervous system</article-title><source>Drug Des. Devel. Ther.</source><year>2018</year><volume>12</volume><fpage>1479</fpage><lpage>1489</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S160776</pub-id><?supplied-pmid 29872270?><pub-id pub-id-type="pmid">29872270</pub-id></element-citation></ref><ref id="B146-biomolecules-11-00011"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sa</surname><given-names>L.</given-names></name><name><surname>Wei</surname><given-names>X.</given-names></name><name><surname>Huang</surname><given-names>Q.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>D.</given-names></name><name><surname>Mei</surname><given-names>R.</given-names></name><name><surname>Hu</surname><given-names>X.</given-names></name></person-group><article-title>Contribution of salidroside to the relieve of symptom and sign in the early acute stage of osteoarthritis in rat model</article-title><source>J. Ethnopharmacol.</source><year>2020</year><volume>259</volume><fpage>112883</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.112883</pub-id><?supplied-pmid 32315736?><pub-id pub-id-type="pmid">32315736</pub-id></element-citation></ref><ref id="B147-biomolecules-11-00011"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Ji</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>P.</given-names></name></person-group><article-title>Salidroside alleviates cartilage degeneration through NF-&#x003ba;B pathway in Osteoarthritis Rats</article-title><source>Drug Des. Devel. Ther.</source><year>2020</year><volume>14</volume><fpage>1445</fpage><lpage>1454</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S242862</pub-id><?supplied-pmid 32341638?><pub-id pub-id-type="pmid">32341638</pub-id></element-citation></ref><ref id="B148-biomolecules-11-00011"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shati</surname><given-names>A.A.</given-names></name></person-group><article-title>Salidroside ameliorates diabetic nephropathy in rats by activating renal AMPK/SIRT1 signaling pathway</article-title><source>J. Food Biochem.</source><year>2020</year><volume>44</volume><pub-id pub-id-type="doi">10.1111/jfbc.13158</pub-id></element-citation></ref><ref id="B149-biomolecules-11-00011"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>A.</given-names></name><name><surname>Ju</surname><given-names>X.-L.</given-names></name></person-group><article-title>Advances in research on anticancer properties of Salidroside</article-title><source>Chin. J. Integr. Med.</source><year>2020</year><pub-id pub-id-type="doi">10.1007/s11655-020-3190-8</pub-id><?supplied-pmid 32144560?><pub-id pub-id-type="pmid">32144560</pub-id></element-citation></ref><ref id="B150-biomolecules-11-00011"><label>150.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agbo</surname><given-names>M.O.</given-names></name><name><surname>Odimegwu</surname><given-names>D.C.</given-names></name><name><surname>Okoye</surname><given-names>F.B.C.</given-names></name><name><surname>Osadebe</surname><given-names>P.O.</given-names></name></person-group><article-title>Antiviral activity of Salidroside from the leaves of Nigerian mistletoe (Loranthus micranthus Linn) parasitic on Hevea brasiliensis against respiratory syncytial virus</article-title><source>Pak. J. Pharm. Sci.</source><year>2017</year><volume>30</volume><fpage>1251</fpage><lpage>1256</lpage><?supplied-pmid 29039322?><pub-id pub-id-type="pmid">29039322</pub-id></element-citation></ref><ref id="B151-biomolecules-11-00011"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Ding</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>S.</given-names></name></person-group><article-title>The in vitro and in vivo antiviral effects of salidroside from Rhodiola rosea L. against coxsackievirus B3</article-title><source>Phytomedicine</source><year>2009</year><volume>16</volume><fpage>146</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.phymed.2008.07.013</pub-id><?supplied-pmid 18818064?><pub-id pub-id-type="pmid">18818064</pub-id></element-citation></ref><ref id="B152-biomolecules-11-00011"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y.-L.</given-names></name><name><surname>Lin</surname><given-names>Y.-S.</given-names></name><name><surname>Chen</surname><given-names>C.-L.</given-names></name><name><surname>Wan</surname><given-names>S.-W.</given-names></name><name><surname>Ou</surname><given-names>Y.-D.</given-names></name><name><surname>Yu</surname><given-names>C.-Y.</given-names></name><name><surname>Tsai</surname><given-names>T.-T.</given-names></name><name><surname>Tseng</surname><given-names>P.-C.</given-names></name><name><surname>Lin</surname><given-names>C.-F.</given-names></name></person-group><article-title>Dengue virus infection causes the activation of distinct NF- <italic>&#x003ba;</italic> B pathways for inducible Nitric Oxide synthase and TNF- <italic>&#x003b1;</italic> expression in RAW264.7 Cells</article-title><source>Mediators Inflamm.</source><year>2015</year><volume>2015</volume><fpage>274025</fpage><pub-id pub-id-type="doi">10.1155/2015/274025</pub-id><?supplied-pmid 26199460?><pub-id pub-id-type="pmid">26199460</pub-id></element-citation></ref><ref id="B153-biomolecules-11-00011"><label>153.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.</given-names></name><name><surname>Jung</surname><given-names>J.-C.</given-names></name><name><surname>Jang</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Ali</surname><given-names>Z.</given-names></name><name><surname>Khan</surname><given-names>I.A.</given-names></name><name><surname>Oh</surname><given-names>S.</given-names></name></person-group><article-title>Anti-inflammatory and neuroprotective effects of constituents isolated from <italic>Rhodiola rosea</italic></article-title><source>Evidence-Based Complement. Altern. Med.</source><year>2013</year><volume>2013</volume><fpage>514049</fpage><pub-id pub-id-type="doi">10.1155/2013/514049</pub-id></element-citation></ref><ref id="B154-biomolecules-11-00011"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>G.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name></person-group><article-title>Activity of compounds from Chinese herbal medicine Rhodiola kirilowii (Regel) Maxim against HCV NS3 serine protease</article-title><source>Antivir. Res.</source><year>2007</year><volume>76</volume><fpage>86</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2007.06.001</pub-id><?supplied-pmid 17624450?><pub-id pub-id-type="pmid">17624450</pub-id></element-citation></ref><ref id="B155-biomolecules-11-00011"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>N.</given-names></name><name><surname>Mishra</surname><given-names>K.P.</given-names></name><name><surname>Ganju</surname><given-names>L.</given-names></name></person-group><article-title>Salidroside exhibits anti-dengue virus activity by upregulating host innate immune factors</article-title><source>Arch. Virol.</source><year>2016</year><volume>161</volume><fpage>3331</fpage><lpage>3344</lpage><pub-id pub-id-type="doi">10.1007/s00705-016-3034-1</pub-id><pub-id pub-id-type="pmid">27581807</pub-id></element-citation></ref><ref id="B156-biomolecules-11-00011"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gack</surname><given-names>M.U.</given-names></name></person-group><article-title>Mechanisms of RIG-I-Like Receptor activation and manipulation by Viral Pathogens</article-title><source>J. Virol.</source><year>2014</year><volume>88</volume><fpage>5213</fpage><lpage>5216</lpage><pub-id pub-id-type="doi">10.1128/JVI.03370-13</pub-id><pub-id pub-id-type="pmid">24623415</pub-id></element-citation></ref><ref id="B157-biomolecules-11-00011"><label>157.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro-S&#x000e1;nchez</surname><given-names>E.</given-names></name><name><surname>Despr&#x000e8;s</surname><given-names>P.</given-names></name><name><surname>Cedillo-Barr&#x000f3;n</surname><given-names>L.</given-names></name></person-group><article-title>Innate immune responses to Dengue virus</article-title><source>Arch. Med. Res.</source><year>2005</year><volume>36</volume><fpage>425</fpage><lpage>435</lpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2005.04.007</pub-id><pub-id pub-id-type="pmid">16099317</pub-id></element-citation></ref><ref id="B158-biomolecules-11-00011"><label>158.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sadler</surname><given-names>A.J.</given-names></name><name><surname>Williams</surname><given-names>B.R.G.</given-names></name></person-group><article-title>Structure and function of the protein Kinase R</article-title><source>Interferon: The 50th Anniversary</source><publisher-name>Springer</publisher-name><publisher-loc>Berlin/Heidelberg, Germany</publisher-loc><year>2007</year><fpage>253</fpage><lpage>292</lpage></element-citation></ref><ref id="B159-biomolecules-11-00011"><label>159.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltr&#x000e1;n</surname><given-names>D.</given-names></name><name><surname>L&#x000f3;pez-Verg&#x000e8;s</surname><given-names>S.</given-names></name></person-group><article-title>NK Cells during Dengue disease and their recognition of Dengue virus-infected cells</article-title><source>Front. Immunol.</source><year>2014</year><volume>5</volume><pub-id pub-id-type="doi">10.3389/fimmu.2014.00192</pub-id></element-citation></ref><ref id="B160-biomolecules-11-00011"><label>160.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martins</surname><given-names>F.O.</given-names></name><name><surname>Esteves</surname><given-names>P.F.</given-names></name><name><surname>Mendes</surname><given-names>G.S.</given-names></name><name><surname>Barbi</surname><given-names>N.S.</given-names></name><name><surname>Menezes</surname><given-names>F.S.</given-names></name><name><surname>Romanos</surname><given-names>M.T.</given-names></name></person-group><article-title>Verbascoside isolated from Lepechinia speciosa has inhibitory activity against HSV-1 and HSV-2 in vitro</article-title><source>Nat. Prod. Commun.</source><year>2009</year><volume>4</volume><fpage>1934578X0900401217</fpage><pub-id pub-id-type="doi">10.1177/1934578X0900401217</pub-id></element-citation></ref><ref id="B161-biomolecules-11-00011"><label>161.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alipieva</surname><given-names>K.</given-names></name><name><surname>Korkina</surname><given-names>L.</given-names></name><name><surname>Orhan</surname><given-names>I.E.</given-names></name><name><surname>Georgiev</surname><given-names>M.I.</given-names></name></person-group><article-title>Verbascoside&#x02014;A review of its occurrence, (bio)synthesis and pharmacological significance</article-title><source>Biotechnol. Adv.</source><year>2014</year><volume>32</volume><fpage>1065</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2014.07.001</pub-id><pub-id pub-id-type="pmid">25048704</pub-id></element-citation></ref><ref id="B162-biomolecules-11-00011"><label>162.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarenga</surname><given-names>T.A.</given-names></name><name><surname>Bertanha</surname><given-names>C.S.</given-names></name><name><surname>de Oliveira</surname><given-names>P.F.</given-names></name><name><surname>Tavares</surname><given-names>D.C.</given-names></name><name><surname>Gimenez</surname><given-names>V.M.M.</given-names></name><name><surname>Silva</surname><given-names>M.L.A.</given-names></name><name><surname>Cunha</surname><given-names>W.R.</given-names></name><name><surname>Janu&#x000e1;rio</surname><given-names>A.H.</given-names></name><name><surname>Pauletti</surname><given-names>P.M.</given-names></name></person-group><article-title>Lipoxygenase inhibitory activity of <italic>Cuspidaria pulchra</italic> and isolated compounds</article-title><source>Nat. Prod. Res.</source><year>2015</year><volume>29</volume><fpage>1083</fpage><lpage>1086</lpage><pub-id pub-id-type="doi">10.1080/14786419.2014.981182</pub-id><pub-id pub-id-type="pmid">25428032</pub-id></element-citation></ref><ref id="B163-biomolecules-11-00011"><label>163.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand&#x000e3;o</surname><given-names>G.C.</given-names></name><name><surname>Kroon</surname><given-names>E.G.</given-names></name><name><surname>dos Santos</surname><given-names>J.R.</given-names></name><name><surname>Stehmann</surname><given-names>J.R.</given-names></name><name><surname>Lombardi</surname><given-names>J.A.</given-names></name><name><surname>Oliveira</surname><given-names>A.B.</given-names></name></person-group><article-title>de Antiviral activities of plants occurring in the state of Minas Gerais, Brazil: Part 2. Screening Bignoniaceae species</article-title><source>Rev. Bras. Farmacogn.</source><year>2010</year><volume>20</volume><fpage>742</fpage><lpage>750</lpage><pub-id pub-id-type="doi">10.1590/S0102-695X2010005000035</pub-id></element-citation></ref><ref id="B164-biomolecules-11-00011"><label>164.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>W.</given-names></name><name><surname>Xiong</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name></person-group><article-title>Anti-inflammatory constituents from Bidens frondosa</article-title><source>Molecules</source><year>2015</year><volume>20</volume><fpage>18496</fpage><lpage>18510</lpage><pub-id pub-id-type="doi">10.3390/molecules201018496</pub-id><?supplied-pmid 26473814?><pub-id pub-id-type="pmid">26473814</pub-id></element-citation></ref><ref id="B165-biomolecules-11-00011"><label>165.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brand&#x000e3;o</surname><given-names>G.</given-names></name><name><surname>Kroon</surname><given-names>E.</given-names></name><name><surname>Souza</surname><given-names>D.</given-names></name><name><surname>Filho</surname><given-names>J.</given-names></name><name><surname>Oliveira</surname><given-names>A.</given-names></name></person-group><article-title>Chemistry and antiviral activity of Arrabidaea pulchra (Bignoniaceae)</article-title><source>Molecules</source><year>2013</year><volume>18</volume><fpage>9919</fpage><lpage>9932</lpage><pub-id pub-id-type="doi">10.3390/molecules18089919</pub-id><?supplied-pmid 23959197?><pub-id pub-id-type="pmid">23959197</pub-id></element-citation></ref><ref id="B166-biomolecules-11-00011"><label>166.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDougall</surname><given-names>B.</given-names></name><name><surname>King</surname><given-names>P.J.</given-names></name><name><surname>Wu</surname><given-names>B.W.</given-names></name><name><surname>Hostomsky</surname><given-names>Z.</given-names></name><name><surname>Reinecke</surname><given-names>M.G.</given-names></name><name><surname>Robinson</surname><given-names>W.E.</given-names></name></person-group><article-title>Dicaffeoylquinic and Dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase</article-title><source>Antimicrob. Agents Chemother.</source><year>1998</year><volume>42</volume><fpage>140</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1128/AAC.42.1.140</pub-id><?supplied-pmid 9449274?><pub-id pub-id-type="pmid">9449274</pub-id></element-citation></ref><ref id="B167-biomolecules-11-00011"><label>167.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>J.N.</given-names></name><name><surname>Bolraa</surname><given-names>S.</given-names></name><name><surname>Ji</surname><given-names>M.</given-names></name><name><surname>He</surname><given-names>Q.Q.</given-names></name><name><surname>Ma</surname><given-names>C.M.</given-names></name></person-group><article-title>Quantification and antioxidant and anti-HCV activities of the constituents from the inflorescences of <italic>Scabiosa comosa</italic> and <italic>S. tschilliensis</italic></article-title><source>Nat. Prod. Res.</source><year>2016</year><volume>30</volume><fpage>590</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1080/14786419.2015.1027701</pub-id><?supplied-pmid 25835468?><pub-id pub-id-type="pmid">25835468</pub-id></element-citation></ref><ref id="B168-biomolecules-11-00011"><label>168.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname><given-names>E.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name></person-group><article-title>Inhibition of NF-kappa B by sodium salicylate and aspirin</article-title><source>Science</source><year>1994</year><volume>265</volume><fpage>956</fpage><lpage>959</lpage><pub-id pub-id-type="doi">10.1126/science.8052854</pub-id><pub-id pub-id-type="pmid">8052854</pub-id></element-citation></ref><ref id="B169-biomolecules-11-00011"><label>169.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitchell</surname><given-names>J.A.</given-names></name><name><surname>Saunders</surname><given-names>M.</given-names></name><name><surname>Barnes</surname><given-names>P.J.</given-names></name><name><surname>Newton</surname><given-names>R.</given-names></name><name><surname>Belvisi</surname><given-names>M.G.</given-names></name></person-group><article-title>Sodium Salicylate inhibits Cyclo-Oxygenase-2 activity independently of transcription factor (nuclear factor &#x003ba;B) activation: Role of arachidonic acid</article-title><source>Mol. Pharmacol.</source><year>1997</year><volume>51</volume><fpage>907</fpage><lpage>912</lpage><pub-id pub-id-type="doi">10.1124/mol.51.6.907</pub-id><pub-id pub-id-type="pmid">9187256</pub-id></element-citation></ref><ref id="B170-biomolecules-11-00011"><label>170.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bitko</surname><given-names>V.</given-names></name><name><surname>Velazquez</surname><given-names>A.</given-names></name><name><surname>Yang</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>Y.-C.</given-names></name><name><surname>Barik</surname><given-names>S.</given-names></name></person-group><article-title>Transcriptional induction of multiple Cytokines by human respiratory Syncytial Virus requires activation of NF-&#x003ba;B and is inhibited by Sodium Salicylate and aspirin</article-title><source>Virology</source><year>1997</year><volume>232</volume><fpage>369</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1006/viro.1997.8582</pub-id><pub-id pub-id-type="pmid">9191851</pub-id></element-citation></ref><ref id="B171-biomolecules-11-00011"><label>171.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Speir</surname><given-names>E.</given-names></name><name><surname>Yu</surname><given-names>Z.-X.</given-names></name><name><surname>Ferrans</surname><given-names>V.J.</given-names></name><name><surname>Huang</surname><given-names>E.-S.</given-names></name><name><surname>Epstein</surname><given-names>S.E.</given-names></name></person-group><article-title>Aspirin attenuates Cytomegalovirus infectivity and gene expression mediated by Cyclooxygenase-2 in coronary artery smooth muscle cells</article-title><source>Circ. Res.</source><year>1998</year><volume>83</volume><fpage>210</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1161/01.RES.83.2.210</pub-id><pub-id pub-id-type="pmid">9686761</pub-id></element-citation></ref><ref id="B172-biomolecules-11-00011"><label>172.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C.-J.</given-names></name><name><surname>Raung</surname><given-names>S.-L.</given-names></name><name><surname>Kuo</surname><given-names>M.-D.</given-names></name><name><surname>Wang</surname><given-names>Y.-M.</given-names></name></person-group><article-title>Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs</article-title><source>J. Gen. Virol.</source><year>2002</year><volume>83</volume><fpage>1897</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1099/0022-1317-83-8-1897</pub-id><pub-id pub-id-type="pmid">12124453</pub-id></element-citation></ref><ref id="B173-biomolecules-11-00011"><label>173.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>C.-L.</given-names></name><name><surname>Lin</surname><given-names>Y.-L.</given-names></name><name><surname>Wu</surname><given-names>B.-C.</given-names></name><name><surname>Tsao</surname><given-names>C.-H.</given-names></name><name><surname>Wang</surname><given-names>M.-C.</given-names></name><name><surname>Liu</surname><given-names>C.-I.</given-names></name><name><surname>Huang</surname><given-names>Y.-L.</given-names></name><name><surname>Chen</surname><given-names>J.-H.</given-names></name><name><surname>Wang</surname><given-names>J.-P.</given-names></name><name><surname>Chen</surname><given-names>L.-K.</given-names></name></person-group><article-title>Salicylates inhibit Flavivirus replication independently of blocking nuclear factor Kappa B activation</article-title><source>J. Virol.</source><year>2001</year><volume>75</volume><fpage>7828</fpage><lpage>7839</lpage><pub-id pub-id-type="doi">10.1128/JVI.75.17.7828-7839.2001</pub-id><?supplied-pmid 11483726?><pub-id pub-id-type="pmid">11483726</pub-id></element-citation></ref><ref id="B174-biomolecules-11-00011"><label>174.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Guo</surname><given-names>W.</given-names></name><name><surname>Gegner</surname><given-names>J.A.</given-names></name><name><surname>Lin</surname><given-names>S.</given-names></name><name><surname>Han</surname><given-names>J.</given-names></name></person-group><article-title>Characterization of the structure and function of a New Mitogen-activated Protein Kinase (p38&#x003b2;)</article-title><source>J. Biol. Chem.</source><year>1996</year><volume>271</volume><fpage>17920</fpage><lpage>17926</lpage><pub-id pub-id-type="doi">10.1074/jbc.271.30.17920</pub-id><?supplied-pmid 8663524?><pub-id pub-id-type="pmid">8663524</pub-id></element-citation></ref><ref id="B175-biomolecules-11-00011"><label>175.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>D.</given-names></name></person-group><article-title>Anti-platelet agents: Past, present and future</article-title><source>ISBT Sci. Ser.</source><year>2020</year><volume>15</volume><fpage>131</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1111/voxs.12529</pub-id></element-citation></ref><ref id="B176-biomolecules-11-00011"><label>176.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarenga</surname><given-names>T.A.</given-names></name><name><surname>de Oliveira</surname><given-names>P.F.</given-names></name><name><surname>de Souza</surname><given-names>J.M.</given-names></name><name><surname>Tavares</surname><given-names>D.C.</given-names></name><name><surname>Andrade e Silva</surname><given-names>M.L.</given-names></name><name><surname>Cunha</surname><given-names>W.R.</given-names></name><name><surname>Groppo</surname><given-names>M.</given-names></name><name><surname>Janu&#x000e1;rio</surname><given-names>A.H.</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>L.G.</given-names></name><name><surname>Pauletti</surname><given-names>P.M.</given-names></name></person-group><article-title>Schistosomicidal Activity of Alkyl-phenols from the Cashew <italic>Anacardium occidentale</italic> against <italic>Schistosoma mansoni</italic> Adult Worms</article-title><source>J. Agric. Food Chem.</source><year>2016</year><volume>64</volume><fpage>8821</fpage><lpage>8827</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.6b04200</pub-id><pub-id pub-id-type="pmid">27934289</pub-id></element-citation></ref><ref id="B177-biomolecules-11-00011"><label>177.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuang</surname><given-names>J.-X.</given-names></name><name><surname>Hu</surname><given-names>Y.-H.</given-names></name><name><surname>Yang</surname><given-names>M.-H.</given-names></name><name><surname>Liu</surname><given-names>F.-J.</given-names></name><name><surname>Qiu</surname><given-names>L.</given-names></name><name><surname>Zhou</surname><given-names>X.-W.</given-names></name><name><surname>Chen</surname><given-names>Q.-X.</given-names></name></person-group><article-title>Irreversible competitive inhibitory kinetics of Cardol Triene on mushroom Tyrosinase</article-title><source>J. Agric. Food Chem.</source><year>2010</year><volume>58</volume><fpage>12993</fpage><lpage>12998</lpage><pub-id pub-id-type="doi">10.1021/jf103723k</pub-id><pub-id pub-id-type="pmid">21121650</pub-id></element-citation></ref><ref id="B178-biomolecules-11-00011"><label>178.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matutino Bastos</surname><given-names>T.</given-names></name><name><surname>Mannochio Russo</surname><given-names>H.</given-names></name><name><surname>Silvio Moretti</surname><given-names>N.</given-names></name><name><surname>Schenkman</surname><given-names>S.</given-names></name><name><surname>Marcourt</surname><given-names>L.</given-names></name><name><surname>Gupta</surname><given-names>M.</given-names></name><name><surname>Wolfender</surname><given-names>J.-L.</given-names></name><name><surname>Ferreira Queiroz</surname><given-names>E.</given-names></name><name><surname>Botelho Pereira Soares</surname><given-names>M.</given-names></name></person-group><article-title>Chemical constituents of Anacardium occidentale as inhibitors of Trypanosoma cruzi Sirtuins</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1299</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24071299</pub-id></element-citation></ref><ref id="B179-biomolecules-11-00011"><label>179.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanyaboon</surname><given-names>P.</given-names></name><name><surname>Saelee</surname><given-names>T.</given-names></name><name><surname>Suroengrit</surname><given-names>A.</given-names></name><name><surname>Hengphasatporn</surname><given-names>K.</given-names></name><name><surname>Rungrotmongkol</surname><given-names>T.</given-names></name><name><surname>Chavasiri</surname><given-names>W.</given-names></name><name><surname>Boonyasuppayakorn</surname><given-names>S.</given-names></name></person-group><article-title>Cardol triene inhibits dengue infectivity by targeting kl loops and preventing envelope fusion</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>16643</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-35035-w</pub-id><pub-id pub-id-type="pmid">30413789</pub-id></element-citation></ref><ref id="B180-biomolecules-11-00011"><label>180.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>HERBST</surname><given-names>K.H.</given-names></name></person-group><article-title>Albothyl as a hemostatic agent in otorhinolaryngology</article-title><source>Z. Laryngol. Rhinol. Otol.</source><year>1959</year><volume>38</volume><fpage>837</fpage><pub-id pub-id-type="pmid">14401222</pub-id></element-citation></ref><ref id="B181-biomolecules-11-00011"><label>181.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Silva</surname><given-names>L.A.F.</given-names></name><name><surname>Fioravanti</surname><given-names>M.C.S.</given-names></name><name><surname>Oliveira</surname><given-names>K.S.</given-names></name><name><surname>Atayde</surname><given-names>I.B.</given-names></name><name><surname>Andrade</surname><given-names>M.A.</given-names></name><name><surname>Jayme</surname><given-names>V.S.</given-names></name><name><surname>Rabelo</surname><given-names>R.E.</given-names></name><name><surname>Romani</surname><given-names>A.F.</given-names></name><name><surname>Ara&#x000fa;jo</surname><given-names>E.G.</given-names></name></person-group><article-title>Local utilization of Metacresolsulfonic acid combined with Streptomycin in the treatment of Actinomycosis</article-title><source>Ann. N. Y. Acad. Sci.</source><year>2004</year><volume>1026</volume><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1196/annals.1307.042</pub-id><pub-id pub-id-type="pmid">15604505</pub-id></element-citation></ref><ref id="B182-biomolecules-11-00011"><label>182.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>A.</given-names></name><name><surname>Al-sobayil</surname><given-names>F.A.</given-names></name><name><surname>Al-Hawas</surname><given-names>A.</given-names></name></person-group><article-title>Evaluating the effectiveness of different treatments of uterine infections in female camels (Camelus dromedarius)</article-title><source>Theriogenology</source><year>2010</year><volume>74</volume><fpage>40</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.theriogenology.2009.12.017</pub-id><pub-id pub-id-type="pmid">20172597</pub-id></element-citation></ref><ref id="B183-biomolecules-11-00011"><label>183.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomlinson</surname><given-names>S.</given-names></name><name><surname>Malmstrom</surname><given-names>R.</given-names></name><name><surname>Watowich</surname><given-names>S.</given-names></name></person-group><article-title>New approaches to structure-based discovery of Dengue protease inhibitors</article-title><source>Infect. Disord.-Drug Targets</source><year>2009</year><volume>9</volume><fpage>327</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.2174/1871526510909030327</pub-id><?supplied-pmid 19519486?><pub-id pub-id-type="pmid">19519486</pub-id></element-citation></ref><ref id="B184-biomolecules-11-00011"><label>184.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiss</surname><given-names>B.J.</given-names></name><name><surname>Stahla</surname><given-names>H.</given-names></name><name><surname>Hannah</surname><given-names>A.M.</given-names></name><name><surname>Gari</surname><given-names>H.H.</given-names></name><name><surname>Keenan</surname><given-names>S.M.</given-names></name></person-group><article-title>Focus on flaviviruses: Current and future drug targets</article-title><source>Future Med. Chem.</source><year>2009</year><volume>1</volume><fpage>327</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.4155/fmc.09.27</pub-id><?supplied-pmid 20165556?><pub-id pub-id-type="pmid">20165556</pub-id></element-citation></ref><ref id="B185-biomolecules-11-00011"><label>185.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D.</given-names></name><name><surname>Mao</surname><given-names>F.</given-names></name><name><surname>Ye</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>C.</given-names></name><name><surname>Luo</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>X.</given-names></name></person-group><article-title>Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells</article-title><source>Acta Pharmacol. Sin.</source><year>2015</year><volume>36</volume><fpage>1126</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1038/aps.2015.56</pub-id><?supplied-pmid 26279156?><pub-id pub-id-type="pmid">26279156</pub-id></element-citation></ref><ref id="B186-biomolecules-11-00011"><label>186.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanprapaph</surname><given-names>S.</given-names></name><name><surname>Saparpakorn</surname><given-names>P.</given-names></name><name><surname>Sangma</surname><given-names>C.</given-names></name><name><surname>Niyomrattanakit</surname><given-names>P.</given-names></name><name><surname>Hannongbua</surname><given-names>S.</given-names></name><name><surname>Angsuthanasombat</surname><given-names>C.</given-names></name><name><surname>Katzenmeier</surname><given-names>G.</given-names></name></person-group><article-title>Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2005</year><volume>330</volume><fpage>1237</fpage><lpage>1246</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.03.107</pub-id><pub-id pub-id-type="pmid">15823576</pub-id></element-citation></ref><ref id="B187-biomolecules-11-00011"><label>187.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Majdzadeh</surname><given-names>N.</given-names></name><name><surname>Chavez</surname><given-names>C.</given-names></name><name><surname>Chin</surname><given-names>P.C.</given-names></name><name><surname>Morrison</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Park</surname><given-names>J.</given-names></name><name><surname>Chugh</surname><given-names>P.</given-names></name><name><surname>Chen</surname><given-names>H.-M.</given-names></name><etal/></person-group><article-title>Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: Identification of 3&#x02032; substituted indolones as a scaffold for the development of neuroprotective drugs</article-title><source>J. Neurochem.</source><year>2005</year><volume>93</volume><fpage>538</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.03004.x</pub-id><pub-id pub-id-type="pmid">15836613</pub-id></element-citation></ref><ref id="B188-biomolecules-11-00011"><label>188.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lackey</surname><given-names>K.</given-names></name><name><surname>Cory</surname><given-names>M.</given-names></name><name><surname>Davis</surname><given-names>R.</given-names></name><name><surname>Frye</surname><given-names>S.V.</given-names></name><name><surname>Harris</surname><given-names>P.A.</given-names></name><name><surname>Hunter</surname><given-names>R.N.</given-names></name><name><surname>Jung</surname><given-names>D.K.</given-names></name><name><surname>McDonald</surname><given-names>O.B.</given-names></name><name><surname>McNutt</surname><given-names>R.W.</given-names></name><name><surname>Peel</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>The discovery of potent cRaf1 kinase inhibitors</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2000</year><volume>10</volume><fpage>223</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/S0960-894X(99)00668-X</pub-id><pub-id pub-id-type="pmid">10698440</pub-id></element-citation></ref><ref id="B189-biomolecules-11-00011"><label>189.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.-M.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>D&#x02019;Mello</surname><given-names>S.R.</given-names></name></person-group><article-title>Inhibition of ATF-3 expression by B-Raf mediates the neuroprotective action of GW5074</article-title><source>J. Neurochem.</source><year>2008</year><volume>105</volume><fpage>1300</fpage><lpage>1312</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05226.x</pub-id><pub-id pub-id-type="pmid">18194435</pub-id></element-citation></ref><ref id="B190-biomolecules-11-00011"><label>190.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>P.C.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Morrison</surname><given-names>B.E.</given-names></name><name><surname>Siddiq</surname><given-names>A.</given-names></name><name><surname>Ratan</surname><given-names>R.R.</given-names></name><name><surname>Bottiglieri</surname><given-names>T.</given-names></name><name><surname>D&#x02019;Mello</surname><given-names>S.R.</given-names></name></person-group><article-title>The c-Raf inhibitor GW5074 provides neuroprotection invitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism</article-title><source>J. Neurochem.</source><year>2004</year><volume>90</volume><fpage>595</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02530.x</pub-id><pub-id pub-id-type="pmid">15255937</pub-id></element-citation></ref><ref id="B191-biomolecules-11-00011"><label>191.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opoku-Temeng</surname><given-names>C.</given-names></name><name><surname>Onyedibe</surname><given-names>K.I.</given-names></name><name><surname>Aryal</surname><given-names>U.K.</given-names></name><name><surname>Sintim</surname><given-names>H.O.</given-names></name></person-group><article-title>Proteomic analysis of bacterial response to a 4-hydroxybenzylidene indolinone compound, which re-sensitizes bacteria to traditional antibiotics</article-title><source>J. Proteom.</source><year>2019</year><volume>202</volume><fpage>103368</fpage><pub-id pub-id-type="doi">10.1016/j.jprot.2019.04.018</pub-id></element-citation></ref><ref id="B192-biomolecules-11-00011"><label>192.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfleiderer</surname><given-names>P.</given-names></name><name><surname>Sumandea</surname><given-names>M.P.</given-names></name><name><surname>Rybin</surname><given-names>V.O.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Steinberg</surname><given-names>S.F.</given-names></name></person-group><article-title>Raf-1: A novel cardiac troponin T kinase</article-title><source>J. Muscle Res. Cell Motil.</source><year>2009</year><volume>30</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1007/s10974-009-9176-y</pub-id><pub-id pub-id-type="pmid">19381846</pub-id></element-citation></ref><ref id="B193-biomolecules-11-00011"><label>193.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arita</surname><given-names>M.</given-names></name><name><surname>Wakita</surname><given-names>T.</given-names></name><name><surname>Shimizu</surname><given-names>H.</given-names></name></person-group><article-title>Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity</article-title><source>J. Gen. Virol.</source><year>2008</year><volume>89</volume><fpage>2518</fpage><lpage>2530</lpage><pub-id pub-id-type="doi">10.1099/vir.0.2008/002915-0</pub-id><?supplied-pmid 18796721?><pub-id pub-id-type="pmid">18796721</pub-id></element-citation></ref><ref id="B194-biomolecules-11-00011"><label>194.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Atkinson</surname><given-names>S.</given-names></name><name><surname>Fraser</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>C.</given-names></name><name><surname>Maher</surname><given-names>B.</given-names></name><name><surname>Roman</surname><given-names>N.</given-names></name><name><surname>Forwood</surname><given-names>J.</given-names></name><name><surname>Wagstaff</surname><given-names>K.</given-names></name><name><surname>Borg</surname><given-names>N.</given-names></name><name><surname>Jans</surname><given-names>D.</given-names></name></person-group><article-title>Novel Flavivirus antiviral that targets the host nuclear transport importin &#x003b1;/&#x003b2;1 heterodimer</article-title><source>Cells</source><year>2019</year><volume>8</volume><elocation-id>281</elocation-id><pub-id pub-id-type="doi">10.3390/cells8030281</pub-id><?supplied-pmid 30909636?><pub-id pub-id-type="pmid">30909636</pub-id></element-citation></ref><ref id="B195-biomolecules-11-00011"><label>195.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y.-J.</given-names></name><name><surname>Lee</surname><given-names>Y.M.</given-names></name><name><surname>Lee</surname><given-names>C.-K.</given-names></name><name><surname>Jung</surname><given-names>J.K.</given-names></name><name><surname>Han</surname><given-names>S.B.</given-names></name><name><surname>Hong</surname><given-names>J.T.</given-names></name></person-group><article-title>Therapeutic applications of compounds in the Magnolia family</article-title><source>Pharmacol. Ther.</source><year>2011</year><volume>130</volume><fpage>157</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.01.010</pub-id><pub-id pub-id-type="pmid">21277893</pub-id></element-citation></ref><ref id="B196-biomolecules-11-00011"><label>196.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zhu</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group><article-title>Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-&#x003ba;B activation and cytokine production of glial cells</article-title><source>Neurosci. Lett.</source><year>2013</year><volume>534</volume><fpage>123</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.neulet.2012.11.052</pub-id><?supplied-pmid 23262090?><pub-id pub-id-type="pmid">23262090</pub-id></element-citation></ref><ref id="B197-biomolecules-11-00011"><label>197.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>S.</given-names></name></person-group><article-title>Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin</article-title><source>Acta Pharmacol. Sin.</source><year>2005</year><volume>26</volume><fpage>1063</fpage><lpage>1068</lpage><pub-id pub-id-type="doi">10.1111/j.1745-7254.2005.00164.x</pub-id><pub-id pub-id-type="pmid">16115372</pub-id></element-citation></ref><ref id="B198-biomolecules-11-00011"><label>198.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>J.-L.</given-names></name><name><surname>Man</surname><given-names>K.-M.</given-names></name><name><surname>Huang</surname><given-names>P.-H.</given-names></name><name><surname>Chen</surname><given-names>W.-C.</given-names></name><name><surname>Chen</surname><given-names>D.-C.</given-names></name><name><surname>Cheng</surname><given-names>Y.-W.</given-names></name><name><surname>Liu</surname><given-names>P.-L.</given-names></name><name><surname>Chou</surname><given-names>M.-C.</given-names></name><name><surname>Chen</surname><given-names>Y.-H.</given-names></name></person-group><article-title>Honokiol and Magnolol as multifunctional antioxidative molecules for dermatologic disorders</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>6452</fpage><lpage>6465</lpage><pub-id pub-id-type="doi">10.3390/molecules15096452</pub-id><pub-id pub-id-type="pmid">20877235</pub-id></element-citation></ref><ref id="B199-biomolecules-11-00011"><label>199.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Cheng</surname><given-names>P.</given-names></name><name><surname>Wu</surname><given-names>A.-H.</given-names></name></person-group><article-title>Honokiol inhibits carotid artery atherosclerotic plaque formation by suppressing inflammation and oxidative stress</article-title><source>Aging</source><year>2020</year><volume>12</volume><fpage>8016</fpage><lpage>8028</lpage><pub-id pub-id-type="doi">10.18632/aging.103120</pub-id><pub-id pub-id-type="pmid">32365054</pub-id></element-citation></ref><ref id="B200-biomolecules-11-00011"><label>200.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talarek</surname><given-names>S.</given-names></name><name><surname>Listos</surname><given-names>J.</given-names></name><name><surname>Barreca</surname><given-names>D.</given-names></name><name><surname>Tellone</surname><given-names>E.</given-names></name><name><surname>Sureda</surname><given-names>A.</given-names></name><name><surname>Nabavi</surname><given-names>S.F.</given-names></name><name><surname>Braidy</surname><given-names>N.</given-names></name><name><surname>Nabavi</surname><given-names>S.M.</given-names></name></person-group><article-title>Neuroprotective effects of honokiol: From chemistry to medicine</article-title><source>BioFactors</source><year>2017</year><volume>43</volume><fpage>760</fpage><lpage>769</lpage><pub-id pub-id-type="doi">10.1002/biof.1385</pub-id><pub-id pub-id-type="pmid">28817221</pub-id></element-citation></ref><ref id="B201-biomolecules-11-00011"><label>201.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahm</surname><given-names>E.-R.</given-names></name><name><surname>Arlotti</surname><given-names>J.A.</given-names></name><name><surname>Marynowski</surname><given-names>S.W.</given-names></name><name><surname>Singh</surname><given-names>S.V.</given-names></name></person-group><article-title>Honokiol, a constituent of oriental medicinal herb Magnolia officinalis, inhibits growth of PC-3 Xenografts in vivo in association with Apoptosis induction</article-title><source>Clin. Cancer Res.</source><year>2008</year><volume>14</volume><fpage>1248</fpage><lpage>1257</lpage><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-1926</pub-id><pub-id pub-id-type="pmid">18281560</pub-id></element-citation></ref><ref id="B202-biomolecules-11-00011"><label>202.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>X.</given-names></name><name><surname>Cerimele</surname><given-names>F.</given-names></name><name><surname>Ushio-Fukai</surname><given-names>M.</given-names></name><name><surname>Waqas</surname><given-names>M.</given-names></name><name><surname>Campbell</surname><given-names>P.M.</given-names></name><name><surname>Govindarajan</surname><given-names>B.</given-names></name><name><surname>Der</surname><given-names>C.J.</given-names></name><name><surname>Battle</surname><given-names>T.</given-names></name><name><surname>Frank</surname><given-names>D.A.</given-names></name><name><surname>Ye</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Honokiol, a small molecular weight natural product, inhibits Angiogenesis in vitro and tumor growth in Vivo</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>35501</fpage><lpage>35507</lpage><pub-id pub-id-type="doi">10.1074/jbc.M302967200</pub-id><pub-id pub-id-type="pmid">12816951</pub-id></element-citation></ref><ref id="B203-biomolecules-11-00011"><label>203.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fried</surname><given-names>L.E.</given-names></name><name><surname>Arbiser</surname><given-names>J.L.</given-names></name></person-group><article-title>Honokiol, a multifunctional antiangiogenic and antitumor agent</article-title><source>Antioxid. Redox Signal.</source><year>2009</year><volume>11</volume><fpage>1139</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1089/ars.2009.2440</pub-id><?supplied-pmid 19203212?><pub-id pub-id-type="pmid">19203212</pub-id></element-citation></ref><ref id="B204-biomolecules-11-00011"><label>204.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.Y.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Jeong</surname><given-names>S.-I.</given-names></name><name><surname>Jahng</surname><given-names>K.Y.</given-names></name><name><surname>Yu</surname><given-names>K.-Y.</given-names></name></person-group><article-title>Antimicrobial effects and resistant regulation of Magnolol and Honokiol on Methicillin-resistant <italic>Staphylococcus aureus</italic></article-title><source>Biomed Res. Int.</source><year>2015</year><volume>2015</volume><fpage>283630</fpage><pub-id pub-id-type="doi">10.1155/2015/283630</pub-id><?supplied-pmid 26357651?><pub-id pub-id-type="pmid">26357651</pub-id></element-citation></ref><ref id="B205-biomolecules-11-00011"><label>205.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>S.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Tan</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>X.</given-names></name></person-group><article-title>Inhibition of herpes simplex Virus-1 replication by natural compound Honokiol</article-title><source>Virol. Sin.</source><year>2019</year><volume>34</volume><fpage>315</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1007/s12250-019-00104-5</pub-id><?supplied-pmid 30915606?><pub-id pub-id-type="pmid">30915606</pub-id></element-citation></ref><ref id="B206-biomolecules-11-00011"><label>206.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>K.-H.</given-names></name><name><surname>Wang</surname><given-names>Y.-W.</given-names></name><name><surname>Lee</surname><given-names>W.-P.</given-names></name><name><surname>Lan</surname><given-names>K.-L.</given-names></name><name><surname>Tseng</surname><given-names>S.-H.</given-names></name><name><surname>Hung</surname><given-names>L.-R.</given-names></name><name><surname>Yen</surname><given-names>S.-H.</given-names></name><name><surname>Lin</surname><given-names>H.-C.</given-names></name><name><surname>Lee</surname><given-names>S.-D.</given-names></name></person-group><article-title>Multiple effects of honokiol on the life cycle of hepatitis C virus</article-title><source>Liver Int.</source><year>2012</year><volume>32</volume><fpage>989</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1111/j.1478-3231.2011.02621.x</pub-id><pub-id pub-id-type="pmid">22098176</pub-id></element-citation></ref><ref id="B207-biomolecules-11-00011"><label>207.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>C.-Y.</given-names></name><name><surname>Chen</surname><given-names>S.-J.</given-names></name><name><surname>Wu</surname><given-names>H.-N.</given-names></name><name><surname>Ping</surname><given-names>Y.-H.</given-names></name><name><surname>Lin</surname><given-names>C.-Y.</given-names></name><name><surname>Shiuan</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>C.-L.</given-names></name><name><surname>Lee</surname><given-names>Y.-R.</given-names></name><name><surname>Huang</surname><given-names>K.-J.</given-names></name></person-group><article-title>Honokiol, a lignan Biphenol derived from the Magnolia tree, inhibits Dengue virus type 2 infection</article-title><source>Viruses</source><year>2015</year><volume>7</volume><fpage>4894</fpage><lpage>4910</lpage><pub-id pub-id-type="doi">10.3390/v7092852</pub-id><pub-id pub-id-type="pmid">26378567</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="biomolecules-11-00011-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Chemical structure of heteroside phenolic compounds.</p></caption><graphic xlink:href="biomolecules-11-00011-g001"/></fig><fig id="biomolecules-11-00011-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Chemical structure of flavonoids, phenylpropanoids and derivatives.</p></caption><graphic xlink:href="biomolecules-11-00011-g002"/></fig><fig id="biomolecules-11-00011-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Other types of phenolic compounds.</p></caption><graphic xlink:href="biomolecules-11-00011-g003"/></fig><fig id="biomolecules-11-00011-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Main antiviral mechanisms of phenolic compounds against dengue virus.</p></caption><graphic xlink:href="biomolecules-11-00011-g004"/></fig><table-wrap id="biomolecules-11-00011-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">biomolecules-11-00011-t001_Table 1</object-id><label>Table 1</label><caption><p>Phenolic compounds with activity against dengue virus.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound and Structure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IUPAC Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Experimental Model Used</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mechanism of Action</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Geraniin</bold>
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[(1R,7R,8S,26R,28S,29R,38R)- 1,13,14,15,18,19,20,34,35,39,39-undecahydroxy-2,5,10,23,31-pentaoxo-6,9,24,27,30,40 exaoxaoctacyclo[34.3.1.04,38.07,26.08,29.011,16.017,22.032,37]tetraconta-3,11,13,15,17,19,21,32,34,36-decaen-28-yl] 3,4,5-trihydroxybenzoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.91 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Possible effect on viral particle<break/>Effect on cellular proteins involved in viral replication cycle and cellular metabolisms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B44-biomolecules-11-00011" ref-type="bibr">44</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells<break/>Molecular docking</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.75 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dose-dependent virucidal effect<break/>Inhibition of adhesion of viral particle<break/>Possible inhibition of early steps of virus replication cycle<break/>Interference with cell receptor interaction by binding to the E-DIII protein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-biomolecules-11-00011" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BALB/c mice</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.78&#x02009;&#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Viremia reduction<break/>Prevention of liver damage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B47-biomolecules-11-00011" ref-type="bibr">47</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Chebulagic Acid</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-[(4R,5S,7R,25S,26R,29S,30S,31S)-13,14,15,18,19,20,31,35,36-nonahydroxy-2,10,23,28,32-pentaoxo-5-(3,4,5-trihydroxybenzoyl)oxy-3,6,9,24,27,33-hexaoxaheptacyclo[28.7.1.04,25.07,26.011,16.017,22.034,38]octatriaconta-1(37),11,13,15,17,19,21,34(38),35-nonaen-29-yl]acetic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HELA, VERO, A549 and HEp-2 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.11 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of viral particle adhesion and fusion to cell membrane steps<break/>Possible GAG-competitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-biomolecules-11-00011" ref-type="bibr">58</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Punicalagin</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(1R,35R,38R,55S)-6,7,8,11,12,23,24,27,28,29,37,43,44,45,48,49,50-heptadecahydroxy-2,14,21,33,36,39,54-heptaoxaundecacyclo[33.20.0.04,9.010,19.013,18.016,25.017,22.026,31.038,55.041,46.047,52]pentapentaconta-4,6,8,10,12,16,18,22,24,26,28,30,41,43,45,47,49,51-octadecaene-3,15,20,32,40,53-hexone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HELA, VERO, A549 and HEp-2 cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.86 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of viral particle adhesion and fusion to cell membrane steps<break/>Possible GAG-competitor</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B58-biomolecules-11-00011" ref-type="bibr">58</xref>]</td></tr><tr><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Quercetin</bold>
</td><td rowspan="7" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U937-DC-SIGN cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.5 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of TNF-<italic>&#x003b1;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-biomolecules-11-00011" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Molecular docking</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported<break/>Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In silico interaction with E, NS1, NS3 and NS5 proteins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-biomolecules-11-00011" ref-type="bibr">89</xref>,<xref rid="B90-biomolecules-11-00011" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19.2 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition in pre and posttreatment strategies but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-biomolecules-11-00011" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BHK-21 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">125 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Possible virucide effect</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B73-biomolecules-11-00011" ref-type="bibr">73</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Molecular docking and enzymatic reaction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.2 &#x000b5;M <sup>a</sup><break/>22.7 &#x000b5;M <sup>b</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Enzymatic inhibition of DENV-2 <sup>a</sup> and DENV-3 <sup>b</sup> NS2B-NS3 protease and in silico interaction with DENV-3 protease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B91-biomolecules-11-00011" ref-type="bibr">91</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In silico</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protease binding</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B92-biomolecules-11-00011" ref-type="bibr">92</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In silico; BHK-21 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Protease binding; inhibition adsorption of viral particles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B88-biomolecules-11-00011" ref-type="bibr">88</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Fisetin</bold>
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromen-4-one</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">U937-DC-SIGN cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.3 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Downregulation of TNF-<italic>&#x003b1;</italic></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B85-biomolecules-11-00011" ref-type="bibr">85</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Molecular docking</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported<break/>Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In silico interaction with E, NS1, NS2B-NS3 and NS5 proteins</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B89-biomolecules-11-00011" ref-type="bibr">89</xref>,<xref rid="B90-biomolecules-11-00011" ref-type="bibr">90</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.12 &#x000b5;g/mL <sup>c</sup><break/>55 &#x000b5;g/mL <sup>d</sup><break/>50 &#x000b5;g/mL <sup>e</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition in pre <sup>c</sup> and posttreatment <sup>d</sup> strategies, and genome inhibition <sup>e</sup> but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B95-biomolecules-11-00011" ref-type="bibr">95</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Naringin</bold>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">((2S)-7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47.9 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition in posttreatment strategy but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-biomolecules-11-00011" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">168.2 &#x003bc;g mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anti-adsorption activity with reduction in RNA production</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B96-biomolecules-11-00011" ref-type="bibr">96</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Catechin</bold>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-ddihydro-2H-chromene-3,5,7-triol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.7 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition in pre and posttreatment strategies but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B87-biomolecules-11-00011" ref-type="bibr">87</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-biomolecules-11-00011" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Delphinidin</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-(3,4,5-trihydroxyphenyl)chromenylium-3,5,7-triol;chloride</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-biomolecules-11-00011" ref-type="bibr">97</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>EGCG</bold>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.0 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition in pretreatment strategy but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B97-biomolecules-11-00011" ref-type="bibr">97</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Directed to viral particle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B98-biomolecules-11-00011" ref-type="bibr">98</xref>]</td></tr><tr><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Resveratrol</bold>
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">5-[(E)-2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HEK293T/17 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24.37 &#x003bc;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dose-dependent inhibition in stages after viral entry but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B109-biomolecules-11-00011" ref-type="bibr">109</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huh7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Induction of HMGB1 protein accumulation<break/>Induction of interferon stimulated genes (ISG)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-biomolecules-11-00011" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huh7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.12 nM <sup>f</sup><break/>7.22 nM <sup>g</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of viral genome not affecting the viral polymerase (resveratrol analogs PNR-4-44 <sup>f</sup> and PNR-5-02 <sup>g</sup>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B112-biomolecules-11-00011" ref-type="bibr">112</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Nordihydroguaiaretic acid</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Huh-7, U937 and VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Reduction in the amount of lipid droplets; Reduction in the production of NS1; Prevention of the correct assembly of the DENV viral particle</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-biomolecules-11-00011" ref-type="bibr">123</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>Curcumin</bold>
</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">(1E,6E)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BHK-21 or VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.51 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intracellular accumulation of viral proteins and ubiquitin-conjugated proteins but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B141-biomolecules-11-00011" ref-type="bibr">141</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Could affect cell-membrane and viral envelope structure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B142-biomolecules-11-00011" ref-type="bibr">142</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Salidroside</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[2-(4-hydroxyphenyl)ethoxy]oxane-3,4,5-triol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">hPBMC, VERO and THP-1 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Activation of type 1 interferons via IRF-3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B155-biomolecules-11-00011" ref-type="bibr">155</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Verbascoside</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">([(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO and LLCMK2 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.4 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B165-biomolecules-11-00011" ref-type="bibr">165</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Caffeoylcalleryanin</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[3-hydroxy-4-[[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO and LLCMK2 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.8 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B165-biomolecules-11-00011" ref-type="bibr">165</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Sodium salicylate</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Sodium 2-hydroxybenzoate</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BHK-21 and N18 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Unreported</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dose-dependent inhibition posttreatment but mechanism not completely elucidated</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B173-biomolecules-11-00011" ref-type="bibr">173</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Cardol triene</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5-[(8Z,11Z)-pentadeca-8,11,14-trienyl]benzene-1,3-diol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.13 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of cell membrane fusion with the viral envelope protein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B179-biomolecules-11-00011" ref-type="bibr">179</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Policresulen</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-hydroxy-3,5-bis[(4-hydroxy-2-methyl-5-sulfophenyl)methyl]-4-methylbenzenesulfonic acid</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BHK-21 cells transfected with Rlu-DENV-Rep</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.99 &#x003bc;g/mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of DENV2 NS2B/NS3 protease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B185-biomolecules-11-00011" ref-type="bibr">185</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>GW5074</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">(3Z)-3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VERO cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.4 &#x000b5;M <sup>h</sup><break/>0.5 &#x000b5;M <sup>i</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibition of NS5&#x02013;IMP&#x003b1;/&#x003b2;1 interaction in vitro <sup>h</sup> as well as NS5 nuclear localization in infected cells; posttreatment activity <sup>i</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B194-biomolecules-11-00011" ref-type="bibr">194</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Honokiol</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BHK and Huh7 cells</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10.6 &#x000b5;M</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibit early steps of DENV infection, suppressing the upregulation of early endosomes<break/>Reduce viral protein expression (NS1 and NS3) and double-stranded RNA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B207-biomolecules-11-00011" ref-type="bibr">207</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Enzymatic inhibition of DENV-2, <sup>b</sup> DENV-3, <sup>c</sup> Inhibition in pre, <sup>d</sup> posttreatment, <sup>e</sup> genome inhibition, <sup>f</sup> resveratrol analogs PNR-4-44, <sup>g</sup> PNR-5-02, <sup>h</sup> Inhibition of NS5&#x02013;IMP&#x003b1;/&#x003b2;1 interaction in vitro, <sup>i</sup> NS5 nuclear localization in infected cells; posttreatment activity.</p></fn></table-wrap-foot></table-wrap></floats-group></article>